<https://w3id.org/SKGO/phm> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Ontology> .
<https://w3id.org/SKGO/phm> <http://www.w3.org/2002/07/owl#imports> <http://ns.nature.com/terms/> .
<https://w3id.org/SKGO/phm> <http://www.w3.org/2002/07/owl#imports> <http://purl.org/ontology/bibo/> .
<https://w3id.org/SKGO/phm> <http://www.w3.org/2002/07/owl#imports> <http://xmlns.com/foaf/0.1/> .
<https://w3id.org/SKGO/phm> <http://purl.org/dc/elements/1.1/creator> "Zeynep Say, Aysegul Say, Sahar Vahdati, Said Fathalla" .
<https://w3id.org/SKGO/phm> <http://purl.org/dc/terms/license> "Creative Commons Attribution 3.0 (CC BY 3.0)" .
<https://w3id.org/SKGO/phm> <http://www.w3.org/2002/07/owl#versionInfo> "2.0" .
<https://w3id.org/SKGO/phm> <http://www.w3.org/2004/02/skos/core#definition> "PharmSci is an Ontology for describing Pharmaceutical Science research.\nThe aim of building ontology is to help Pharmaceutical Science researchers to find scientific research close to their work or their research topic. Ontology covers the study design for the pharmaceutical science research which is a Clinical Study includes experimental and non-experimental studies." .
# 
# 
# #################################################################
# #
# #    Annotation properties
# #
# #################################################################
# 
# 
# http://purl.org/dc/elements/1.1/contributor
<http://purl.org/dc/elements/1.1/contributor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/coverage
<http://purl.org/dc/elements/1.1/coverage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/creator
<http://purl.org/dc/elements/1.1/creator> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/format
<http://purl.org/dc/elements/1.1/format> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/identifier
<http://purl.org/dc/elements/1.1/identifier> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/language
<http://purl.org/dc/elements/1.1/language> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/publisher
<http://purl.org/dc/elements/1.1/publisher> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/relation
<http://purl.org/dc/elements/1.1/relation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/rights
<http://purl.org/dc/elements/1.1/rights> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/source
<http://purl.org/dc/elements/1.1/source> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/subject
<http://purl.org/dc/elements/1.1/subject> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/elements/1.1/type
<http://purl.org/dc/elements/1.1/type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
# 
# http://purl.org/dc/terms/abstract
<http://purl.org/dc/terms/abstract> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/abstract> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/description> .
# 
# http://purl.org/dc/terms/accessRights
<http://purl.org/dc/terms/accessRights> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/accessRights> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/rights> .
<http://purl.org/dc/terms/accessRights> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/RightsStatement> .
# 
# http://purl.org/dc/terms/alternative
<http://purl.org/dc/terms/alternative> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/alternative> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/title> .
<http://purl.org/dc/terms/alternative> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/available
<http://purl.org/dc/terms/available> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/available> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/available> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/bibliographicCitation
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/identifier> .
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/dc/terms/BibliographicResource> .
# 
# http://purl.org/dc/terms/conformsTo
<http://purl.org/dc/terms/conformsTo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/conformsTo> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
<http://purl.org/dc/terms/conformsTo> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/Standard> .
# 
# http://purl.org/dc/terms/contributor
<http://purl.org/dc/terms/contributor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/contributor> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/contributor> .
<http://purl.org/dc/terms/contributor> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/Agent> .
# 
# http://purl.org/dc/terms/coverage
<http://purl.org/dc/terms/coverage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/coverage> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/coverage> .
<http://purl.org/dc/terms/coverage> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/LocationPeriodOrJurisdiction> .
# 
# http://purl.org/dc/terms/created
<http://purl.org/dc/terms/created> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/created> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/created> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/creator
<http://purl.org/dc/terms/creator> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/creator> .
<http://purl.org/dc/terms/creator> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/Agent> .
<http://purl.org/dc/terms/creator> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/10/swap/pim/contact#Person> .
# 
# http://purl.org/dc/terms/date
<http://purl.org/dc/terms/date> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/date> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/date> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/dateAccepted
<http://purl.org/dc/terms/dateAccepted> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/dateAccepted> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/dateAccepted> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/dateCopyrighted
<http://purl.org/dc/terms/dateCopyrighted> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/dateCopyrighted> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/dateCopyrighted> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/dateSubmitted
<http://purl.org/dc/terms/dateSubmitted> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/dateSubmitted> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/dateSubmitted> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/description
<http://purl.org/dc/terms/description> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/description> .
<http://purl.org/dc/terms/description> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> .
<http://purl.org/dc/terms/description> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/ScienceOnto/phm#ResearchStatement> .
# 
# http://purl.org/dc/terms/extent
<http://purl.org/dc/terms/extent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/extent> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/format> .
<http://purl.org/dc/terms/extent> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/SizeOrDuration> .
# 
# http://purl.org/dc/terms/format
<http://purl.org/dc/terms/format> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/format> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/format> .
<http://purl.org/dc/terms/format> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/MediaTypeOrExtent> .
# 
# http://purl.org/dc/terms/hasFormat
<http://purl.org/dc/terms/hasFormat> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/hasFormat> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/hasPart
<http://purl.org/dc/terms/hasPart> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/hasPart> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/hasVersion
<http://purl.org/dc/terms/hasVersion> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/hasVersion> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/identifier
<http://purl.org/dc/terms/identifier> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/identifier> .
<http://purl.org/dc/terms/identifier> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/isFormatOf
<http://purl.org/dc/terms/isFormatOf> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/isFormatOf> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/isPartOf
<http://purl.org/dc/terms/isPartOf> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/isPartOf> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/isReferencedBy
<http://purl.org/dc/terms/isReferencedBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/isReferencedBy> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/isReplacedBy
<http://purl.org/dc/terms/isReplacedBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/isReplacedBy> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/isRequiredBy
<http://purl.org/dc/terms/isRequiredBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/isRequiredBy> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/isVersionOf
<http://purl.org/dc/terms/isVersionOf> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/isVersionOf> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/issued
<http://purl.org/dc/terms/issued> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/issued> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/issued> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/language
<http://purl.org/dc/terms/language> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/language> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/language> .
<http://purl.org/dc/terms/language> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/LinguisticSystem> .
# 
# http://purl.org/dc/terms/license
<http://purl.org/dc/terms/license> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/license> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/rights> .
<http://purl.org/dc/terms/license> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/LicenseDocument> .
# 
# http://purl.org/dc/terms/medium
<http://purl.org/dc/terms/medium> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/medium> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/format> .
<http://purl.org/dc/terms/medium> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/PhysicalMedium> .
# 
# http://purl.org/dc/terms/modified
<http://purl.org/dc/terms/modified> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/modified> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/modified> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/publisher
<http://purl.org/dc/terms/publisher> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/publisher> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/publisher> .
<http://purl.org/dc/terms/publisher> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/Agent> .
# 
# http://purl.org/dc/terms/references
<http://purl.org/dc/terms/references> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/references> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/relation
<http://purl.org/dc/terms/relation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/relation> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/replaces
<http://purl.org/dc/terms/replaces> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/replaces> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/requires
<http://purl.org/dc/terms/requires> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/requires> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/relation> .
# 
# http://purl.org/dc/terms/rights
<http://purl.org/dc/terms/rights> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/rights> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/rights> .
<http://purl.org/dc/terms/rights> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/RightsStatement> .
# 
# http://purl.org/dc/terms/source
<http://purl.org/dc/terms/source> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/source> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/source> .
# 
# http://purl.org/dc/terms/spatial
<http://purl.org/dc/terms/spatial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/spatial> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/coverage> .
<http://purl.org/dc/terms/spatial> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/Location> .
# 
# http://purl.org/dc/terms/subject
<http://purl.org/dc/terms/subject> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/subject> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/subject> .
# 
# http://purl.org/dc/terms/tableOfContents
<http://purl.org/dc/terms/tableOfContents> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/tableOfContents> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/description> .
# 
# http://purl.org/dc/terms/temporal
<http://purl.org/dc/terms/temporal> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/temporal> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/coverage> .
<http://purl.org/dc/terms/temporal> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/dc/terms/PeriodOfTime> .
# 
# http://purl.org/dc/terms/title
<http://purl.org/dc/terms/title> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/title> .
<http://purl.org/dc/terms/title> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# http://purl.org/dc/terms/type
<http://purl.org/dc/terms/type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/type> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/type> .
<http://purl.org/dc/terms/type> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Class> .
# 
# http://purl.org/dc/terms/valid
<http://purl.org/dc/terms/valid> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AnnotationProperty> .
<http://purl.org/dc/terms/valid> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/elements/1.1/date> .
<http://purl.org/dc/terms/valid> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# 
# 
# #################################################################
# #
# #    Datatypes
# #
# #################################################################
# 
# 
# http://purl.org/dc/terms/Box
<http://purl.org/dc/terms/Box> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/ISO3166
<http://purl.org/dc/terms/ISO3166> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/ISO639-2
<http://purl.org/dc/terms/ISO639-2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/ISO639-3
<http://purl.org/dc/terms/ISO639-3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/Period
<http://purl.org/dc/terms/Period> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/Point
<http://purl.org/dc/terms/Point> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/RFC1766
<http://purl.org/dc/terms/RFC1766> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/RFC3066
<http://purl.org/dc/terms/RFC3066> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/RFC4646
<http://purl.org/dc/terms/RFC4646> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/RFC5646
<http://purl.org/dc/terms/RFC5646> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/URI
<http://purl.org/dc/terms/URI> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://purl.org/dc/terms/W3CDTF
<http://purl.org/dc/terms/W3CDTF> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://www.w3.org/2001/XMLSchema#date
<http://www.w3.org/2001/XMLSchema#date> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# http://www.w3.org/2001/XMLSchema#gYear
<http://www.w3.org/2001/XMLSchema#gYear> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Datatype> .
# 
# 
# 
# #################################################################
# #
# #    Object Properties
# #
# #################################################################
# 
# 
# http://ns.nature.com/terms/relation
<http://ns.nature.com/terms/relation> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
# 
# http://purl.org/dc/terms/alternative
<http://purl.org/dc/terms/alternative> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<http://purl.org/dc/terms/alternative> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/title> .
# 
# http://purl.org/dc/terms/coverage
<http://purl.org/dc/terms/coverage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
# 
# http://purl.org/dc/terms/creator
<http://purl.org/dc/terms/creator> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<http://purl.org/dc/terms/creator> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/contributor> .
<http://purl.org/dc/terms/creator> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/ontology/bibo/Article> .
# 
# http://purl.org/dc/terms/hasPart
<http://purl.org/dc/terms/hasPart> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/relation> .
# 
# http://purl.org/dc/terms/isPartOf
<http://purl.org/dc/terms/isPartOf> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/relation> .
# 
# http://purl.org/dc/terms/isReferencedBy
<http://purl.org/dc/terms/isReferencedBy> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/relation> .
# 
# http://purl.org/dc/terms/isVersionOf
<http://purl.org/dc/terms/isVersionOf> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/relation> .
# 
# http://purl.org/dc/terms/publisher
<http://purl.org/dc/terms/publisher> <http://www.w3.org/2000/01/rdf-schema#domain> <http://ns.nature.com/terms/Publication> .
# 
# http://purl.org/dc/terms/references
<http://purl.org/dc/terms/references> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/relation> .
# 
# http://purl.org/dc/terms/title
<http://purl.org/dc/terms/title> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid1 .
_:genid1 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid1 <http://www.w3.org/2002/07/owl#unionOf> _:genid3 .
_:genid3 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid3 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <http://ns.nature.com/terms/Publication> .
_:genid3 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid2 .
_:genid2 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid2 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <http://purl.org/ontology/bibo/Article> .
_:genid2 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
# 
# http://purl.org/dc/terms/type
<http://purl.org/dc/terms/type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
# 
# https://w3id.org/SKGO/phm#addressesStudy
<https://w3id.org/SKGO/phm#addressesStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#addressesStudy> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#addressesStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#addressesStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#addressesStudy> <http://www.w3.org/2000/01/rdf-schema#domain> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#addressesStudy> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#addressesStudy> <http://purl.org/dc/elements/1.1/description> "To give attention to or deal with a research or study."@en .
<https://w3id.org/SKGO/phm#addressesStudy> <http://www.w3.org/2000/01/rdf-schema#label> "addressesStudy"@en .
<https://w3id.org/SKGO/phm#addressesStudy> <http://www.w3.org/2004/02/skos/core#definition> "To give attention to or deal with a research or study."@en .
# 
# https://w3id.org/SKGO/phm#examinedBy
<https://w3id.org/SKGO/phm#examinedBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#examinedBy> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#examinedBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#examinedBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ReflexiveProperty> .
<https://w3id.org/SKGO/phm#examinedBy> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid4 .
_:genid4 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid4 <http://www.w3.org/2002/07/owl#unionOf> _:genid6 .
_:genid6 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid6 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Hypothesis> .
_:genid6 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid5 .
_:genid5 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid5 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
_:genid5 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#examinedBy> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#examinedBy> <http://purl.org/dc/elements/1.1/description> "To look at or consider a statement carefully and in detail in order to explore and discover."@en .
<https://w3id.org/SKGO/phm#examinedBy> <http://www.w3.org/2000/01/rdf-schema#label> "examinedBy"@en .
<https://w3id.org/SKGO/phm#examinedBy> <http://www.w3.org/2004/02/skos/core#definition> "To look at or consider a statement carefully and in detail in order to explore and discover."@en .
# 
# https://w3id.org/SKGO/phm#hasBlotAnalysis
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#BlotAnalysis> .
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://purl.org/dc/elements/1.1/description> "Experiment uses as a method for the transfer of protein, RNA or DNA molecules."@en .
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://www.w3.org/2000/01/rdf-schema#label> "useBlotAnalysis"@en .
<https://w3id.org/SKGO/phm#hasBlotAnalysis> <http://www.w3.org/2004/02/skos/core#definition> "Experiment uses as a method for the transfer of protein, RNA or DNA molecules."@en .
# 
# https://w3id.org/SKGO/phm#hasClinicalProblem
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://purl.org/dc/elements/1.1/description> "Problem or a difficulty, disorder, condition occurs in Clinical Study."@en .
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://www.w3.org/2000/01/rdf-schema#label> "hasClinicalProblem"@en .
<https://w3id.org/SKGO/phm#hasClinicalProblem> <http://www.w3.org/2004/02/skos/core#definition> "Problem or a difficulty, disorder, condition occurs in Clinical Study."@en .
# 
# https://w3id.org/SKGO/phm#hasDisease
<https://w3id.org/SKGO/phm#hasDisease> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasDisease> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasDisease> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasDisease> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasDisease> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Patient> .
<https://w3id.org/SKGO/phm#hasDisease> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#hasDisease> <http://purl.org/dc/elements/1.1/description> "Person who shows a definite pathological process having a characteristic set of signs and symptoms."@en .
<https://w3id.org/SKGO/phm#hasDisease> <http://www.w3.org/2000/01/rdf-schema#label> "hasDisease"@en .
<https://w3id.org/SKGO/phm#hasDisease> <http://www.w3.org/2004/02/skos/core#definition> "Person who shows a definite pathological process having a characteristic set of signs and symptoms."@en .
# 
# https://w3id.org/SKGO/phm#hasExperiment
<https://w3id.org/SKGO/phm#hasExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperiment> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasExperiment> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#hasExperiment> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#hasExperiment> <http://purl.org/dc/elements/1.1/description> "Study has a procedure done in order to discover or demonstrate some fact or general truth"@en .
<https://w3id.org/SKGO/phm#hasExperiment> <http://www.w3.org/2000/01/rdf-schema#label> "hasExperiment"@en .
<https://w3id.org/SKGO/phm#hasExperiment> <http://www.w3.org/2004/02/skos/core#definition> "Study has a procedure done in order to discover or demonstrate some fact or general truth"@en .
# 
# https://w3id.org/SKGO/phm#hasExperimentKit
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#ExperimentKit> .
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://purl.org/dc/elements/1.1/description> "Identification of the kit/biologicals used in the experiment."@en .
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://www.w3.org/2000/01/rdf-schema#label> "hasExperimentKit"@en .
<https://w3id.org/SKGO/phm#hasExperimentKit> <http://www.w3.org/2004/02/skos/core#definition> "Identification of the kit/biologicals used in the experiment."@en .
# 
# https://w3id.org/SKGO/phm#hasExperimentMaterial
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://purl.org/dc/elements/1.1/description> "Experiment has materials are culture collections and chemicals used for executing of an experiment."@en .
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://www.w3.org/2000/01/rdf-schema#label> "hasExperimentMaterial"@en .
<https://w3id.org/SKGO/phm#hasExperimentMaterial> <http://www.w3.org/2004/02/skos/core#definition> "Experiment has materials are culture collections and chemicals used for executing of an experiment."@en .
# 
# https://w3id.org/SKGO/phm#hasExperimentMethod
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> .
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://purl.org/dc/elements/1.1/description> "An experiment has method is a way to solve a scientific task by executing a scientific experiment."@en .
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://www.w3.org/2000/01/rdf-schema#label> "hasExperimentMethod"@en .
<https://w3id.org/SKGO/phm#hasExperimentMethod> <http://www.w3.org/2004/02/skos/core#definition> "An experiment has method is a way to solve a scientific task by executing a scientific experiment."@en .
# 
# https://w3id.org/SKGO/phm#hasExperimentalSetting
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#ExperimentSetting> .
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://purl.org/dc/elements/1.1/description> "Experiment identifies the designed experiment involves the investigator assigning some or all conditions to subjects."@en .
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://www.w3.org/2000/01/rdf-schema#label> "hasExperimentSetting"@en .
<https://w3id.org/SKGO/phm#hasExperimentalSetting> <http://www.w3.org/2004/02/skos/core#definition> "Experiment identifies the designed experiment involves the investigator assigning some or all conditions to subjects."@en .
# 
# https://w3id.org/SKGO/phm#hasHypothesis
<https://w3id.org/SKGO/phm#hasHypothesis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasHypothesis> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasHypothesis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasHypothesis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasHypothesis> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#hasHypothesis> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#hasHypothesis> <http://purl.org/dc/elements/1.1/description> "Referencing a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment."@en .
<https://w3id.org/SKGO/phm#hasHypothesis> <http://www.w3.org/2000/01/rdf-schema#label> "hasResearchStatement"@en .
<https://w3id.org/SKGO/phm#hasHypothesis> <http://www.w3.org/2004/02/skos/core#definition> "Referencing a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment."@en .
# 
# https://w3id.org/SKGO/phm#hasInvestigation
<https://w3id.org/SKGO/phm#hasInvestigation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasInvestigation> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasInvestigation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasInvestigation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasInvestigation> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#hasInvestigation> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Investigation> .
<https://w3id.org/SKGO/phm#hasInvestigation> <http://purl.org/dc/elements/1.1/description> "Study which acts or processes of examining."@en .
<https://w3id.org/SKGO/phm#hasInvestigation> <http://www.w3.org/2000/01/rdf-schema#label> "hasInvestigation"@en .
<https://w3id.org/SKGO/phm#hasInvestigation> <http://www.w3.org/2004/02/skos/core#definition> "Study which acts or processes of examining."@en .
# 
# https://w3id.org/SKGO/phm#hasProtein
<https://w3id.org/SKGO/phm#hasProtein> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasProtein> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasProtein> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasProtein> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasProtein> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Cell> .
<https://w3id.org/SKGO/phm#hasProtein> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#hasProtein> <http://purl.org/dc/elements/1.1/description> "Referencing any of a group of complex organic macromolecules ."@en .
<https://w3id.org/SKGO/phm#hasProtein> <http://www.w3.org/2000/01/rdf-schema#label> "hasProtein"@en .
<https://w3id.org/SKGO/phm#hasProtein> <http://www.w3.org/2004/02/skos/core#definition> "Referencing any of a group of complex organic macromolecules ."@en .
# 
# https://w3id.org/SKGO/phm#hasStudyDesign
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#StudyDesign> .
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://purl.org/dc/elements/1.1/description> "Clinical Study defines the study design for the trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings."@en .
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://www.w3.org/2000/01/rdf-schema#label> "hasStudyDesign"@en .
<https://w3id.org/SKGO/phm#hasStudyDesign> <http://www.w3.org/2004/02/skos/core#definition> "Clinical Study defines the study design for the trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings."@en .
# 
# https://w3id.org/SKGO/phm#hasTreatment
<https://w3id.org/SKGO/phm#hasTreatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#hasTreatment> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#hasTreatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#hasTreatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#hasTreatment> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid7 .
_:genid7 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid7 <http://www.w3.org/2002/07/owl#unionOf> _:genid9 .
_:genid9 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid9 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> .
_:genid9 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid8 .
_:genid8 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid8 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
_:genid8 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#hasTreatment> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#hasTreatment> <http://purl.org/dc/elements/1.1/description> "Defining a period in a clinical study during which subjects receive therapeutic treatment."@en .
<https://w3id.org/SKGO/phm#hasTreatment> <http://www.w3.org/2000/01/rdf-schema#label> "useTreatment"@en .
<https://w3id.org/SKGO/phm#hasTreatment> <http://www.w3.org/2004/02/skos/core#definition> "Defining a period in a clinical study during which subjects receive therapeutic treatment."@en .
# 
# https://w3id.org/SKGO/phm#has_Treatment
<https://w3id.org/SKGO/phm#has_Treatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#has_Treatment> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#has_Treatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#has_Treatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#has_Treatment> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#has_Treatment> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#has_Treatment> <http://purl.org/dc/elements/1.1/description> "Disease that has a therapeutic treatment."@en .
<https://w3id.org/SKGO/phm#has_Treatment> <http://www.w3.org/2000/01/rdf-schema#label> "hasTreatment"@en .
<https://w3id.org/SKGO/phm#has_Treatment> <http://www.w3.org/2004/02/skos/core#definition> "Disease that has a therapeutic treatment."@en .
# 
# https://w3id.org/SKGO/phm#investigate
<https://w3id.org/SKGO/phm#investigate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#investigate> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#investigate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#investigate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ReflexiveProperty> .
<https://w3id.org/SKGO/phm#investigate> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#investigate> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#investigate> <http://purl.org/dc/elements/1.1/description> "To observe or inquire into in detail; examine systematically."@en .
<https://w3id.org/SKGO/phm#investigate> <http://www.w3.org/2000/01/rdf-schema#label> "investigate"@en .
<https://w3id.org/SKGO/phm#investigate> <http://www.w3.org/2004/02/skos/core#definition> "To observe or inquire into in detail; examine systematically."@en .
# 
# https://w3id.org/SKGO/phm#investigatesProblem
<https://w3id.org/SKGO/phm#investigatesProblem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#investigatesProblem> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#investigatesProblem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#investigatesProblem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#investigatesProblem> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#investigatesProblem> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#investigatesProblem> <http://purl.org/dc/elements/1.1/description> "To examine an issue, problem, statement of research or study."@en .
<https://w3id.org/SKGO/phm#investigatesProblem> <http://www.w3.org/2000/01/rdf-schema#label> "investigatesProblem"@en .
<https://w3id.org/SKGO/phm#investigatesProblem> <http://www.w3.org/2004/02/skos/core#definition> "To examine an issue, problem, statement of research or study."@en .
# 
# https://w3id.org/SKGO/phm#isClinicalTrial
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#SymmetricProperty> .
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ReflexiveProperty> .
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Patient> .
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#ClinicalTrial> .
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://purl.org/dc/elements/1.1/description> "Patients are chosen as Clinical Trial for Clinical Study."@en .
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://www.w3.org/2000/01/rdf-schema#label> "isClinicalTrial"@en .
<https://w3id.org/SKGO/phm#isClinicalTrial> <http://www.w3.org/2004/02/skos/core#definition> "Patients are chosen as Clinical Trial for Clinical Study."@en .
# 
# https://w3id.org/SKGO/phm#obtainedfrom
<https://w3id.org/SKGO/phm#obtainedfrom> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#obtainedfrom> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#obtainedfrom> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#obtainedfrom> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid10 .
_:genid10 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid10 <http://www.w3.org/2002/07/owl#unionOf> _:genid12 .
_:genid12 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid12 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ExperimentKit> .
_:genid12 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid11 .
_:genid11 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid11 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
_:genid11 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#obtainedfrom> <http://www.w3.org/2000/01/rdf-schema#range> <http://xmlns.com/foaf/0.1/Organization> .
<https://w3id.org/SKGO/phm#obtainedfrom> <http://purl.org/dc/elements/1.1/description> "Get, acquire, or secure something."@en .
<https://w3id.org/SKGO/phm#obtainedfrom> <http://www.w3.org/2000/01/rdf-schema#label> "obtainedfrom"@en .
<https://w3id.org/SKGO/phm#obtainedfrom> <http://www.w3.org/2004/02/skos/core#definition> "Get, acquire, or secure something."@en .
# 
# https://w3id.org/SKGO/phm#obtainedfromPatient
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Patient> .
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://purl.org/dc/elements/1.1/description> "Get, acquire, or secure specimen from patient."@en .
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://www.w3.org/2000/01/rdf-schema#label> "obtainedfromPatient"@en .
<https://w3id.org/SKGO/phm#obtainedfromPatient> <http://www.w3.org/2004/02/skos/core#definition> "Get, acquire, or secure specimen from patient."@en .
# 
# https://w3id.org/SKGO/phm#performsExperiment
<https://w3id.org/SKGO/phm#performsExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#performsExperiment> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#performsExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#performsExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#performsExperiment> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#performsExperiment> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#performsExperiment> <http://purl.org/dc/elements/1.1/description> "Clinical Study performs particular Experiment."@en .
<https://w3id.org/SKGO/phm#performsExperiment> <http://www.w3.org/2000/01/rdf-schema#label> "performsExperiment"@en .
<https://w3id.org/SKGO/phm#performsExperiment> <http://www.w3.org/2004/02/skos/core#definition> "Clinical Study performs particular Experiment."@en .
# 
# https://w3id.org/SKGO/phm#refersExperiment
<https://w3id.org/SKGO/phm#refersExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#refersExperiment> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#refersExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#refersExperiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#refersExperiment> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Investigation> .
<https://w3id.org/SKGO/phm#refersExperiment> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#refersExperiment> <http://purl.org/dc/elements/1.1/description> "To relate investigation to a particular Experiment."@en .
<https://w3id.org/SKGO/phm#refersExperiment> <http://www.w3.org/2000/01/rdf-schema#label> "refersExperiment"@en .
<https://w3id.org/SKGO/phm#refersExperiment> <http://www.w3.org/2004/02/skos/core#definition> "To relate investigation to a particular Experiment."@en .
# 
# https://w3id.org/SKGO/phm#resistantTo
<https://w3id.org/SKGO/phm#resistantTo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#resistantTo> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#resistantTo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#resistantTo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#resistantTo> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Cell> .
<https://w3id.org/SKGO/phm#resistantTo> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#resistantTo> <http://purl.org/dc/elements/1.1/description> "Cell definitions resistant to drugs."@en .
<https://w3id.org/SKGO/phm#resistantTo> <http://www.w3.org/2000/01/rdf-schema#label> "resistantTo"@en .
<https://w3id.org/SKGO/phm#resistantTo> <http://www.w3.org/2004/02/skos/core#definition> "Cell definitions resistant to drugs."@en .
# 
# https://w3id.org/SKGO/phm#testOn
<https://w3id.org/SKGO/phm#testOn> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#testOn> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#testOn> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#testOn> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#testOn> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#testOn> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#ClinicalTrial> .
<https://w3id.org/SKGO/phm#testOn> <http://purl.org/dc/elements/1.1/description> "To prove; to try a substance; to determine the chemical nature of a substance on Patient."@en .
<https://w3id.org/SKGO/phm#testOn> <http://www.w3.org/2000/01/rdf-schema#label> "testOn"@en .
<https://w3id.org/SKGO/phm#testOn> <http://www.w3.org/2004/02/skos/core#definition> "To prove; to try a substance; to determine the chemical nature of a substance on Patient."@en .
# 
# https://w3id.org/SKGO/phm#useAssay
<https://w3id.org/SKGO/phm#useAssay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#useAssay> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#useAssay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#useAssay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#useAssay> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#useAssay> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#useAssay> <http://purl.org/dc/elements/1.1/description> "Method referencing a assay to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system."@en .
<https://w3id.org/SKGO/phm#useAssay> <http://www.w3.org/2000/01/rdf-schema#label> "useAssay"@en .
<https://w3id.org/SKGO/phm#useAssay> <http://www.w3.org/2004/02/skos/core#definition> "Method referencing a assay to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system."@en .
# 
# https://w3id.org/SKGO/phm#useCellLine
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid13 .
_:genid13 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid13 <http://www.w3.org/2002/07/owl#unionOf> _:genid15 .
_:genid15 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid15 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
_:genid15 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid14 .
_:genid14 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid14 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
_:genid14 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#CellLine> .
# 
# https://w3id.org/SKGO/phm#useDrug
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid16 .
_:genid16 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid16 <http://www.w3.org/2002/07/owl#unionOf> _:genid19 .
_:genid19 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid19 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
_:genid19 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid18 .
_:genid18 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid18 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
_:genid18 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid17 .
_:genid17 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid17 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Treatment> .
_:genid17 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Drug> .
# 
# https://w3id.org/SKGO/phm#useGene
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid20 .
_:genid20 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid20 <http://www.w3.org/2002/07/owl#unionOf> _:genid22 .
_:genid22 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid22 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
_:genid22 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid21 .
_:genid21 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid21 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
_:genid21 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Gene> .
# 
# https://w3id.org/SKGO/phm#useProbe
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid23 .
_:genid23 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid23 <http://www.w3.org/2002/07/owl#unionOf> _:genid25 .
_:genid25 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid25 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
_:genid25 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid24 .
_:genid24 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid24 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
_:genid24 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Probe> .
# 
# https://w3id.org/SKGO/phm#useReagent
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Reagent> .
# 
# https://w3id.org/SKGO/phm#useSpecimen
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid26 .
_:genid26 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid26 <http://www.w3.org/2002/07/owl#unionOf> _:genid28 .
_:genid28 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid28 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
_:genid28 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid27 .
_:genid27 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid27 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Treatment> .
_:genid27 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#Specimen> .
# 
# https://w3id.org/SKGO/phm#useStatisticalAnalysis
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> .
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topObjectProperty> .
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AsymmetricProperty> .
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#IrreflexiveProperty> .
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/2000/01/rdf-schema#range> <https://w3id.org/SKGO/phm#StatisticalAnalysis> .
# 
# 
# 
# #################################################################
# #
# #    Data properties
# #
# #################################################################
# 
# 
# http://ns.nature.com/terms/name
<http://ns.nature.com/terms/name> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid29 .
_:genid29 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid29 <http://www.w3.org/2002/07/owl#unionOf> _:genid33 .
_:genid33 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid33 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <http://ns.nature.com/terms/Contributor> .
_:genid33 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid32 .
_:genid32 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid32 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <http://ns.nature.com/terms/Publisher> .
_:genid32 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid31 .
_:genid31 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid31 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ClinicalStudy> .
_:genid31 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid30 .
_:genid30 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid30 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
_:genid30 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
# 
# http://purl.org/dc/terms/abstract
<http://purl.org/dc/terms/abstract> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<http://purl.org/dc/terms/abstract> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/description> .
# 
# http://purl.org/dc/terms/alternative
<http://purl.org/dc/terms/alternative> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
# 
# http://purl.org/dc/terms/bibliographicCitation
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://purl.org/dc/terms/identifier> .
# 
# http://purl.org/dc/terms/identifier
<http://purl.org/dc/terms/identifier> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
# 
# http://purl.org/dc/terms/title
<http://purl.org/dc/terms/title> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
# 
# http://purl.org/ontology/bibo/abstract
<http://purl.org/ontology/bibo/abstract> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid34 .
_:genid34 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid34 <http://www.w3.org/2002/07/owl#unionOf> _:genid36 .
_:genid36 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid36 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <http://purl.org/ontology/bibo/Article> .
_:genid36 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid35 .
_:genid35 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid35 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <http://www.w3.org/2000/01/rdf-schema#Resource> .
_:genid35 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<http://purl.org/ontology/bibo/abstract> <http://purl.org/dc/elements/1.1/description> "A summary of the resource."@en .
# 
# https://w3id.org/SKGO/phm#assayTitle
<https://w3id.org/SKGO/phm#assayTitle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#assayTitle> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#assayTitle> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#assayTitle> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#assayTitle> <http://purl.org/dc/elements/1.1/description> "Title of the assay."@en .
<https://w3id.org/SKGO/phm#assayTitle> <http://www.w3.org/2000/01/rdf-schema#label> "assayTitle"@en .
<https://w3id.org/SKGO/phm#assayTitle> <http://www.w3.org/2004/02/skos/core#definition> "Title of the assay." .
# 
# https://w3id.org/SKGO/phm#failureReason
<https://w3id.org/SKGO/phm#failureReason> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#failureReason> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#failureReason> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#failureReason> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> .
<https://w3id.org/SKGO/phm#failureReason> <http://purl.org/dc/elements/1.1/description> "The reasons or causes of a condition or  a fact of not achieving the desired end or ends."@en .
<https://w3id.org/SKGO/phm#failureReason> <http://www.w3.org/2000/01/rdf-schema#label> "failureReason"@en .
<https://w3id.org/SKGO/phm#failureReason> <http://www.w3.org/2004/02/skos/core#definition> "The reasons or causes of a condition or  a fact of not achieving the desired end or ends."@en .
# 
# https://w3id.org/SKGO/phm#hasAssayMethod
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#hasDrugEffects
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#hasEligibilityCriteria
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid37 .
_:genid37 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid37 <http://www.w3.org/2002/07/owl#unionOf> _:genid39 .
_:genid39 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid39 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ClinicalTrial> .
_:genid39 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid38 .
_:genid38 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid38 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Patient> .
_:genid38 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#hasEvidence
<https://w3id.org/SKGO/phm#hasEvidence> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasEvidence> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasEvidence> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#hasEvidence> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#hasEvidence> <http://purl.org/dc/elements/1.1/description> "Information, including verifiable facts and data that support a practice or belief."@en .
<https://w3id.org/SKGO/phm#hasEvidence> <http://www.w3.org/2000/01/rdf-schema#label> "hasEvidence"@en .
<https://w3id.org/SKGO/phm#hasEvidence> <http://www.w3.org/2004/02/skos/core#definition> "Information, including verifiable facts and data that support a practice or belief."@en .
# 
# https://w3id.org/SKGO/phm#hasExperimentalResult
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#hasFindings
<https://w3id.org/SKGO/phm#hasFindings> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasFindings> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasFindings> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#hasFindings> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#hasLimitations
<https://w3id.org/SKGO/phm#hasLimitations> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasLimitations> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasLimitations> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#hasLimitations> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#hasLimitations> <http://purl.org/dc/elements/1.1/description> "Conditions or restrictions of research study."@en .
<https://w3id.org/SKGO/phm#hasLimitations> <http://www.w3.org/2000/01/rdf-schema#label> "hasLimitations"@en .
<https://w3id.org/SKGO/phm#hasLimitations> <http://www.w3.org/2004/02/skos/core#definition> "Conditions or restrictions of research study."@en .
# 
# https://w3id.org/SKGO/phm#hasMutationResult
<https://w3id.org/SKGO/phm#hasMutationResult> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasMutationResult> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasMutationResult> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#hasMutationResult> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#hasOverexpressionGene
<https://w3id.org/SKGO/phm#hasOverexpressionGene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasOverexpressionGene> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasOverexpressionGene> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#hasOverexpressionGene> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#hasOverexpressionGene> <http://purl.org/dc/elements/1.1/description> "The Gene that has overexpression which leads to the abundant target protein expression subsequently."@en .
<https://w3id.org/SKGO/phm#hasOverexpressionGene> <http://www.w3.org/2000/01/rdf-schema#label> "hasOverexpressionGene"@en .
<https://w3id.org/SKGO/phm#hasOverexpressionGene> <http://www.w3.org/2004/02/skos/core#definition> "The Gene that has overexpression which leads to the abundant target protein expression subsequently."@en .
# 
# https://w3id.org/SKGO/phm#hasProblemSolution
<https://w3id.org/SKGO/phm#hasProblemSolution> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasProblemSolution> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasProblemSolution> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#hasProblemSolution> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#hasProblemSolution> <http://purl.org/dc/elements/1.1/description> "Problem has the answer  or the explanation for something."@en .
<https://w3id.org/SKGO/phm#hasProblemSolution> <http://www.w3.org/2000/01/rdf-schema#label> "hasProblemSolution"@en .
<https://w3id.org/SKGO/phm#hasProblemSolution> <http://www.w3.org/2004/02/skos/core#definition> "Problem has the answer  or the explanation for something."@en .
# 
# https://w3id.org/SKGO/phm#hasSuggestion
<https://w3id.org/SKGO/phm#hasSuggestion> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasSuggestion> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasSuggestion> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#hasSuggestion> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#hasTargetingMethod
<https://w3id.org/SKGO/phm#hasTargetingMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasTargetingMethod> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasTargetingMethod> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#hasTargetingMethod> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#hasTargetingMethod> <http://purl.org/dc/elements/1.1/description> "The process of having proteins contain certain signals such that the proteins are directed specifically towards certain cellular locations"@en .
<https://w3id.org/SKGO/phm#hasTargetingMethod> <http://www.w3.org/2000/01/rdf-schema#label> "hasTargetingMethod"@en .
<https://w3id.org/SKGO/phm#hasTargetingMethod> <http://www.w3.org/2004/02/skos/core#definition> "The process of having proteins contain certain signals such that the proteins are directed specifically towards certain cellular locations"@en .
# 
# https://w3id.org/SKGO/phm#hasTissueLocalization
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> .
# 
# https://w3id.org/SKGO/phm#hasTitle
<https://w3id.org/SKGO/phm#hasTitle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#hasTitle> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#hasTitle> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid40 .
_:genid40 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid40 <http://www.w3.org/2002/07/owl#unionOf> _:genid42 .
_:genid42 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid42 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ClinicalStudy> .
_:genid42 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid41 .
_:genid41 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid41 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
_:genid41 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#hasTitle> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#hasTitle> <http://purl.org/dc/elements/1.1/description> "A name that describes something."@en .
<https://w3id.org/SKGO/phm#hasTitle> <http://www.w3.org/2000/01/rdf-schema#label> "hasTitle"@en .
<https://w3id.org/SKGO/phm#hasTitle> <http://www.w3.org/2004/02/skos/core#definition> "A name that describes something."@en .
# 
# https://w3id.org/SKGO/phm#name
<https://w3id.org/SKGO/phm#name> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#name> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#name> <http://www.w3.org/2000/01/rdf-schema#domain> _:genid43 .
_:genid43 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
_:genid43 <http://www.w3.org/2002/07/owl#unionOf> _:genid46 .
_:genid46 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid46 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Disease> .
_:genid46 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid45 .
_:genid45 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid45 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Drug> .
_:genid45 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid44 .
_:genid44 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid44 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
_:genid44 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<https://w3id.org/SKGO/phm#name> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> .
<https://w3id.org/SKGO/phm#name> <http://purl.org/dc/elements/1.1/description> "A word or words by which an entity is designated and distinguished from others."@en .
<https://w3id.org/SKGO/phm#name> <http://www.w3.org/2004/02/skos/core#definition> "A word or words by which an entity is designated and distinguished from others."@en .
# 
# https://w3id.org/SKGO/phm#treatmentOutcome
<https://w3id.org/SKGO/phm#treatmentOutcome> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> .
<https://w3id.org/SKGO/phm#treatmentOutcome> <http://www.w3.org/2000/01/rdf-schema#subPropertyOf> <http://www.w3.org/2002/07/owl#topDataProperty> .
<https://w3id.org/SKGO/phm#treatmentOutcome> <http://www.w3.org/2000/01/rdf-schema#domain> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#treatmentOutcome> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#treatmentOutcome> <http://purl.org/dc/elements/1.1/description> "A final product or end result of treatment."@en .
<https://w3id.org/SKGO/phm#treatmentOutcome> <http://www.w3.org/2000/01/rdf-schema#label> "treatmentOutcome"@en .
<https://w3id.org/SKGO/phm#treatmentOutcome> <http://www.w3.org/2004/02/skos/core#definition> "A final product or end result of treatment."@en .
# 
# 
# 
# #################################################################
# #
# #    Classes
# #
# #################################################################
# 
# 
# http://ns.nature.com/terms/Publication
<http://ns.nature.com/terms/Publication> <http://purl.org/dc/elements/1.1/description> "The :Publication class groups together all individuals (or part of) created as the result of the publishing process. Note that we are not referring here to the physical artefacts, but just their abstract counterparts."@en .
# 
# http://ns.nature.com/terms/Publisher
<http://ns.nature.com/terms/Publisher> <http://purl.org/dc/elements/1.1/description> "The :Publisher class represents organizations involved in the publishing business."@en .
# 
# http://purl.org/dc/dcam/VocabularyEncodingScheme
<http://purl.org/dc/dcam/VocabularyEncodingScheme> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/dcmitype/Collection
<http://purl.org/dc/dcmitype/Collection> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/AgentClass
<http://purl.org/dc/terms/AgentClass> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<http://purl.org/dc/terms/AgentClass> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.w3.org/2000/01/rdf-schema#Class> .
# 
# http://purl.org/dc/terms/BibliographicResource
<http://purl.org/dc/terms/BibliographicResource> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/Frequency
<http://purl.org/dc/terms/Frequency> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/LicenseDocument
<http://purl.org/dc/terms/LicenseDocument> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<http://purl.org/dc/terms/LicenseDocument> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.org/dc/terms/RightsStatement> .
# 
# http://purl.org/dc/terms/LinguisticSystem
<http://purl.org/dc/terms/LinguisticSystem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/MethodOfAccrual
<http://purl.org/dc/terms/MethodOfAccrual> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/MethodOfInstruction
<http://purl.org/dc/terms/MethodOfInstruction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/PhysicalResource
<http://purl.org/dc/terms/PhysicalResource> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/Policy
<http://purl.org/dc/terms/Policy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/ProvenanceStatement
<http://purl.org/dc/terms/ProvenanceStatement> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/RightsStatement
<http://purl.org/dc/terms/RightsStatement> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://purl.org/dc/terms/Standard
<http://purl.org/dc/terms/Standard> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# http://www.w3.org/2000/10/swap/pim/contact#Person
<http://www.w3.org/2000/10/swap/pim/contact#Person> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment
<https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> <http://purl.org/dc/elements/1.1/description> "An experimental method is a way to solve a scientific task by executing a scientific experiment."@en .
<https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> <http://www.w3.org/2000/01/rdf-schema#label> "ExperimentMethod"@en .
<https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> <http://www.w3.org/2004/02/skos/core#definition> "An experimental method is a way to solve a scientific task by executing a scientific experiment."@en .
# 
# https://w3id.org/SKGO/phm#Assay
<https://w3id.org/SKGO/phm#Assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Assay> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Assay> <http://purl.org/dc/elements/1.1/description> "A set of instructions, methodology, operations, required reagents, instruments to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system."@en .
<https://w3id.org/SKGO/phm#Assay> <http://www.w3.org/2000/01/rdf-schema#label> "Assay"@en .
<https://w3id.org/SKGO/phm#Assay> <http://www.w3.org/2004/02/skos/core#definition> "A set of instructions, methodology, operations, required reagents, instruments to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system."@en .
# 
# https://w3id.org/SKGO/phm#AssayKit
<https://w3id.org/SKGO/phm#AssayKit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#AssayKit> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Assay> .
# 
# https://w3id.org/SKGO/phm#AssayMethod
<https://w3id.org/SKGO/phm#AssayMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#AssayMethod> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Assay> .
# 
# https://w3id.org/SKGO/phm#BlotAnalysis
<https://w3id.org/SKGO/phm#BlotAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#BlotAnalysis> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#BlotAnalysis> <http://purl.org/dc/elements/1.1/description> "The transfer of protein, RNA or DNA molecules from a thick acrylamide or agarose gel to a paper like membrane by capilliarity or an electric field, preserving the spatial arrangement."@en .
<https://w3id.org/SKGO/phm#BlotAnalysis> <http://www.w3.org/2000/01/rdf-schema#label> "BlotAnalysis"@en .
<https://w3id.org/SKGO/phm#BlotAnalysis> <http://www.w3.org/2004/02/skos/core#definition> "The transfer of protein, RNA or DNA molecules from a thick acrylamide or agarose gel to a paper like membrane by capilliarity or an electric field, preserving the spatial arrangement."@en .
# 
# https://w3id.org/SKGO/phm#Calculations
<https://w3id.org/SKGO/phm#Calculations> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# https://w3id.org/SKGO/phm#Cell
<https://w3id.org/SKGO/phm#Cell> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Cell> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Cell> <http://purl.org/dc/elements/1.1/description> "A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane."@en .
<https://w3id.org/SKGO/phm#Cell> <http://www.w3.org/2000/01/rdf-schema#label> "Cell"@en .
<https://w3id.org/SKGO/phm#Cell> <http://www.w3.org/2004/02/skos/core#definition> "A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane."@en .
# 
# https://w3id.org/SKGO/phm#CellLine
<https://w3id.org/SKGO/phm#CellLine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#CellLine> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
<https://w3id.org/SKGO/phm#CellLine> <http://www.w3.org/2000/01/rdf-schema#label> "CellLine"@en .
<https://w3id.org/SKGO/phm#CellLine> <http://www.w3.org/2004/02/skos/core#definition> "The term 'line' is used when a culture has undergone an intentional experimental process to establish a more uniform and stable population of cells."@en .
# 
# https://w3id.org/SKGO/phm#Chemical
<https://w3id.org/SKGO/phm#Chemical> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Chemical> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
<https://w3id.org/SKGO/phm#Chemical> <http://www.w3.org/2000/01/rdf-schema#label> "Chemical"@en .
<https://w3id.org/SKGO/phm#Chemical> <http://www.w3.org/2004/02/skos/core#definition> "A substance composed of chemical elements."@en .
# 
# https://w3id.org/SKGO/phm#ClinicalProblem
<https://w3id.org/SKGO/phm#ClinicalProblem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ClinicalProblem> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#ClinicalProblem> <http://purl.org/dc/elements/1.1/description> "A difficulty, disorder, or condition needing resolution."@en .
<https://w3id.org/SKGO/phm#ClinicalProblem> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalProblem"@en .
<https://w3id.org/SKGO/phm#ClinicalProblem> <http://www.w3.org/2004/02/skos/core#definition> "A difficulty, disorder, or condition needing resolution."@en .
# 
# https://w3id.org/SKGO/phm#ClinicalStudy
<https://w3id.org/SKGO/phm#ClinicalStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ClinicalStudy> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#ClinicalStudy> <http://purl.org/dc/elements/1.1/description> "A research study involving human subjects designed to answer specific questions about the safety and efficacy of a biomedical intervention (drug, treatment, device), or new ways of using a known drug, treatment or device."@en .
<https://w3id.org/SKGO/phm#ClinicalStudy> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalStudy"@en .
<https://w3id.org/SKGO/phm#ClinicalStudy> <http://www.w3.org/2004/02/skos/core#definition> "A research study involving human subjects designed to answer specific questions about the safety and efficacy of a biomedical intervention (drug, treatment, device), or new ways of using a known drug, treatment or device."@en .
# 
# https://w3id.org/SKGO/phm#ClinicalTrial
<https://w3id.org/SKGO/phm#ClinicalTrial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ClinicalTrial> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#ClinicalTrial> <http://purl.org/dc/elements/1.1/description> "Clinical trial an experiment performed on human beings in order to evaluate the comparative efficacy of two or more therapies."@en .
<https://w3id.org/SKGO/phm#ClinicalTrial> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial"@en .
<https://w3id.org/SKGO/phm#ClinicalTrial> <http://www.w3.org/2004/02/skos/core#definition> "Clinical trial an experiment performed on human beings in order to evaluate the comparative efficacy of two or more therapies."@en .
# 
# https://w3id.org/SKGO/phm#Disease
<https://w3id.org/SKGO/phm#Disease> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Disease> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Disease> <http://purl.org/dc/elements/1.1/description> "A definite pathological process having a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown."@en .
<https://w3id.org/SKGO/phm#Disease> <http://www.w3.org/2000/01/rdf-schema#label> "Disease"@en .
<https://w3id.org/SKGO/phm#Disease> <http://www.w3.org/2004/02/skos/core#definition> "A definite pathological process having a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown."@en .
# 
# https://w3id.org/SKGO/phm#Drug
<https://w3id.org/SKGO/phm#Drug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Drug> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
<https://w3id.org/SKGO/phm#Drug> <http://www.w3.org/2000/01/rdf-schema#label> "Drug"@en .
<https://w3id.org/SKGO/phm#Drug> <http://www.w3.org/2004/02/skos/core#definition> "Therapeutic agent; any substance, other than food, used in the prevention, diagnosis, alleviation, treatment, or cure of disease. For types or classifications of drugs, see the specific name."@en .
# 
# https://w3id.org/SKGO/phm#EasternBlotting
<https://w3id.org/SKGO/phm#EasternBlotting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#EasternBlotting> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#BlotAnalysis> .
# 
# https://w3id.org/SKGO/phm#ExperimentKit
<https://w3id.org/SKGO/phm#ExperimentKit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ExperimentKit> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#ExperimentKit> <http://purl.org/dc/elements/1.1/description> "The title of the kit/biologicals used in the experiment."@en .
<https://w3id.org/SKGO/phm#ExperimentKit> <http://www.w3.org/2000/01/rdf-schema#label> "ExperimentKit"@en .
<https://w3id.org/SKGO/phm#ExperimentKit> <http://www.w3.org/2004/02/skos/core#definition> "The title of the kit/biologicals used in the experiment."@en .
# 
# https://w3id.org/SKGO/phm#ExperimentMaterial
<https://w3id.org/SKGO/phm#ExperimentMaterial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ExperimentMaterial> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#ExperimentMaterial> <http://purl.org/dc/elements/1.1/description> "Materials are culture collections and chemicals used for executing of an experiment."@en .
<https://w3id.org/SKGO/phm#ExperimentMaterial> <http://www.w3.org/2000/01/rdf-schema#label> "ExperimentMaterial"@en .
<https://w3id.org/SKGO/phm#ExperimentMaterial> <http://www.w3.org/2004/02/skos/core#definition> "Materials are culture collections and chemicals used for executing of an experiment."@en .
# 
# https://w3id.org/SKGO/phm#ExperimentSetting
<https://w3id.org/SKGO/phm#ExperimentSetting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ExperimentSetting> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#ExperimentSetting> <http://purl.org/dc/elements/1.1/description> "A designed experiment involves the investigator assigning (preferably randomly) some or all conditions to subjects."@en .
<https://w3id.org/SKGO/phm#ExperimentSetting> <http://www.w3.org/2000/01/rdf-schema#label> "ExperimentSetting"@en .
<https://w3id.org/SKGO/phm#ExperimentSetting> <http://www.w3.org/2004/02/skos/core#definition> "A designed experiment involves the investigator assigning (preferably randomly) some or all conditions to subjects."@en .
# 
# https://w3id.org/SKGO/phm#ExperimentalStudy
<https://w3id.org/SKGO/phm#ExperimentalStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ExperimentalStudy> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#StudyDesign> .
# 
# https://w3id.org/SKGO/phm#Gene
<https://w3id.org/SKGO/phm#Gene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Gene> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
<https://w3id.org/SKGO/phm#Gene> <http://www.w3.org/2000/01/rdf-schema#label> "Gene"@en .
<https://w3id.org/SKGO/phm#Gene> <http://www.w3.org/2004/02/skos/core#definition> "One of the biologic units of heredity, self-reproducing, and located at a definite position (locus) on a particular chromosome."@en .
# 
# https://w3id.org/SKGO/phm#Hypothesis
<https://w3id.org/SKGO/phm#Hypothesis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Hypothesis> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Hypothesis> <http://purl.org/dc/elements/1.1/description> "A supposition that appears to explain a group of phenomena and is advanced as a bases for further investigation."@en .
<https://w3id.org/SKGO/phm#Hypothesis> <http://www.w3.org/2000/01/rdf-schema#label> "Hypothesis"@en .
<https://w3id.org/SKGO/phm#Hypothesis> <http://www.w3.org/2004/02/skos/core#definition> "A supposition that appears to explain a group of phenomena and is advanced as a bases for further investigation."@en .
# 
# https://w3id.org/SKGO/phm#Investigation
<https://w3id.org/SKGO/phm#Investigation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Investigation> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Investigation> <http://purl.org/dc/elements/1.1/description> "Investigation is the process of carrying out a plan or procedure so as to discover facts or information about the object of study."@en .
<https://w3id.org/SKGO/phm#Investigation> <http://www.w3.org/2000/01/rdf-schema#label> "Investigation"@en .
<https://w3id.org/SKGO/phm#Investigation> <http://www.w3.org/2004/02/skos/core#definition> "Investigation is the process of carrying out a plan or procedure so as to discover facts or information about the object of study."@en .
# 
# https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells
<https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> <http://purl.org/dc/elements/1.1/description> "A procedure done in order to discover or demonstrate some fact or general truth."@en .
<https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> <http://www.w3.org/2000/01/rdf-schema#label> "Experiment"@en .
<https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> <http://www.w3.org/2004/02/skos/core#definition> "A procedure done in order to discover or demonstrate some fact or general truth."@en .
# 
# https://w3id.org/SKGO/phm#NorthernBlotting
<https://w3id.org/SKGO/phm#NorthernBlotting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#NorthernBlotting> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#BlotAnalysis> .
<https://w3id.org/SKGO/phm#NorthernBlotting> <http://purl.org/dc/elements/1.1/description> "A technique used to detect a specific mRNA sequence, which consists of electrophoresing RNA fragments, transferring those fragments to a membrane, then adding a labelled nucleic acid probe to the milieu."@en .
<https://w3id.org/SKGO/phm#NorthernBlotting> <http://www.w3.org/2000/01/rdf-schema#label> "NorthernBlotting"@en .
<https://w3id.org/SKGO/phm#NorthernBlotting> <http://www.w3.org/2004/02/skos/core#definition> "A technique used to detect a specific mRNA sequence, which consists of electrophoresing RNA fragments, transferring those fragments to a membrane, then adding a labelled nucleic acid probe to the milieu."@en .
# 
# https://w3id.org/SKGO/phm#ObservationalStudy
<https://w3id.org/SKGO/phm#ObservationalStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ObservationalStudy> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#StudyDesign> .
# 
# https://w3id.org/SKGO/phm#Patient
<https://w3id.org/SKGO/phm#Patient> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Patient> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Patient> <http://purl.org/dc/elements/1.1/description> "A person who is under medical care or treatment."@en .
<https://w3id.org/SKGO/phm#Patient> <http://www.w3.org/2000/01/rdf-schema#label> "Patient"@en .
<https://w3id.org/SKGO/phm#Patient> <http://www.w3.org/2004/02/skos/core#definition> "A person who is under medical care or treatment."@en .
# 
# https://w3id.org/SKGO/phm#Probe
<https://w3id.org/SKGO/phm#Probe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Probe> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
<https://w3id.org/SKGO/phm#Probe> <http://www.w3.org/2000/01/rdf-schema#label> "Probe"@en .
<https://w3id.org/SKGO/phm#Probe> <http://www.w3.org/2004/02/skos/core#definition> "A radioactive or chemiluminescent DNA or RNA fragment used to detect the presence of a complementary fragment."@en .
# 
# https://w3id.org/SKGO/phm#Reagent
<https://w3id.org/SKGO/phm#Reagent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Reagent> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
<https://w3id.org/SKGO/phm#Reagent> <http://www.w3.org/2000/01/rdf-schema#label> "Reagent"@en .
<https://w3id.org/SKGO/phm#Reagent> <http://www.w3.org/2004/02/skos/core#definition> "A substance used to produce a chemical reaction so as to detect, measure, or produce other substances."@en .
# 
# https://w3id.org/SKGO/phm#ReviewStudy
<https://w3id.org/SKGO/phm#ReviewStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ReviewStudy> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#StudyDesign> .
<https://w3id.org/SKGO/phm#ReviewStudy> <http://purl.org/dc/elements/1.1/description> "Reviews are a type of literature review that uses systematic methods to collect secondary data, critically appraise research studies, and synthesize findings qualitatively or quantitatively."@en .
<https://w3id.org/SKGO/phm#ReviewStudy> <http://www.w3.org/2000/01/rdf-schema#label> "ReviewStudy"@en .
<https://w3id.org/SKGO/phm#ReviewStudy> <http://www.w3.org/2004/02/skos/core#definition> "Reviews are a type of literature review that uses systematic methods to collect secondary data, critically appraise research studies, and synthesize findings qualitatively or quantitatively."@en .
# 
# https://w3id.org/SKGO/phm#SouthernBlotting
<https://w3id.org/SKGO/phm#SouthernBlotting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#SouthernBlotting> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#BlotAnalysis> .
<https://w3id.org/SKGO/phm#SouthernBlotting> <http://purl.org/dc/elements/1.1/description> "A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe."@en .
<https://w3id.org/SKGO/phm#SouthernBlotting> <http://www.w3.org/2000/01/rdf-schema#label> "SouthernBlotting"@en .
<https://w3id.org/SKGO/phm#SouthernBlotting> <http://www.w3.org/2004/02/skos/core#definition> "A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe."@en .
# 
# https://w3id.org/SKGO/phm#Specimen
<https://w3id.org/SKGO/phm#Specimen> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Specimen> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentMaterial> .
<https://w3id.org/SKGO/phm#Specimen> <http://www.w3.org/2000/01/rdf-schema#label> "Specimen"@en .
<https://w3id.org/SKGO/phm#Specimen> <http://www.w3.org/2004/02/skos/core#definition> "A small sample or part taken to show the nature of the whole, such as a small quantity of urine for urinalysis or a small fragment of tissue for microscopic study."@en .
# 
# https://w3id.org/SKGO/phm#StatisticalAnalysis
<https://w3id.org/SKGO/phm#StatisticalAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#StatisticalAnalysis> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
# 
# https://w3id.org/SKGO/phm#Study
<https://w3id.org/SKGO/phm#Study> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
# 
# https://w3id.org/SKGO/phm#StudyDesign
<https://w3id.org/SKGO/phm#StudyDesign> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#StudyDesign> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#StudyDesign> <http://purl.org/dc/elements/1.1/description> "Study design is the formulation of trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings."@en .
<https://w3id.org/SKGO/phm#StudyDesign> <http://www.w3.org/2000/01/rdf-schema#label> "StudyDesign"@en .
<https://w3id.org/SKGO/phm#StudyDesign> <http://www.w3.org/2004/02/skos/core#definition> "Study design is the formulation of trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings."@en .
# 
# https://w3id.org/SKGO/phm#Treatment
<https://w3id.org/SKGO/phm#Treatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#Treatment> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#Treatment> <http://purl.org/dc/elements/1.1/description> "A period in a clinical study during which subjects receive therapeutic treatment or an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process."@en .
<https://w3id.org/SKGO/phm#Treatment> <http://www.w3.org/2000/01/rdf-schema#label> "Treatment"@en .
<https://w3id.org/SKGO/phm#Treatment> <http://www.w3.org/2004/02/skos/core#definition> "A period in a clinical study during which subjects receive therapeutic treatment or an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process."@en .
# 
# https://w3id.org/SKGO/phm#WesternBlotting
<https://w3id.org/SKGO/phm#WesternBlotting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#WesternBlotting> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#BlotAnalysis> .
<https://w3id.org/SKGO/phm#WesternBlotting> <http://purl.org/dc/elements/1.1/description> "A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane."@en .
<https://w3id.org/SKGO/phm#WesternBlotting> <http://www.w3.org/2000/01/rdf-schema#label> "WesternBlotting"@en .
<https://w3id.org/SKGO/phm#WesternBlotting> <http://www.w3.org/2004/02/skos/core#definition> "A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane."@en .
# 
# https://w3id.org/SKGO/phm#ex_vivo
<https://w3id.org/SKGO/phm#ex_vivo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#ex_vivo> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentSetting> .
# 
# https://w3id.org/SKGO/phm#in_silico
<https://w3id.org/SKGO/phm#in_silico> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#in_silico> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentSetting> .
# 
# https://w3id.org/SKGO/phm#in_vitro
<https://w3id.org/SKGO/phm#in_vitro> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#in_vitro> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentSetting> .
# 
# https://w3id.org/SKGO/phm#in_vivo
<https://w3id.org/SKGO/phm#in_vivo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#in_vivo> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#ExperimentSetting> .
# 
# https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA
<https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> .
<https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/SKGO/phm#Study> .
<https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> <http://purl.org/dc/elements/1.1/description> "It is a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment."@en .
<https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> <http://www.w3.org/2000/01/rdf-schema#label> "ResearchStatement"@en .
<https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> <http://www.w3.org/2004/02/skos/core#definition> "It is a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment."@en .
# 
# 
# 
# #################################################################
# #
# #    Individuals
# #
# #################################################################
# 
# 
# http://purl.org/dc/aboutdcmi#DCMI
<http://purl.org/dc/aboutdcmi#DCMI> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/
<http://purl.org/dc/terms/> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/> <http://purl.org/dc/terms/modified> "2012-06-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/> <http://purl.org/dc/terms/publisher> <http://purl.org/dc/aboutdcmi#DCMI> .
<http://purl.org/dc/terms/> <http://purl.org/dc/terms/title> "DCMI Metadata Terms - other"@en .
# 
# http://purl.org/dc/terms/Agent
<http://purl.org/dc/terms/Agent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/Agent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/AgentClass> .
# 
# http://purl.org/dc/terms/AgentClass
<http://purl.org/dc/terms/AgentClass> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/BibliographicResource
<http://purl.org/dc/terms/BibliographicResource> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/Box
<http://purl.org/dc/terms/Box> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/DCMIType
<http://purl.org/dc/terms/DCMIType> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/DCMIType> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/DCMIType> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#DCMIType-005> .
<http://purl.org/dc/terms/DCMIType> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/DCMIType> <http://purl.org/dc/terms/modified> "2012-06-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/DCMIType> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of classes specified by the DCMI Type Vocabulary, used to categorize the nature or genre of the resource."@en .
<http://purl.org/dc/terms/DCMIType> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/DCMIType> <http://www.w3.org/2000/01/rdf-schema#label> "DCMI Type Vocabulary"@en .
<http://purl.org/dc/terms/DCMIType> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://purl.org/dc/dcmitype/> .
# 
# http://purl.org/dc/terms/DDC
<http://purl.org/dc/terms/DDC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/DDC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/DDC> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#DDC-003> .
<http://purl.org/dc/terms/DDC> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/DDC> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/DDC> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of conceptual resources specified by the Dewey Decimal Classification."@en .
<http://purl.org/dc/terms/DDC> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/DDC> <http://www.w3.org/2000/01/rdf-schema#label> "DDC"@en .
<http://purl.org/dc/terms/DDC> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.oclc.org/dewey/> .
# 
# http://purl.org/dc/terms/FileFormat
<http://purl.org/dc/terms/FileFormat> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/Frequency
<http://purl.org/dc/terms/Frequency> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/IMT
<http://purl.org/dc/terms/IMT> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/IMT> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/IMT> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#IMT-004> .
<http://purl.org/dc/terms/IMT> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/IMT> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/IMT> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of media types specified by the Internet Assigned Numbers Authority."@en .
<http://purl.org/dc/terms/IMT> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/IMT> <http://www.w3.org/2000/01/rdf-schema#label> "IMT"@en .
<http://purl.org/dc/terms/IMT> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.iana.org/assignments/media-types/> .
# 
# http://purl.org/dc/terms/ISO3166
<http://purl.org/dc/terms/ISO3166> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/ISO639-2
<http://purl.org/dc/terms/ISO639-2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/ISO639-3
<http://purl.org/dc/terms/ISO639-3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/Jurisdiction
<http://purl.org/dc/terms/Jurisdiction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/LCC
<http://purl.org/dc/terms/LCC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/LCC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/LCC> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#LCC-003> .
<http://purl.org/dc/terms/LCC> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/LCC> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/LCC> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of conceptual resources specified by the Library of Congress Classification."@en .
<http://purl.org/dc/terms/LCC> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/LCC> <http://www.w3.org/2000/01/rdf-schema#label> "LCC"@en .
<http://purl.org/dc/terms/LCC> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://lcweb.loc.gov/catdir/cpso/lcco/lcco.html> .
# 
# http://purl.org/dc/terms/LCSH
<http://purl.org/dc/terms/LCSH> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/LCSH> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/LCSH> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#LCSH-003> .
<http://purl.org/dc/terms/LCSH> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/LCSH> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/LCSH> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of labeled concepts specified by the Library of Congress Subject Headings."@en .
<http://purl.org/dc/terms/LCSH> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/LCSH> <http://www.w3.org/2000/01/rdf-schema#label> "LCSH"@en .
# 
# http://purl.org/dc/terms/LicenseDocument
<http://purl.org/dc/terms/LicenseDocument> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/LinguisticSystem
<http://purl.org/dc/terms/LinguisticSystem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/Location
<http://purl.org/dc/terms/Location> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/LocationPeriodOrJurisdiction
<http://purl.org/dc/terms/LocationPeriodOrJurisdiction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/MESH
<http://purl.org/dc/terms/MESH> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/MESH> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/MESH> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#MESH-003> .
<http://purl.org/dc/terms/MESH> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/MESH> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/MESH> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of labeled concepts specified by the Medical Subject Headings."@en .
<http://purl.org/dc/terms/MESH> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/MESH> <http://www.w3.org/2000/01/rdf-schema#label> "MeSH"@en .
<http://purl.org/dc/terms/MESH> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.nlm.nih.gov/mesh/meshhome.html> .
# 
# http://purl.org/dc/terms/MediaType
<http://purl.org/dc/terms/MediaType> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/MediaTypeOrExtent
<http://purl.org/dc/terms/MediaTypeOrExtent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/MethodOfAccrual
<http://purl.org/dc/terms/MethodOfAccrual> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/MethodOfInstruction
<http://purl.org/dc/terms/MethodOfInstruction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/NLM
<http://purl.org/dc/terms/NLM> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/NLM> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/NLM> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#NLM-002> .
<http://purl.org/dc/terms/NLM> <http://purl.org/dc/terms/issued> "2005-06-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/NLM> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/NLM> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of conceptual resources specified by the National Library of Medicine Classification."@en .
<http://purl.org/dc/terms/NLM> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/NLM> <http://www.w3.org/2000/01/rdf-schema#label> "NLM"@en .
<http://purl.org/dc/terms/NLM> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://wwwcf.nlm.nih.gov/class/> .
# 
# http://purl.org/dc/terms/Period
<http://purl.org/dc/terms/Period> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/PeriodOfTime
<http://purl.org/dc/terms/PeriodOfTime> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/PhysicalMedium
<http://purl.org/dc/terms/PhysicalMedium> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/PhysicalResource
<http://purl.org/dc/terms/PhysicalResource> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/Point
<http://purl.org/dc/terms/Point> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/Policy
<http://purl.org/dc/terms/Policy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/ProvenanceStatement
<http://purl.org/dc/terms/ProvenanceStatement> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/RFC1766
<http://purl.org/dc/terms/RFC1766> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/RFC3066
<http://purl.org/dc/terms/RFC3066> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/RFC4646
<http://purl.org/dc/terms/RFC4646> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/RFC5646
<http://purl.org/dc/terms/RFC5646> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/RightsStatement
<http://purl.org/dc/terms/RightsStatement> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/SizeOrDuration
<http://purl.org/dc/terms/SizeOrDuration> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/Standard
<http://purl.org/dc/terms/Standard> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/TGN
<http://purl.org/dc/terms/TGN> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/TGN> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/TGN> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#TGN-003> .
<http://purl.org/dc/terms/TGN> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/TGN> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/TGN> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of places specified by the Getty Thesaurus of Geographic Names."@en .
<http://purl.org/dc/terms/TGN> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/TGN> <http://www.w3.org/2000/01/rdf-schema#label> "TGN"@en .
<http://purl.org/dc/terms/TGN> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.getty.edu/research/tools/vocabulary/tgn/index.html> .
# 
# http://purl.org/dc/terms/UDC
<http://purl.org/dc/terms/UDC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://purl.org/dc/terms/UDC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/dcam/VocabularyEncodingScheme> .
<http://purl.org/dc/terms/UDC> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#UDC-003> .
<http://purl.org/dc/terms/UDC> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/UDC> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/UDC> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of conceptual resources specified by the Universal Decimal Classification."@en .
<http://purl.org/dc/terms/UDC> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/UDC> <http://www.w3.org/2000/01/rdf-schema#label> "UDC"@en .
<http://purl.org/dc/terms/UDC> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.udcc.org/> .
# 
# http://purl.org/dc/terms/URI
<http://purl.org/dc/terms/URI> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/W3CDTF
<http://purl.org/dc/terms/W3CDTF> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/abstract
<http://purl.org/dc/terms/abstract> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/accessRights
<http://purl.org/dc/terms/accessRights> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/accrualMethod
<http://purl.org/dc/terms/accrualMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/accrualPeriodicity
<http://purl.org/dc/terms/accrualPeriodicity> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/accrualPolicy
<http://purl.org/dc/terms/accrualPolicy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/alternative
<http://purl.org/dc/terms/alternative> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/audience
<http://purl.org/dc/terms/audience> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/available
<http://purl.org/dc/terms/available> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/bibliographicCitation
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/conformsTo
<http://purl.org/dc/terms/conformsTo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/contributor
<http://purl.org/dc/terms/contributor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/coverage
<http://purl.org/dc/terms/coverage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/created
<http://purl.org/dc/terms/created> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/creator
<http://purl.org/dc/terms/creator> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/date
<http://purl.org/dc/terms/date> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/dateAccepted
<http://purl.org/dc/terms/dateAccepted> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/dateCopyrighted
<http://purl.org/dc/terms/dateCopyrighted> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/dateSubmitted
<http://purl.org/dc/terms/dateSubmitted> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/description
<http://purl.org/dc/terms/description> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/educationLevel
<http://purl.org/dc/terms/educationLevel> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/extent
<http://purl.org/dc/terms/extent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/format
<http://purl.org/dc/terms/format> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/hasFormat
<http://purl.org/dc/terms/hasFormat> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/hasPart
<http://purl.org/dc/terms/hasPart> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/hasVersion
<http://purl.org/dc/terms/hasVersion> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/identifier
<http://purl.org/dc/terms/identifier> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/instructionalMethod
<http://purl.org/dc/terms/instructionalMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/isFormatOf
<http://purl.org/dc/terms/isFormatOf> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/isPartOf
<http://purl.org/dc/terms/isPartOf> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/isReferencedBy
<http://purl.org/dc/terms/isReferencedBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/isReplacedBy
<http://purl.org/dc/terms/isReplacedBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/isRequiredBy
<http://purl.org/dc/terms/isRequiredBy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/isVersionOf
<http://purl.org/dc/terms/isVersionOf> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/issued
<http://purl.org/dc/terms/issued> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/language
<http://purl.org/dc/terms/language> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/license
<http://purl.org/dc/terms/license> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/mediator
<http://purl.org/dc/terms/mediator> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/medium
<http://purl.org/dc/terms/medium> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/modified
<http://purl.org/dc/terms/modified> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/provenance
<http://purl.org/dc/terms/provenance> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/publisher
<http://purl.org/dc/terms/publisher> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/references
<http://purl.org/dc/terms/references> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/relation
<http://purl.org/dc/terms/relation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/replaces
<http://purl.org/dc/terms/replaces> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/requires
<http://purl.org/dc/terms/requires> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/rights
<http://purl.org/dc/terms/rights> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/rightsHolder
<http://purl.org/dc/terms/rightsHolder> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/source
<http://purl.org/dc/terms/source> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/spatial
<http://purl.org/dc/terms/spatial> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/subject
<http://purl.org/dc/terms/subject> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/tableOfContents
<http://purl.org/dc/terms/tableOfContents> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/temporal
<http://purl.org/dc/terms/temporal> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/title
<http://purl.org/dc/terms/title> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/type
<http://purl.org/dc/terms/type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# http://purl.org/dc/terms/valid
<http://purl.org/dc/terms/valid> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#A._T._FoJo
<https://w3id.org/SKGO/phm#A._T._FoJo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#A._T._FoJo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#A._T._FoJo> <http://www.w3.org/2000/01/rdf-schema#label> "A. T. Fojo" .
# 
# https://w3id.org/SKGO/phm#ABCA2
<https://w3id.org/SKGO/phm#ABCA2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ABCA2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#ABCA2> <http://www.w3.org/2000/01/rdf-schema#label> "ABCA2"@en .
# 
# https://w3id.org/SKGO/phm#ABC_genes
<https://w3id.org/SKGO/phm#ABC_genes> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ABC_genes> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#ABC_genes> <http://www.w3.org/2000/01/rdf-schema#label> "ABC_genes"@en .
# 
# https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#hasExperimentMethod> <https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#CAVE> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Cyclosporine> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Cytarabine> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Daunorubicin> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Epirubicin> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Etoposide> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#IL-2> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Mitoxantrone> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Paclitaxel> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#VAD> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Vindesine> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#CAV/EP> .
<https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> <http://www.w3.org/2000/01/rdf-schema#label> "ABC_transporters_and_in_vitro_MDR"@en .
# 
# https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters> .
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <http://ns.nature.com/terms/publicationYear> "2005"^^<http://www.w3.org/2001/XMLSchema#gYear> .
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <http://purl.org/ontology/bibo/abstract> "One of the major problems related with anticancer chemotherapy is resistance against anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter proteins that are responsible for drug resistance and a low bioavailability of drugs by pumping a variety of drugs out cells at the expense of ATP hydrolysis. One strategy for reversal of the resistance of tumor cells\nexpressing ABC transporters is combined use of anticancer drugs with chemosensitizers. In this review, the physiological functions and structures of ABC transporters, and the development of chemosensitizers are described focusing on well-known proteins including P-glycoprotein, multidrug resistance associated protein, and breast cancer resistance protein."^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Cheol-Hee_Choi> .
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#Cancer_Cell_International> .
<https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal> <http://purl.org/dc/terms/title> "ABC transporters as multidrug resistance mechanisms and the\ndevelopment of chemosensitizers for their reversal"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Leukaemia> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Lung_cancer> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Non_Smallcell_Lung_Cancer> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Small_Cell_Lung_Cancer> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <https://w3id.org/SKGO/phm#investigatesProblem> <https://w3id.org/SKGO/phm#Drug_Resistance> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <http://ns.nature.com/terms/name> "MULTIDRUG RESISTANCE IN CANCER" .
<https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> <http://www.w3.org/2000/01/rdf-schema#label> "ABC transporters in human cancers"@en .
# 
# https://w3id.org/SKGO/phm#ADE
<https://w3id.org/SKGO/phm#ADE> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ADE> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#ADE> <http://www.w3.org/2000/01/rdf-schema#label> "ADE"@en .
# 
# https://w3id.org/SKGO/phm#ALL
<https://w3id.org/SKGO/phm#ALL> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ALL> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#ALL> <http://www.w3.org/2000/01/rdf-schema#label> "ALL"@en .
# 
# https://w3id.org/SKGO/phm#AML
<https://w3id.org/SKGO/phm#AML> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#AML> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#AML> <http://www.w3.org/2000/01/rdf-schema#label> "AML"@en .
# 
# https://w3id.org/SKGO/phm#AML_sample
<https://w3id.org/SKGO/phm#AML_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#AML_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#AML_sample> <https://w3id.org/SKGO/phm#obtainedfromPatient> <https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> .
<https://w3id.org/SKGO/phm#AML_sample> <http://www.w3.org/2000/01/rdf-schema#label> "AML_sample"@en .
# 
# https://w3id.org/SKGO/phm#ARUN_K._RISHI
<https://w3id.org/SKGO/phm#ARUN_K._RISHI> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ARUN_K._RISHI> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#ARUN_K._RISHI> <http://www.w3.org/2000/01/rdf-schema#label> "Arun k. Rishi" .
# 
# https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://ns.nature.com/terms/publicationYear> "1998"^^<http://www.w3.org/2001/XMLSchema#gYear> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/ontology/bibo/abstract> "MCF-7yAdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent reduction in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein. RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in\nMCF-7yAdrVp cells relative to parental MCF-7 cells. The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP). Enforced expression of the full-length\nBCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123\nin the cloned transfected cells. BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7yAdrVp human breast cancer cells."@en .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#ARUN_K._RISHI> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#L._AUSTIN_DOYLE> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#LYNNE_V._ABRUZZO> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#TAMMY_KROGMANN> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#WEIDONG_YANG> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#YONGMING_GAO> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA> .
<https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells> <http://purl.org/dc/terms/title> "A multidrug resistance transporter from human MCF-7 breast cancer cells"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#Accumulation_Bioassay
<https://w3id.org/SKGO/phm#Accumulation_Bioassay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Accumulation_Bioassay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#Accumulation_Bioassay> <http://www.w3.org/2000/01/rdf-schema#label> "Accumulation_Bioassay"@en .
# 
# https://w3id.org/SKGO/phm#Actinomycin_D
<https://w3id.org/SKGO/phm#Actinomycin_D> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Actinomycin_D> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Actinomycin_D> <http://www.w3.org/2000/01/rdf-schema#label> "Actinomycin_D"@en .
# 
# https://w3id.org/SKGO/phm#Acute_lymphoblastic_leukemia
<https://w3id.org/SKGO/phm#Acute_lymphoblastic_leukemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Acute_lymphoblastic_leukemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Acute_lymphoblastic_leukemia> <http://www.w3.org/2000/01/rdf-schema#label> "Acute_lymphoblastic_leukemia"@en .
# 
# https://w3id.org/SKGO/phm#Adrenocortical_Cancer
<https://w3id.org/SKGO/phm#Adrenocortical_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Adrenocortical_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Adrenocortical_Cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Adrenocortical_Cancer"@en .
# 
# https://w3id.org/SKGO/phm#Advanced_and_recurrent_breast_cancer_sample
<https://w3id.org/SKGO/phm#Advanced_and_recurrent_breast_cancer_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Advanced_and_recurrent_breast_cancer_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#Advanced_and_recurrent_breast_cancer_sample> <https://w3id.org/SKGO/phm#obtainedfromPatient> <https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> .
<https://w3id.org/SKGO/phm#Advanced_and_recurrent_breast_cancer_sample> <http://www.w3.org/2000/01/rdf-schema#label> "Advanced_and_recurrent_breast_cancer_sample"@en .
# 
# https://w3id.org/SKGO/phm#American_Type_Culture_Collection
<https://w3id.org/SKGO/phm#American_Type_Culture_Collection> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#American_Type_Culture_Collection> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
# 
# https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function
<https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#AML> .
<https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Leukaemia> .
<https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function> <https://w3id.org/SKGO/phm#investigatesProblem> <https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells> .
<https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> .
<https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function> <http://www.w3.org/2000/01/rdf-schema#label> "Analysis_of_leukemic_blast_MDR_function"@en .
# 
# https://w3id.org/SKGO/phm#Anthracyclines-doxorubucin_daunorubicin_epirubicin
<https://w3id.org/SKGO/phm#Anthracyclines-doxorubucin_daunorubicin_epirubicin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Anthracyclines-doxorubucin_daunorubicin_epirubicin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Anthracyclines-doxorubucin_daunorubicin_epirubicin> <http://www.w3.org/2000/01/rdf-schema#label> "Anthracyclines-doxorubucin_daunorubicin_epirubicin"@en .
# 
# https://w3id.org/SKGO/phm#Anthranilic-acid-based_drug
<https://w3id.org/SKGO/phm#Anthranilic-acid-based_drug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Anthranilic-acid-based_drug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Anthranilic-acid-based_drug> <http://www.w3.org/2000/01/rdf-schema#label> "Anthranilic-acid-based_drug"@en .
# 
# https://w3id.org/SKGO/phm#AssayKit
<https://w3id.org/SKGO/phm#AssayKit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#AssayKit> <http://xmlns.com/foaf/0.1/name> "AssayKit"@en .
# 
# https://w3id.org/SKGO/phm#AssayKit15
<https://w3id.org/SKGO/phm#AssayKit15> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit16
<https://w3id.org/SKGO/phm#AssayKit16> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit17
<https://w3id.org/SKGO/phm#AssayKit17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit18
<https://w3id.org/SKGO/phm#AssayKit18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit19
<https://w3id.org/SKGO/phm#AssayKit19> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit2
<https://w3id.org/SKGO/phm#AssayKit2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit20
<https://w3id.org/SKGO/phm#AssayKit20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit3
<https://w3id.org/SKGO/phm#AssayKit3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit4
<https://w3id.org/SKGO/phm#AssayKit4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit5
<https://w3id.org/SKGO/phm#AssayKit5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit6
<https://w3id.org/SKGO/phm#AssayKit6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit7
<https://w3id.org/SKGO/phm#AssayKit7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit8
<https://w3id.org/SKGO/phm#AssayKit8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayKit9
<https://w3id.org/SKGO/phm#AssayKit9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#AssayMethod
<https://w3id.org/SKGO/phm#AssayMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#AssayMethod> <http://xmlns.com/foaf/0.1/name> "AssayMethod"@en .
# 
# https://w3id.org/SKGO/phm#Asuka_Mizutani
<https://w3id.org/SKGO/phm#Asuka_Mizutani> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Asuka_Mizutani> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#Asuka_Mizutani> <http://www.w3.org/2000/01/rdf-schema#label> "Asuka Mizutani" .
# 
# https://w3id.org/SKGO/phm#BBR3390
<https://w3id.org/SKGO/phm#BBR3390> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#BBR3390> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#BBR3390> <http://www.w3.org/2000/01/rdf-schema#label> "BBR3390"@en .
# 
# https://w3id.org/SKGO/phm#BCRP
<https://w3id.org/SKGO/phm#BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#BCRP> <http://www.w3.org/2000/01/rdf-schema#label> "BCRP"@en .
# 
# https://w3id.org/SKGO/phm#BD_Biosciences_La_Jolla_CA
<https://w3id.org/SKGO/phm#BD_Biosciences_La_Jolla_CA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#BD_Biosciences_La_Jolla_CA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
# 
# https://w3id.org/SKGO/phm#BH3_profiling
<https://w3id.org/SKGO/phm#BH3_profiling> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#BH3_profiling> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#hasExperimentMethod> <https://w3id.org/SKGO/phm#BH3_profiling_method> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#Gastrointestinal_stromal_tumour_GIST_cell_lines> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#Melanoma> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#Pancreatic_cancer_cell_lines> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#ERBB2\u2011amplified_breast_cancer_cell_lines> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Bevacizumab> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Bortezomib> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Cetuximab> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Crizotinib> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Dasatinib> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Gefitinib> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Nilotinib> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Trastuzumab> .
<https://w3id.org/SKGO/phm#BH3_profiling> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Vemurafenib> .
<https://w3id.org/SKGO/phm#BH3_profiling> <http://www.w3.org/2000/01/rdf-schema#label> "BH3_profiling"@en .
# 
# https://w3id.org/SKGO/phm#BH3_profiling_method
<https://w3id.org/SKGO/phm#BH3_profiling_method> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#BH3_profiling_method> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> .
<https://w3id.org/SKGO/phm#BH3_profiling_method> <https://w3id.org/SKGO/phm#useAssay> <https://w3id.org/SKGO/phm#Functional_Assay> .
<https://w3id.org/SKGO/phm#BH3_profiling_method> <http://www.w3.org/2000/01/rdf-schema#label> "BH3_profiling_method"@en .
# 
# https://w3id.org/SKGO/phm#Bevacizumab
<https://w3id.org/SKGO/phm#Bevacizumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Bevacizumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Bevacizumab> <http://www.w3.org/2000/01/rdf-schema#label> "Bevacizumab"@en .
# 
# https://w3id.org/SKGO/phm#Blast_populations_in_the_two_bioassays
<https://w3id.org/SKGO/phm#Blast_populations_in_the_two_bioassays> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Blast_populations_in_the_two_bioassays> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#StatisticalAnalysis> .
<https://w3id.org/SKGO/phm#Blast_populations_in_the_two_bioassays> <http://www.w3.org/2000/01/rdf-schema#label> "Blast populations in the two bioassays"@en .
<https://w3id.org/SKGO/phm#Blast_populations_in_the_two_bioassays> <http://www.w3.org/2004/02/skos/core#definition> "P-gp accumulation ratio, P-gp efflux ratio, percent unimpeded efflux for total MDR activity, percent efflux in the presence of zosuquidar, and percent inhibition of efflux by zosuquidar"@en .
# 
# https://w3id.org/SKGO/phm#Bone_marrow_aspirates
<https://w3id.org/SKGO/phm#Bone_marrow_aspirates> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Bone_marrow_aspirates> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#Bone_marrow_aspirates> <https://w3id.org/SKGO/phm#obtainedfrom> <https://w3id.org/SKGO/phm#50_patients_with_newly_diagnosed_AML> .
<https://w3id.org/SKGO/phm#Bone_marrow_aspirates> <http://www.w3.org/2000/01/rdf-schema#label> "Bone_marrow_aspirates"@en .
# 
# https://w3id.org/SKGO/phm#Bortezomib
<https://w3id.org/SKGO/phm#Bortezomib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Bortezomib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Bortezomib> <http://www.w3.org/2000/01/rdf-schema#label> "Bortezomib"@en .
# 
# https://w3id.org/SKGO/phm#Branimir_I._Sikic
<https://w3id.org/SKGO/phm#Branimir_I._Sikic> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Branimir_I._Sikic> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#Branimir_I._Sikic> <http://www.w3.org/2000/01/rdf-schema#label> "Branimir I. Sikic" .
# 
# https://w3id.org/SKGO/phm#Breast_Cancer
<https://w3id.org/SKGO/phm#Breast_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Breast_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Breast_Cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Breast_Cancer"@en .
# 
# https://w3id.org/SKGO/phm#Breast_cancer_samples
<https://w3id.org/SKGO/phm#Breast_cancer_samples> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Breast_cancer_samples> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#Breast_cancer_samples> <https://w3id.org/SKGO/phm#obtainedfromPatient> <https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer> .
<https://w3id.org/SKGO/phm#Breast_cancer_samples> <http://www.w3.org/2000/01/rdf-schema#label> "Breast_cancer_samples"@en .
# 
# https://w3id.org/SKGO/phm#CAVE
<https://w3id.org/SKGO/phm#CAVE> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#CAVE> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#CAVE> <http://www.w3.org/2000/01/rdf-schema#label> "CAVE"@en .
# 
# https://w3id.org/SKGO/phm#CCL_127__PC12
<https://w3id.org/SKGO/phm#CCL_127__PC12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#CCL_127__PC12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#CCL_127__PC12> <http://www.w3.org/2000/01/rdf-schema#label> "CCL_127__PC12"@en .
# 
# https://w3id.org/SKGO/phm#CI1033
<https://w3id.org/SKGO/phm#CI1033> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#CI1033> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#CI1033> <http://www.w3.org/2000/01/rdf-schema#label> "CI1033"@en .
# 
# https://w3id.org/SKGO/phm#CLONTECH
<https://w3id.org/SKGO/phm#CLONTECH> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#CLONTECH> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
# 
# https://w3id.org/SKGO/phm#CML
<https://w3id.org/SKGO/phm#CML> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#CML> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#CML> <http://www.w3.org/2000/01/rdf-schema#label> "CML"@en .
# 
# https://w3id.org/SKGO/phm#Caitriona_Holohan
<https://w3id.org/SKGO/phm#Caitriona_Holohan> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Caitriona_Holohan> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#Caitriona_Holohan> <http://www.w3.org/2000/01/rdf-schema#label> "Caitriona Holohan" .
# 
# https://w3id.org/SKGO/phm#Cancer_Cell_International
<https://w3id.org/SKGO/phm#Cancer_Cell_International> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Cancer_Cell_International> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publisher> .
# 
# https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Actinomycin_D> .
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Doxorubicin> .
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Mitomycin_C> .
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Vincristine> .
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#Peripheral_blood_lymphocytes> .
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <https://w3id.org/SKGO/phm#treatmentOutcome> "Vinca alkaloid, doxorubicin, or actinomycin D might not be effective in the therapy of pheochromocytoma."@en .
<https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> <http://www.w3.org/2000/01/rdf-schema#label> "Cancer_chemotherapy_doxorubicin_vinblastine"@en .
# 
# https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://purl.org/ontology/bibo/abstract> "Resistance to chemotherapy and molecularly targeted therapies is a major\nproblem facing current cancer research. The mechanisms of resistance to ‘classical’ cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific molecular targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. With the increasing arsenal of anticancer agents, improving preclinical models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug\nresistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification."@en .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Caitriona_Holohan> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Daniel_B._Longley> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Patrick_G._Johnston> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Sandra_Van_Schaeybroeck> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd> .
<https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm> <http://purl.org/dc/terms/title> "Cancer drug resistance: an evolving paradigm"@en .
# 
# https://w3id.org/SKGO/phm#Carboplatin
<https://w3id.org/SKGO/phm#Carboplatin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Carboplatin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Carboplatin> <http://www.w3.org/2000/01/rdf-schema#label> "Carboplatin"@en .
# 
# https://w3id.org/SKGO/phm#Catherine_Booth-Genthe
<https://w3id.org/SKGO/phm#Catherine_Booth-Genthe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Catherine_Booth-Genthe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#Catherine_Booth-Genthe> <http://www.w3.org/2000/01/rdf-schema#label> "Catherine Booth Genthe" .
# 
# https://w3id.org/SKGO/phm#Cetuximab
<https://w3id.org/SKGO/phm#Cetuximab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Cetuximab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Cetuximab> <http://www.w3.org/2000/01/rdf-schema#label> "Cetuximab"@en .
# 
# https://w3id.org/SKGO/phm#Chemotherapy
<https://w3id.org/SKGO/phm#Chemotherapy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Chemotherapy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#Chemotherapy> <http://www.w3.org/2000/01/rdf-schema#label> "Chemotherapy"@en .
# 
# https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#AML_sample> .
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#Advanced_and_recurrent_breast_cancer_sample> .
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#NSCLC_sample> .
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#Poor-risk_acute_leukaemia_samples> .
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#Refractory_AML_high-risk_MDS_sample> .
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#Relapsed_and_refractory_AML_sample> .
<https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> <http://www.w3.org/2000/01/rdf-schema#label> "Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"@en .
# 
# https://w3id.org/SKGO/phm#Cheol-Hee_Choi
<https://w3id.org/SKGO/phm#Cheol-Hee_Choi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Cheol-Hee_Choi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#Cheol-Hee_Choi> <http://www.w3.org/2000/01/rdf-schema#label> "Cheol Hee Choi" .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution1
<https://w3id.org/SKGO/phm#ClinicalProblemSolution1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution10
<https://w3id.org/SKGO/phm#ClinicalProblemSolution10> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution11
<https://w3id.org/SKGO/phm#ClinicalProblemSolution11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution12
<https://w3id.org/SKGO/phm#ClinicalProblemSolution12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution13
<https://w3id.org/SKGO/phm#ClinicalProblemSolution13> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution14
<https://w3id.org/SKGO/phm#ClinicalProblemSolution14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution15
<https://w3id.org/SKGO/phm#ClinicalProblemSolution15> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution16
<https://w3id.org/SKGO/phm#ClinicalProblemSolution16> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution17
<https://w3id.org/SKGO/phm#ClinicalProblemSolution17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution18
<https://w3id.org/SKGO/phm#ClinicalProblemSolution18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution19
<https://w3id.org/SKGO/phm#ClinicalProblemSolution19> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution2
<https://w3id.org/SKGO/phm#ClinicalProblemSolution2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution20
<https://w3id.org/SKGO/phm#ClinicalProblemSolution20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution3
<https://w3id.org/SKGO/phm#ClinicalProblemSolution3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution4
<https://w3id.org/SKGO/phm#ClinicalProblemSolution4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution5
<https://w3id.org/SKGO/phm#ClinicalProblemSolution5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution6
<https://w3id.org/SKGO/phm#ClinicalProblemSolution6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution7
<https://w3id.org/SKGO/phm#ClinicalProblemSolution7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution8
<https://w3id.org/SKGO/phm#ClinicalProblemSolution8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#ClinicalProblemSolution9
<https://w3id.org/SKGO/phm#ClinicalProblemSolution9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Clonogenic_survival_assays
<https://w3id.org/SKGO/phm#Clonogenic_survival_assays> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Clonogenic_survival_assays> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#Clonogenic_survival_assays> <http://www.w3.org/2000/01/rdf-schema#label> "Clonogenic_survival_assays"@en .
# 
# https://w3id.org/SKGO/phm#Colchicine
<https://w3id.org/SKGO/phm#Colchicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Colchicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Colchicine> <http://www.w3.org/2000/01/rdf-schema#label> "Colchicine"@en .
# 
# https://w3id.org/SKGO/phm#Colerectal_cancer
<https://w3id.org/SKGO/phm#Colerectal_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Colerectal_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Colerectal_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Colerectal_cancer"@en .
# 
# https://w3id.org/SKGO/phm#Colon_Tumor
<https://w3id.org/SKGO/phm#Colon_Tumor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Colon_Tumor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Colon_Tumor> <http://www.w3.org/2000/01/rdf-schema#label> "Colerectal_cancer"@en .
# 
# https://w3id.org/SKGO/phm#Colon_carcinoma
<https://w3id.org/SKGO/phm#Colon_carcinoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Colon_carcinoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#Colon_carcinoma> <https://w3id.org/SKGO/phm#obtainedfrom> <https://w3id.org/SKGO/phm#National_Cancer_Institute> .
<https://w3id.org/SKGO/phm#Colon_carcinoma> <http://www.w3.org/2000/01/rdf-schema#label> "Colon_carcinoma"@en .
# 
# https://w3id.org/SKGO/phm#Crizotinib
<https://w3id.org/SKGO/phm#Crizotinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Crizotinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Crizotinib> <http://www.w3.org/2000/01/rdf-schema#label> "Crizotinib"@en .
# 
# https://w3id.org/SKGO/phm#Cyclosporine
<https://w3id.org/SKGO/phm#Cyclosporine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Cyclosporine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Cyclosporine> <http://www.w3.org/2000/01/rdf-schema#label> "Cyclosporine"@en .
# 
# https://w3id.org/SKGO/phm#Cytarabine
<https://w3id.org/SKGO/phm#Cytarabine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Cytarabine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Cytarabine> <http://www.w3.org/2000/01/rdf-schema#label> "Cytarabine"@en .
# 
# https://w3id.org/SKGO/phm#D._G._POPLACK
<https://w3id.org/SKGO/phm#D._G._POPLACK> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#D._G._POPLACK> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#D._G._POPLACK> <http://www.w3.org/2000/01/rdf-schema#label> "D. G. Poplack" .
# 
# https://w3id.org/SKGO/phm#D._J._SLAMON
<https://w3id.org/SKGO/phm#D._J._SLAMON> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#D._J._SLAMON> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#D._J._SLAMON> <http://www.w3.org/2000/01/rdf-schema#label> "D. J. Slamon" .
# 
# https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS
<https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS> <http://www.w3.org/2000/01/rdf-schema#label> "Douglas D. Ross" .
# 
# https://w3id.org/SKGO/phm#Daniel_B._Longley
<https://w3id.org/SKGO/phm#Daniel_B._Longley> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Daniel_B._Longley> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#Daniel_B._Longley> <http://www.w3.org/2000/01/rdf-schema#label> "Daniel B. Longley" .
# 
# https://w3id.org/SKGO/phm#Dasatinib
<https://w3id.org/SKGO/phm#Dasatinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Dasatinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Dasatinib> <http://www.w3.org/2000/01/rdf-schema#label> "Dasatinib"@en .
# 
# https://w3id.org/SKGO/phm#Daunomycin
<https://w3id.org/SKGO/phm#Daunomycin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Daunomycin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Daunomycin> <http://www.w3.org/2002/07/owl#sameAs> <https://w3id.org/SKGO/phm#Daunorubicin> .
<https://w3id.org/SKGO/phm#Daunomycin> <http://www.w3.org/2000/01/rdf-schema#label> "Daunomycin"@en .
# 
# https://w3id.org/SKGO/phm#Daunorubicin
<https://w3id.org/SKGO/phm#Daunorubicin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Daunorubicin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Daunorubicin> <http://www.w3.org/2000/01/rdf-schema#label> "Daunorubicin"@en .
# 
# https://w3id.org/SKGO/phm#Delta_RNA_Fingerprinting_kit
<https://w3id.org/SKGO/phm#Delta_RNA_Fingerprinting_kit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Delta_RNA_Fingerprinting_kit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ExperimentKit> .
<https://w3id.org/SKGO/phm#Delta_RNA_Fingerprinting_kit> <https://w3id.org/SKGO/phm#obtainedfrom> <https://w3id.org/SKGO/phm#CLONTECH> .
<https://w3id.org/SKGO/phm#Delta_RNA_Fingerprinting_kit> <http://www.w3.org/2000/01/rdf-schema#label> "Delta_RNA_Fingerprinting_kit"@en .
# 
# https://w3id.org/SKGO/phm#Describe_various_approaches_to_combating_multidrug-resistant_cancer
<https://w3id.org/SKGO/phm#Describe_various_approaches_to_combating_multidrug-resistant_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Describe_various_approaches_to_combating_multidrug-resistant_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#Describe_various_approaches_to_combating_multidrug-resistant_cancer> <http://purl.org/dc/terms/description> "The most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters." .
<https://w3id.org/SKGO/phm#Describe_various_approaches_to_combating_multidrug-resistant_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Describe_various_approaches_to_combating_multidrug-resistant_cancer"@en .
# 
# https://w3id.org/SKGO/phm#DiOC2
<https://w3id.org/SKGO/phm#DiOC2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#DiOC2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Reagent> .
<https://w3id.org/SKGO/phm#DiOC2> <https://w3id.org/SKGO/phm#obtainedfrom> <https://w3id.org/SKGO/phm#Invitrogen> .
<https://w3id.org/SKGO/phm#DiOC2> <http://www.w3.org/2000/01/rdf-schema#label> "DiOC2"@en .
# 
# https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#Multidrug_Resistance_Monitoring_in_Cancer> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://ns.nature.com/terms/publicationYear> "2018"@en .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/ontology/bibo/abstract> "Background Little is known about the affinity and stability of\n99mTc-labeled 2-methoxyisobutylisonitrile (99mTc-MIBI) and\ntetrofosmin (99mTc-TF) for imaging of multiple drug resistance\ntransporters in cancer. We examined the affinity of 99mTc-labeled\ncompounds for these transporters and their stability.\nMethods 99mTc-MIBI and 99mTc-TF were incubated in vesicles\nexpressing P-glycoprotein (MDR1), multidrug resistanceassociated\nprotein (MRP)1–4, or breast cancer resistance protein\nwith and without verapamil (MDR1 inhibitor) or MK-\n571 (MRP inhibitor). Time activity curves of 99mTc-labeled\ncompounds were established using SK-N-SH neuroblastoma,\nSK-MEL-28 melanoma, and PC-3 prostate adenocarcinoma\ncell lines, and transporter expression of multiple drug resistance\nwas measured in these cells. The stability was evaluated.\nResults In vesicles, 99mTc-labeled compounds had affinity for\nMDR1 and MRP1. 99mTc-TF had additional affinity for\nMRP2 and MRP3. In SK-N-SH cells expressing MDR1 and\nMRP1, MK-571 produced the highest uptake of both 99mTclabeled\ncompounds. 99mTc-MIBI uptake with inhibitors was\nhigher than 99mTc-TF uptake with inhibitors. 99mTc-TF was\ntaken up more in SK-MEL-28 cells expressing MRP1 and\nMRP2 than PC-3 cells expressing MRP1 and MRP3. 99mTc-\nMIBI was metabolized, whereas 99mTc-TF had high stability.\nConclusion 99mTc-MIBI is exported via MDR1 and MRP1\n(MRP1 > MDR1) at greater levels and more quickly compared\nto 99mTc-TF, which is exported via MDR1 and MRP1–3\n(MRP1 > MDR1; MRP1, 2 >MRP3). Because 99mTc-MIBI\nis metabolized, clinical imaging for monitoring MDR and\nshorter examination times may be possible with an earlier scanning\ntime on late phase imaging. 99mTc-TF has high stability\nand accurately reflects the function of MDR1 and MRP1–3."@en .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Asuka_Mizutani> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Ikumi_Tamai> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Kazuki_Fukuchi> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Keiichi_Kawai> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Kodai_Nishi> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Masato_Kobayashi> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Ryuichi_Nishii> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Takafumi_Tsujiuchi> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Takeo_Nakanishi> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Yuya_Okui> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#Springer_Science+Business_Media_LLC> .
<https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer> <http://purl.org/dc/terms/title> "Different Efflux Transporter Aff inity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer"@en .
# 
# https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators
<https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Daunorubicin> .
<https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Leukotriene_C4> .
<https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Taurocholate> .
<https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> <https://w3id.org/SKGO/phm#treatmentOutcome> "There was increased intracellular\naccumulation of doxorubicin as was evidenced using\nconfocal microscopy and reduced toxicity compared to the\nfree (unencapsulated) doxorubicin."@en .
<https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> <http://www.w3.org/2000/01/rdf-schema#label> "Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"@en .
# 
# https://w3id.org/SKGO/phm#Doxorubicin
<https://w3id.org/SKGO/phm#Doxorubicin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Doxorubicin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Doxorubicin> <http://www.w3.org/2000/01/rdf-schema#label> "Doxorubicin"@en .
# 
# https://w3id.org/SKGO/phm#Drosophila_white_gene
<https://w3id.org/SKGO/phm#Drosophila_white_gene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Drosophila_white_gene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#Drosophila_white_gene> <http://www.w3.org/2000/01/rdf-schema#label> "Drosophila_white_gene"@en .
# 
# https://w3id.org/SKGO/phm#Drug_Resistance
<https://w3id.org/SKGO/phm#Drug_Resistance> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Drug_Resistance> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#Drug_Resistance> <https://w3id.org/SKGO/phm#hasMutationResult> "Dubin-Johnson syndrome" .
<https://w3id.org/SKGO/phm#Drug_Resistance> <https://w3id.org/SKGO/phm#hasTissueLocalization> "Liver, kidney, intestine, adrenal glands, pancreas, lung, ovary" .
<https://w3id.org/SKGO/phm#Drug_Resistance> <https://w3id.org/SKGO/phm#name> "Drug Resistance" .
<https://w3id.org/SKGO/phm#Drug_Resistance> <http://www.w3.org/2000/01/rdf-schema#label> "Drug_Resistance"@en .
# 
# https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#AML> .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Leukaemia> .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Lung_cancer> .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Myeloma> .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR> .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <http://ns.nature.com/terms/name> "Targeting multidrug resistance in cancer" .
<https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> <http://www.w3.org/2000/01/rdf-schema#label> "Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"@en .
# 
# https://w3id.org/SKGO/phm#Drug_resistance_and_its_role_in_clinical_oncology
<https://w3id.org/SKGO/phm#Drug_resistance_and_its_role_in_clinical_oncology> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Drug_resistance_and_its_role_in_clinical_oncology> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#Drug_resistance_and_its_role_in_clinical_oncology> <http://purl.org/dc/terms/description> "Cellular mechanisms of multidrug resistance and ATP-binding cassette (ABC) transporters" .
<https://w3id.org/SKGO/phm#Drug_resistance_and_its_role_in_clinical_oncology> <http://www.w3.org/2000/01/rdf-schema#label> "Drug_resistance_and_its_role_in_clinical_oncology"@en .
# 
# https://w3id.org/SKGO/phm#EasternBlotting
<https://w3id.org/SKGO/phm#EasternBlotting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#EasternBlotting> <http://xmlns.com/foaf/0.1/name> "EasternBlotting"@en .
# 
# https://w3id.org/SKGO/phm#Eastern_Blot_Analysis
<https://w3id.org/SKGO/phm#Eastern_Blot_Analysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Eastern_Blot_Analysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#EasternBlotting> .
<https://w3id.org/SKGO/phm#Eastern_Blot_Analysis> <http://www.w3.org/2000/01/rdf-schema#label> "Eastern_Blot_Analysis"@en .
# 
# https://w3id.org/SKGO/phm#Efflux_Bioassay
<https://w3id.org/SKGO/phm#Efflux_Bioassay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Efflux_Bioassay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#Efflux_Bioassay> <http://www.w3.org/2000/01/rdf-schema#label> "Efflux_Bioassay"@en .
# 
# https://w3id.org/SKGO/phm#Elisabeth_Paietta
<https://w3id.org/SKGO/phm#Elisabeth_Paietta> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Elisabeth_Paietta> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://w3id.org/SKGO/phm#Elisabeth_Paietta> <http://www.w3.org/2000/01/rdf-schema#label> "Elisabeth Paietta" .
# 
# https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Actinomycin_D> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Anthracyclines-doxorubucin_daunorubicin_epirubicin> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Colchicine> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Methotrexate> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Podophyllotoxin-etoposide_teniposide> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP1> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP2> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP3> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP4> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP5> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP6> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP7> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP8> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#mdr1> .
<https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> <http://www.w3.org/2000/01/rdf-schema#label> "Endogenous_and_exogenous_substrates_for_ABC_transporters"@en .
# 
# https://w3id.org/SKGO/phm#Epirubicin
<https://w3id.org/SKGO/phm#Epirubicin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Epirubicin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Epirubicin> <http://www.w3.org/2000/01/rdf-schema#label> "Epirubicin"@en .
# 
# https://w3id.org/SKGO/phm#Etoposide
<https://w3id.org/SKGO/phm#Etoposide> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Etoposide> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Etoposide> <http://www.w3.org/2000/01/rdf-schema#label> "Etoposide"@en .
# 
# https://w3id.org/SKGO/phm#European_Journal_of_Pharmaceutical_Sciences
<https://w3id.org/SKGO/phm#European_Journal_of_Pharmaceutical_Sciences> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#European_Journal_of_Pharmaceutical_Sciences> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publisher> .
# 
# https://w3id.org/SKGO/phm#Evidence17
<https://w3id.org/SKGO/phm#Evidence17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence18
<https://w3id.org/SKGO/phm#Evidence18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence19
<https://w3id.org/SKGO/phm#Evidence19> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence2
<https://w3id.org/SKGO/phm#Evidence2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence20
<https://w3id.org/SKGO/phm#Evidence20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence3
<https://w3id.org/SKGO/phm#Evidence3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence4
<https://w3id.org/SKGO/phm#Evidence4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence5
<https://w3id.org/SKGO/phm#Evidence5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence6
<https://w3id.org/SKGO/phm#Evidence6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence7
<https://w3id.org/SKGO/phm#Evidence7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence8
<https://w3id.org/SKGO/phm#Evidence8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence9
<https://w3id.org/SKGO/phm#Evidence9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function> .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://purl.org/ontology/bibo/abstract> "Background: Multidrug resistance (MDR) transporter proteins such as P-glycoprotein (P-gp) efflux a variety\nof chemotherapeutic drugs from acute myeloid leukemia (AML) blasts leading to clinical drug resistance.\nMethods: This study examined heterogeneity of MDR functional efflux by AML blasts using two flow cytometry\nbioassays. Bone marrow specimens (N = 50) from elderly patients with newly diagnosed AML were analyzed\nfor CD34+ blasts with MDR efflux function. Efflux was measured with a fluorescent dye (DiOC2) as a\nsurrogate for oncology drugs that are substrates for MDR efflux. P-gp-mediated efflux was differentiated from\nnon-P-gp MDR activities using zosuquidar, a highly selective P-gp modulator. The bioassays included a\nzosuquidar-dependent DiOC2 accumulation bioassay that measured only P-gp. The second method, termed the\nefflux bioassay, could detect P-gp and other non-P-gp efflux depending on bioassay culture conditions.\nResults: Sixty-two percent of the specimens were considered positive for blasts with P-gp function, and\n26% of such P-gp-positive specimens also exhibited zosuquidar-resistant (i.e., non-P-gp) MDR efflux activity;\n37% of P-gp-negative AML blast specimens displayed zosuquidar-resistant MDR function in the efflux\nbioassay.\nConclusions: These results confirm the heterogeneous nature of MDR efflux pumps in AML blasts, and provide\nsupport for the hypothesis that non-P-gp MDR contributed to negative results with zosuquidar in AML trials\nlike ECOG-ACRIN E3999."@en .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://purl.org/dc/elements/1.1/title> "Evidence of a Role for Functional Heterogeneity in\nMultidrug Resistance Transporters in Clinical Trials of\nP-Glycoprotein Modulation in Acute Myeloid Leukemia"@en .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Branimir_I._Sikic> .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Elisabeth_Paietta> .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#John_F._Marcelletti> .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Larry_D._Cripe> .
<https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#International_Clinical_Cytometry_Society> .
# 
# https://w3id.org/SKGO/phm#ExperimentalStudy
<https://w3id.org/SKGO/phm#ExperimentalStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ExperimentalStudy> <http://xmlns.com/foaf/0.1/name> "ExperimentalStudy"@en .
# 
# https://w3id.org/SKGO/phm#Experimental_Study
<https://w3id.org/SKGO/phm#Experimental_Study> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Experimental_Study> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ExperimentalStudy> .
<https://w3id.org/SKGO/phm#Experimental_Study> <http://www.w3.org/2000/01/rdf-schema#label> "Experimental Study"@en .
# 
# https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Adrenocortical_Cancer> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Colon_Tumor> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Neuroblastoma> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Neuroepithelioma> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Pheochromocytoma> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Rhabdomyosarcoma> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#investigatesProblem> <https://w3id.org/SKGO/phm#Multiple_chemotherapeutic_agents> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#mdr1_gene_expression> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <http://ns.nature.com/terms/name> "Expression of a multidrug-resistance gene in human tumors and tissues" .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <https://w3id.org/SKGO/phm#hasSuggestion> "Some cases of colon cancer, increased expression of the mdr1 gene might be involved in the intrinsic resistance of these tumors to chemotherapeutic agents." .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> <http://www.w3.org/2000/01/rdf-schema#label> "Expression_of_a_multidrug-resistance_gene"@en .
# 
# https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://ns.nature.com/terms/publicationYear> "1987"^^<http://www.w3.org/2001/XMLSchema#gYear> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://purl.org/ontology/bibo/abstract> "The identification and cloning of a segment of a human multidrug resistance gene (mdrl) was reported recently. To examine the molecular basis of one type of multidrug resistance, we have prepared RNA from human tumors and normal tissues and measured their content of mdrl RNA. We find that the mdrl gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at\nintermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues. The mdrl gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon. In addition, increased expression was detected in a few tumors at the time of relapse following initial chemotherapy. Although controlled clinical studies will be required, our results suggest that measurement of mdrl RNA may prove to be a valuable tool in the design of chemotherapy protocols." .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#D._G._POPLACK> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#D._J._SLAMON> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#I._PASTAN> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#K._UEDA> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#M._M._GOTTESMAN> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA> .
<https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues> <http://purl.org/dc/terms/title> "Expression of a multidrug-resistance gene in human tumors and tissues"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#Finding1
<https://w3id.org/SKGO/phm#Finding1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding10
<https://w3id.org/SKGO/phm#Finding10> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding11
<https://w3id.org/SKGO/phm#Finding11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding12
<https://w3id.org/SKGO/phm#Finding12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding13
<https://w3id.org/SKGO/phm#Finding13> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding14
<https://w3id.org/SKGO/phm#Finding14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding15
<https://w3id.org/SKGO/phm#Finding15> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding16
<https://w3id.org/SKGO/phm#Finding16> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding17
<https://w3id.org/SKGO/phm#Finding17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding18
<https://w3id.org/SKGO/phm#Finding18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding19
<https://w3id.org/SKGO/phm#Finding19> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding2
<https://w3id.org/SKGO/phm#Finding2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding20
<https://w3id.org/SKGO/phm#Finding20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding3
<https://w3id.org/SKGO/phm#Finding3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding4
<https://w3id.org/SKGO/phm#Finding4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding5
<https://w3id.org/SKGO/phm#Finding5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding6
<https://w3id.org/SKGO/phm#Finding6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding7
<https://w3id.org/SKGO/phm#Finding7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding8
<https://w3id.org/SKGO/phm#Finding8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Finding9
<https://w3id.org/SKGO/phm#Finding9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Flavopiridol
<https://w3id.org/SKGO/phm#Flavopiridol> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Flavopiridol> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Flavopiridol> <http://www.w3.org/2000/01/rdf-schema#label> "Flavopiridol"@en .
# 
# https://w3id.org/SKGO/phm#Fluorochrome-labeled_anti-CD_antibodies
<https://w3id.org/SKGO/phm#Fluorochrome-labeled_anti-CD_antibodies> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Fluorochrome-labeled_anti-CD_antibodies> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Reagent> .
<https://w3id.org/SKGO/phm#Fluorochrome-labeled_anti-CD_antibodies> <https://w3id.org/SKGO/phm#obtainedfrom> <https://w3id.org/SKGO/phm#BD_Biosciences_La_Jolla_CA> .
<https://w3id.org/SKGO/phm#Fluorochrome-labeled_anti-CD_antibodies> <http://www.w3.org/2000/01/rdf-schema#label> "Fluorochrome-labeled_anti-CD_antibodies"@en .
# 
# https://w3id.org/SKGO/phm#Fluorouracil
<https://w3id.org/SKGO/phm#Fluorouracil> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Fluorouracil> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Fluorouracil> <http://www.w3.org/2000/01/rdf-schema#label> "Fluorouracil"@en .
# 
# https://w3id.org/SKGO/phm#Functional_Assay
<https://w3id.org/SKGO/phm#Functional_Assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Functional_Assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#Functional_Assay> <http://www.w3.org/2000/01/rdf-schema#label> "Functional_Assay"@en .
# 
# https://w3id.org/SKGO/phm#Functional_Bioassay
<https://w3id.org/SKGO/phm#Functional_Bioassay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Functional_Bioassay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#Functional_Bioassay> <http://www.w3.org/2000/01/rdf-schema#label> "Functional_Bioassay"@en .
# 
# https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy
<https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Treatment> .
<https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#Breast_cancer_samples> .
<https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy> <https://w3id.org/SKGO/phm#failureReason> "PGP expression increased after therapy and was associated with a greater likelihood of treatment failure." .
<https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy> <https://w3id.org/SKGO/phm#treatmentOutcome> "Toxicity" .
<https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy> <http://www.w3.org/2000/01/rdf-schema#label> "Functions_of_ABC_transporters_in_Chemotherapy"@en .
# 
# https://w3id.org/SKGO/phm#Gastrointestinal_stromal_tumour_GIST_cell_lines
<https://w3id.org/SKGO/phm#Gastrointestinal_stromal_tumour_GIST_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Gastrointestinal_stromal_tumour_GIST_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#Gastrointestinal_stromal_tumour_GIST_cell_lines> <http://www.w3.org/2000/01/rdf-schema#label> "Gastrointestinal_stromal_tumour_GIST_cell_lines"@en .
# 
# https://w3id.org/SKGO/phm#Gefitinib
<https://w3id.org/SKGO/phm#Gefitinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Gefitinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Gefitinib> <http://www.w3.org/2000/01/rdf-schema#label> "Gefitinib"@en .
# 
# https://w3id.org/SKGO/phm#Gergely_Szakács
<https://w3id.org/SKGO/phm#Gergely_Szak\u00E1cs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Gergely_Szak\u00E1cs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Growth_inhibition_assays
<https://w3id.org/SKGO/phm#Growth_inhibition_assays> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Growth_inhibition_assays> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#Growth_inhibition_assays> <http://www.w3.org/2000/01/rdf-schema#label> "Growth_inhibition_assays"@en .
# 
# https://w3id.org/SKGO/phm#HTB_10_HTB_11_HTB_38
<https://w3id.org/SKGO/phm#HTB_10_HTB_11_HTB_38> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#HTB_10_HTB_11_HTB_38> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#HTB_10_HTB_11_HTB_38> <http://www.w3.org/2000/01/rdf-schema#label> "HTB_10_HTB_11_HTB_38"@en .
# 
# https://w3id.org/SKGO/phm#Head_and_neck_cancer
<https://w3id.org/SKGO/phm#Head_and_neck_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Head_and_neck_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Head_and_neck_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Head_and_neck_cancer"@en .
# 
# https://w3id.org/SKGO/phm#High-risk_MDS_sample
<https://w3id.org/SKGO/phm#High-risk_MDS_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#High-risk_MDS_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#High-risk_MDS_sample> <http://www.w3.org/2000/01/rdf-schema#label> "High-risk_MDS_sample"@en .
# 
# https://w3id.org/SKGO/phm#I._PASTAN
<https://w3id.org/SKGO/phm#I._PASTAN> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#I._PASTAN> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#IL-2
<https://w3id.org/SKGO/phm#IL-2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#IL-2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#IL-2> <http://www.w3.org/2000/01/rdf-schema#label> "IL-2"@en .
# 
# https://w3id.org/SKGO/phm#Iamivudine
<https://w3id.org/SKGO/phm#Iamivudine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Iamivudine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Iamivudine> <http://www.w3.org/2000/01/rdf-schema#label> "Iamivudine"@en .
# 
# https://w3id.org/SKGO/phm#Idarubicine
<https://w3id.org/SKGO/phm#Idarubicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Idarubicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Idarubicine> <http://www.w3.org/2000/01/rdf-schema#label> "Idarubicine"@en .
# 
# https://w3id.org/SKGO/phm#Idarubicinol
<https://w3id.org/SKGO/phm#Idarubicinol> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Idarubicinol> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Idarubicinol> <http://www.w3.org/2000/01/rdf-schema#label> "Idarubicinol"@en .
# 
# https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP
<https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP> <https://w3id.org/SKGO/phm#hasStudyDesign> <https://w3id.org/SKGO/phm#Review_Study> .
<https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#AML> .
<https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> .
<https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP> <http://www.w3.org/2000/01/rdf-schema#label> "Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"@en .
# 
# https://w3id.org/SKGO/phm#Ifosfamide
<https://w3id.org/SKGO/phm#Ifosfamide> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Ifosfamide> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Ifosfamide> <http://www.w3.org/2000/01/rdf-schema#label> "Ifosfamide"@en .
# 
# https://w3id.org/SKGO/phm#Ikumi_Tamai
<https://w3id.org/SKGO/phm#Ikumi_Tamai> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Ikumi_Tamai> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Imatinib
<https://w3id.org/SKGO/phm#Imatinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Imatinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Imatinib> <http://www.w3.org/2000/01/rdf-schema#label> "Imatinib"@en .
# 
# https://w3id.org/SKGO/phm#Immunosuppressant_cyclosporin_A
<https://w3id.org/SKGO/phm#Immunosuppressant_cyclosporin_A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Immunosuppressant_cyclosporin_A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Immunosuppressant_cyclosporin_A> <http://www.w3.org/2000/01/rdf-schema#label> "Immunosuppressant_cyclosporin_A"@en .
# 
# https://w3id.org/SKGO/phm#Indolocarbazole
<https://w3id.org/SKGO/phm#Indolocarbazole> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Indolocarbazole> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Indolocarbazole> <http://www.w3.org/2000/01/rdf-schema#label> "Indolocarbazole"@en .
# 
# https://w3id.org/SKGO/phm#International_Clinical_Cytometry_Society
<https://w3id.org/SKGO/phm#International_Clinical_Cytometry_Society> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#International_Clinical_Cytometry_Society> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publisher> .
# 
# https://w3id.org/SKGO/phm#Invitrogen
<https://w3id.org/SKGO/phm#Invitrogen> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Invitrogen> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
# 
# https://w3id.org/SKGO/phm#Jill_K._Paterson
<https://w3id.org/SKGO/phm#Jill_K._Paterson> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Jill_K._Paterson> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#John_F._Marcelletti
<https://w3id.org/SKGO/phm#John_F._Marcelletti> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#John_F._Marcelletti> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Joseph_A._Ludwig
<https://w3id.org/SKGO/phm#Joseph_A._Ludwig> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Joseph_A._Ludwig> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#K._UEDA
<https://w3id.org/SKGO/phm#K._UEDA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#K._UEDA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#KB-3-1_KB-8-5_KB-V1
<https://w3id.org/SKGO/phm#KB-3-1_KB-8-5_KB-V1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#KB-3-1_KB-8-5_KB-V1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#KB-3-1_KB-8-5_KB-V1> <http://www.w3.org/2000/01/rdf-schema#label> "KB-3-1_KB-8-5_KB-V1"@en .
# 
# https://w3id.org/SKGO/phm#Kazuki_Fukuchi
<https://w3id.org/SKGO/phm#Kazuki_Fukuchi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Kazuki_Fukuchi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Keiichi_Kawai
<https://w3id.org/SKGO/phm#Keiichi_Kawai> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Keiichi_Kawai> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Kodai_Nishi
<https://w3id.org/SKGO/phm#Kodai_Nishi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Kodai_Nishi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#L._AUSTIN_DOYLE
<https://w3id.org/SKGO/phm#L._AUSTIN_DOYLE> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#L._AUSTIN_DOYLE> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#LYNNE_V._ABRUZZO
<https://w3id.org/SKGO/phm#LYNNE_V._ABRUZZO> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#LYNNE_V._ABRUZZO> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Larry_D._Cripe
<https://w3id.org/SKGO/phm#Larry_D._Cripe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Larry_D._Cripe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Lawrence_D._Mayer
<https://w3id.org/SKGO/phm#Lawrence_D._Mayer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Lawrence_D._Mayer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Leukaemia
<https://w3id.org/SKGO/phm#Leukaemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Leukaemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Leukaemia> <http://www.w3.org/2000/01/rdf-schema#label> "Leukaemia"@en .
# 
# https://w3id.org/SKGO/phm#Leukotriene_C4
<https://w3id.org/SKGO/phm#Leukotriene_C4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Leukotriene_C4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Leukotriene_C4> <http://www.w3.org/2000/01/rdf-schema#label> "Leukotriene_C4"@en .
# 
# https://w3id.org/SKGO/phm#Levels_of_mdrl_mRNA
<https://w3id.org/SKGO/phm#Levels_of_mdrl_mRNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Levels_of_mdrl_mRNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#Levels_of_mdrl_mRNA> <http://purl.org/dc/terms/description> "Since expression of the mdrl gene is responsible for multidrug resistance in tissue culture systems, we measured levels of mdrl mRNA in normal human tissues and in untreated and treated human cancers." .
<https://w3id.org/SKGO/phm#Levels_of_mdrl_mRNA> <http://www.w3.org/2000/01/rdf-schema#label> "Levels_of_mdrl_mRNA"@en .
# 
# https://w3id.org/SKGO/phm#Lung_cancer
<https://w3id.org/SKGO/phm#Lung_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Lung_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Lung_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Lung_cancer"@en .
# 
# https://w3id.org/SKGO/phm#Lymphoma
<https://w3id.org/SKGO/phm#Lymphoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Lymphoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Lymphoma> <http://www.w3.org/2000/01/rdf-schema#label> "Lymphoma"@en .
# 
# https://w3id.org/SKGO/phm#M._M._GOTTESMAN
<https://w3id.org/SKGO/phm#M._M._GOTTESMAN> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#M._M._GOTTESMAN> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#MCF-7_human_breast_carcinoma_cells
<https://w3id.org/SKGO/phm#MCF-7_human_breast_carcinoma_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MCF-7_human_breast_carcinoma_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#MCF-7_human_breast_carcinoma_cells> <https://w3id.org/SKGO/phm#obtainedfrom> <https://w3id.org/SKGO/phm#National_Cancer_Institute> .
<https://w3id.org/SKGO/phm#MCF-7_human_breast_carcinoma_cells> <http://www.w3.org/2000/01/rdf-schema#label> "MCF-7_human_breast_carcinoma_cells"@en .
# 
# https://w3id.org/SKGO/phm#MDR2
<https://w3id.org/SKGO/phm#MDR2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MDR2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MDR2> <http://www.w3.org/2000/01/rdf-schema#label> "MDR2"@en .
# 
# https://w3id.org/SKGO/phm#MRP1
<https://w3id.org/SKGO/phm#MRP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MRP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MRP1> <http://www.w3.org/2000/01/rdf-schema#label> "MRP1"@en .
# 
# https://w3id.org/SKGO/phm#MRP2
<https://w3id.org/SKGO/phm#MRP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MRP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MRP2> <http://www.w3.org/2000/01/rdf-schema#label> "MRP2"@en .
# 
# https://w3id.org/SKGO/phm#MRP3
<https://w3id.org/SKGO/phm#MRP3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MRP3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MRP3> <http://www.w3.org/2000/01/rdf-schema#label> "MRP3"@en .
# 
# https://w3id.org/SKGO/phm#MRP4
<https://w3id.org/SKGO/phm#MRP4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MRP4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MRP4> <http://www.w3.org/2000/01/rdf-schema#label> "MRP4"@en .
# 
# https://w3id.org/SKGO/phm#MRP5
<https://w3id.org/SKGO/phm#MRP5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MRP5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MRP5> <http://www.w3.org/2000/01/rdf-schema#label> "MRP5"@en .
# 
# https://w3id.org/SKGO/phm#MRP6
<https://w3id.org/SKGO/phm#MRP6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MRP6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MRP6> <http://www.w3.org/2000/01/rdf-schema#label> "MRP6"@en .
# 
# https://w3id.org/SKGO/phm#MRP7
<https://w3id.org/SKGO/phm#MRP7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MRP7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MRP7> <http://www.w3.org/2000/01/rdf-schema#label> "MRP7"@en .
# 
# https://w3id.org/SKGO/phm#MRP8
<https://w3id.org/SKGO/phm#MRP8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MRP8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#MRP8> <http://www.w3.org/2000/01/rdf-schema#label> "MRP8"@en .
# 
# https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd
<https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publisher> .
<https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Agent> .
<https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd> <http://ns.nature.com/terms/name> "Macmillan Magazines Ltd"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#Masato_Kobayashi
<https://w3id.org/SKGO/phm#Masato_Kobayashi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Masato_Kobayashi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#ALL> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#CML> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Colerectal_cancer> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Head_and_neck_cancer> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Lymphoma> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Melanoma> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#NSCLC> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Ovarian_cancer> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Pancreatic_cancer> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#BH3_profiling> .
<https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment> <http://www.w3.org/2000/01/rdf-schema#label> "Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"@en .
# 
# https://w3id.org/SKGO/phm#Melanoma
<https://w3id.org/SKGO/phm#Melanoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Melanoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Melanoma> <http://www.w3.org/2000/01/rdf-schema#label> "Melanoma"@en .
# 
# https://w3id.org/SKGO/phm#Melanoma_cell_line
<https://w3id.org/SKGO/phm#Melanoma_cell_line> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Melanoma_cell_line> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#Melanoma_cell_line> <http://www.w3.org/2000/01/rdf-schema#label> "Melanoma_cell_line"@en .
# 
# https://w3id.org/SKGO/phm#Methotrexate
<https://w3id.org/SKGO/phm#Methotrexate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Methotrexate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Methotrexate> <http://www.w3.org/2000/01/rdf-schema#label> "Methotrexate"@en .
# 
# https://w3id.org/SKGO/phm#Michael_M._Gottesman
<https://w3id.org/SKGO/phm#Michael_M._Gottesman> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Michael_M._Gottesman> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Mitomycin_C
<https://w3id.org/SKGO/phm#Mitomycin_C> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Mitomycin_C> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Mitomycin_C> <http://www.w3.org/2000/01/rdf-schema#label> "Mitomycin_C"@en .
# 
# https://w3id.org/SKGO/phm#Mitoxantrone
<https://w3id.org/SKGO/phm#Mitoxantrone> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Mitoxantrone> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Mitoxantrone> <http://www.w3.org/2000/01/rdf-schema#label> "Mitoxantrone"@en .
# 
# https://w3id.org/SKGO/phm#Multidrug_Resistance_Monitoring_in_Cancer
<https://w3id.org/SKGO/phm#Multidrug_Resistance_Monitoring_in_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Multidrug_Resistance_Monitoring_in_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#Multidrug_Resistance_Monitoring_in_Cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Multidrug_Resistance_Monitoring_in_Cancer"@en .
# 
# https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Colerectal_cancer> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Lung_cancer> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Myeloma> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Ovarian_cancer> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Renal_cell_cancer> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <https://w3id.org/SKGO/phm#investigatesProblem> <https://w3id.org/SKGO/phm#Role_of_P-GP_in_MDR> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#Vesicle_transport_experiments> .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <http://ns.nature.com/terms/name> "Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs" .
<https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> <http://www.w3.org/2000/01/rdf-schema#label> "Multidrug_resistance-MDR_in_cancer_Mechanisms"@en .
# 
# https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells> <http://www.w3.org/2000/01/rdf-schema#label> "Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells"@en .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells> <http://www.w3.org/2004/02/skos/core#definition> "Multidrug resistance (MDR) efflux pumps capable of\neliminating chemotherapeutic drugs from tumor cells\ncontribute to clinical drug resistance in acute myeloid\nleukemia (AML) and other cancers."@en .
# 
# https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://ns.nature.com/terms/publicationYear> "2000"^^<http://www.w3.org/2001/XMLSchema#gYear> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://purl.org/ontology/bibo/abstract> "In recent years, there has been an increased understanding of P-glycoprotein (P-GP)-mediated pharmacokinetic interactions. In addition,\nits role in modifying the bioavailability of orally administered drugs via induction or inhibition has been also been demonstrated in\nvarious studies. This overview presents a background on some of the commonly documented mechanisms of multidrug resistance (MDR),\nreversal using modulators of MDR, followed by a discussion on the functional aspects of P-GP in the context of the pharmacokinetic\ninteractions when multiple agents are coadministered. While adverse pharmacokinetic interactions have been documented with first and\nsecond generation MDR modulators, certain newer agents of the third generation class of compounds have been less susceptible in\neliciting pharmacokinetic interactions. Although the review focuses on P-GP and the pharmacology of MDR reversal using MDR\nmodulators, relevance of these drug transport proteins in the context of pharmacokinetic implications (drug absorption, distribution,\nclearance, and interactions) will also be discussed."@en .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Lawrence_D._Mayer> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Rajesh_Krishna> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#European_Journal_of_Pharmaceutical_Sciences> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs> <http://purl.org/dc/terms/title> "Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://ns.nature.com/terms/publicationYear> "2003"^^<http://www.w3.org/2001/XMLSchema#gYear> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://purl.org/ontology/bibo/abstract> "Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines without overexpression of P-glycoprotein or multidrug resistance protein (MRP) family members\nsuggested the existence of another ATP-binding cassette (ABC) transporter capable of causing cancer drug resistance. In one such cell line (MCF-7/AdrVp), the overexpression of a novel member of the G subfamily of ABC transporters was found. The new transporter was termed the breast cancer resistance protein (BCRP), because of its identification in MCF-7 human breast carcinoma cells. BCRP is a 655 amino-acid polypeptide, formally designated as ABCG2. Like all members of the ABC G (white) subfamily, BCRP is a half transporter. Transfection and enforced overexpression of BCRP in drug-sensitive MCF-7 or MDA-MB-231 cells recapitulates the drug-resistance phenotype of MCF-7/AdrVp cells, consistent with current evidence suggesting that\nfunctional BCRP is a homodimer. BCRP maps to chromosome 4q22, downstream from a TATA-less promoter. The spectrum of anticancer drugs effluxed by BCRP includes mitoxantrone, camptothecin-derived and\nindolocarbazole topoisomerase I inhibitors, methotrexate, flavopiridol, and quinazoline ErbB1 inhibitors. Transport of anthracyclines is variable and appears to depend on the presence of a BCRP mutation at codon 482. Potent and\nspecific inhibitors of BCRP are now being developed, opening the door to clinical applications of BCRP inhibition. Owing to tissue localization in the placenta, bile canaliculi, colon, small bowel, and brain microvessel endothelium, BCRP may play a role in protecting the organism from potentially harmful xenobiotics. BCRP expression has also been demonstrated in pluripotential ‘side population’ stem cells, responsible for the characteristic ability of these cells to exclude Hoechst 33342 dye, and possibly for the maintenance of the stem cell\nphenotype. Studies are emerging on the role of BCRP expression in drug resistance in clinical cancers. More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional\nassays, in order to determine the contribution of BCRP to drug resistance in human cancers."@en .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#L._AUSTIN_DOYLE> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#Nature_Publishing_Group> .
<https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP> <http://purl.org/dc/terms/title> "Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#Multiple_chemotherapeutic_agents
<https://w3id.org/SKGO/phm#Multiple_chemotherapeutic_agents> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Multiple_chemotherapeutic_agents> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#Multiple_chemotherapeutic_agents> <http://www.w3.org/2000/01/rdf-schema#label> "Multiple_chemotherapeutic_agents"@en .
# 
# https://w3id.org/SKGO/phm#MutationResult1
<https://w3id.org/SKGO/phm#MutationResult1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult10
<https://w3id.org/SKGO/phm#MutationResult10> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult11
<https://w3id.org/SKGO/phm#MutationResult11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult12
<https://w3id.org/SKGO/phm#MutationResult12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult13
<https://w3id.org/SKGO/phm#MutationResult13> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult14
<https://w3id.org/SKGO/phm#MutationResult14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult15
<https://w3id.org/SKGO/phm#MutationResult15> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult16
<https://w3id.org/SKGO/phm#MutationResult16> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult17
<https://w3id.org/SKGO/phm#MutationResult17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult18
<https://w3id.org/SKGO/phm#MutationResult18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult19
<https://w3id.org/SKGO/phm#MutationResult19> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult2
<https://w3id.org/SKGO/phm#MutationResult2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult20
<https://w3id.org/SKGO/phm#MutationResult20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult3
<https://w3id.org/SKGO/phm#MutationResult3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult4
<https://w3id.org/SKGO/phm#MutationResult4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult5
<https://w3id.org/SKGO/phm#MutationResult5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult6
<https://w3id.org/SKGO/phm#MutationResult6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult7
<https://w3id.org/SKGO/phm#MutationResult7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult8
<https://w3id.org/SKGO/phm#MutationResult8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#MutationResult9
<https://w3id.org/SKGO/phm#MutationResult9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Myeloma
<https://w3id.org/SKGO/phm#Myeloma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Myeloma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Myeloma> <http://www.w3.org/2000/01/rdf-schema#label> "Myeloma"@en .
# 
# https://w3id.org/SKGO/phm#NSCLC
<https://w3id.org/SKGO/phm#NSCLC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#NSCLC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#NSCLC> <http://www.w3.org/2000/01/rdf-schema#label> "NSCLC"@en .
# 
# https://w3id.org/SKGO/phm#NSCLC_cell_lines
<https://w3id.org/SKGO/phm#NSCLC_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#NSCLC_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#NSCLC_cell_lines> <http://www.w3.org/2000/01/rdf-schema#label> "NSCLC_cell_lines"@en .
# 
# https://w3id.org/SKGO/phm#NSCLC_sample
<https://w3id.org/SKGO/phm#NSCLC_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#NSCLC_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#NSCLC_sample> <https://w3id.org/SKGO/phm#obtainedfromPatient> <https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> .
<https://w3id.org/SKGO/phm#NSCLC_sample> <http://www.w3.org/2000/01/rdf-schema#label> "NSCLC_sample"@en .
# 
# https://w3id.org/SKGO/phm#National_Cancer_Institute
<https://w3id.org/SKGO/phm#National_Cancer_Institute> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#National_Cancer_Institute> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
# 
# https://w3id.org/SKGO/phm#Nature_Publishing_Group
<https://w3id.org/SKGO/phm#Nature_Publishing_Group> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Nature_Publishing_Group> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publisher> .
<https://w3id.org/SKGO/phm#Nature_Publishing_Group> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Agent> .
<https://w3id.org/SKGO/phm#Nature_Publishing_Group> <http://ns.nature.com/terms/name> "Nature Publishing Group"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#Neck_squamous_cell_carcinoma_cell_lines
<https://w3id.org/SKGO/phm#Neck_squamous_cell_carcinoma_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Neck_squamous_cell_carcinoma_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#Neck_squamous_cell_carcinoma_cell_lines> <http://www.w3.org/2000/01/rdf-schema#label> "Neck_squamous_cell_carcinoma_cell_lines"@en .
# 
# https://w3id.org/SKGO/phm#Neuroblastoma
<https://w3id.org/SKGO/phm#Neuroblastoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Neuroblastoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Neuroblastoma> <http://www.w3.org/2000/01/rdf-schema#label> "Neuroblastoma"@en .
# 
# https://w3id.org/SKGO/phm#Neuroblastoma_Cell
<https://w3id.org/SKGO/phm#Neuroblastoma_Cell> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Neuroblastoma_Cell> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#Neuroblastoma_Cell> <https://w3id.org/SKGO/phm#obtainedfrom> <https://w3id.org/SKGO/phm#American_Type_Culture_Collection> .
<https://w3id.org/SKGO/phm#Neuroblastoma_Cell> <http://www.w3.org/2000/01/rdf-schema#label> "Neuroblastoma_Cell"@en .
# 
# https://w3id.org/SKGO/phm#Neuroepithelioma
<https://w3id.org/SKGO/phm#Neuroepithelioma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Neuroepithelioma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Neuroepithelioma> <http://www.w3.org/2000/01/rdf-schema#label> "Neuroepithelioma"@en .
# 
# https://w3id.org/SKGO/phm#Nilotinib
<https://w3id.org/SKGO/phm#Nilotinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Nilotinib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Nilotinib> <http://www.w3.org/2000/01/rdf-schema#label> "Nilotinib"@en .
# 
# https://w3id.org/SKGO/phm#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar
<https://w3id.org/SKGO/phm#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar> <http://www.w3.org/2000/01/rdf-schema#label> "Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar"@en .
<https://w3id.org/SKGO/phm#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar> <http://www.w3.org/2004/02/skos/core#definition> "Non-P-gp MDR contributed to negative results with zosuquidar in AML trials\nlike ECOG-ACRIN E3999"@en .
# 
# https://w3id.org/SKGO/phm#Non_Smallcell_Lung_Cancer
<https://w3id.org/SKGO/phm#Non_Smallcell_Lung_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Non_Smallcell_Lung_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Non_Smallcell_Lung_Cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Non_Smallcell_Lung_Cancer"@en .
# 
# https://w3id.org/SKGO/phm#Northern_analysis_of_the_expression_of_BCRP_mRNA
<https://w3id.org/SKGO/phm#Northern_analysis_of_the_expression_of_BCRP_mRNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Northern_analysis_of_the_expression_of_BCRP_mRNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#NorthernBlotting> .
<https://w3id.org/SKGO/phm#Northern_analysis_of_the_expression_of_BCRP_mRNA> <http://www.w3.org/2000/01/rdf-schema#label> "Northern_analysis_of_the_expression_of_BCRP_mRNA"@en .
# 
# https://w3id.org/SKGO/phm#ObservationalStudy
<https://w3id.org/SKGO/phm#ObservationalStudy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ObservationalStudy> <http://xmlns.com/foaf/0.1/name> "ObservationalStudy"@en .
# 
# https://w3id.org/SKGO/phm#Observational_Study
<https://w3id.org/SKGO/phm#Observational_Study> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Observational_Study> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ObservationalStudy> .
<https://w3id.org/SKGO/phm#Observational_Study> <http://www.w3.org/2000/01/rdf-schema#label> "Observational Study"@en .
# 
# https://w3id.org/SKGO/phm#Ovarian_cancer
<https://w3id.org/SKGO/phm#Ovarian_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Ovarian_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Ovarian_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Ovarian_cancer"@en .
# 
# https://w3id.org/SKGO/phm#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance
<https://w3id.org/SKGO/phm#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance> <http://purl.org/dc/terms/description> "The focus of this review is P-GP-mediated MDR, a general overview of the underlying mechanisms and types of drug resistance is presented in the context of the overall MDR phenomenon." .
<https://w3id.org/SKGO/phm#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance> <http://www.w3.org/2000/01/rdf-schema#label> "P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance"@en .
# 
# https://w3id.org/SKGO/phm#Paclitaxel
<https://w3id.org/SKGO/phm#Paclitaxel> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Paclitaxel> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Paclitaxel> <http://www.w3.org/2000/01/rdf-schema#label> "Paclitaxel"@en .
# 
# https://w3id.org/SKGO/phm#Pancreatic_cancer
<https://w3id.org/SKGO/phm#Pancreatic_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Pancreatic_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Pancreatic_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Pancreatic_cancer"@en .
# 
# https://w3id.org/SKGO/phm#Pancreatic_cancer_cell_lines
<https://w3id.org/SKGO/phm#Pancreatic_cancer_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Pancreatic_cancer_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#Pancreatic_cancer_cell_lines> <http://www.w3.org/2000/01/rdf-schema#label> "Pancreatic_cancer_cell_lines"@en .
# 
# https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer
<https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Patient> .
<https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Adrenocortical_Cancer> .
<https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer> <https://w3id.org/SKGO/phm#has_Treatment> <https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy> .
<https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Patient_with_adrenocortical_cancer_and_breast_cancer"@en .
# 
# https://w3id.org/SKGO/phm#Patrick_G._Johnston
<https://w3id.org/SKGO/phm#Patrick_G._Johnston> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Patrick_G._Johnston> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Peripheral_blood_lymphocytes
<https://w3id.org/SKGO/phm#Peripheral_blood_lymphocytes> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Peripheral_blood_lymphocytes> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#Peripheral_blood_lymphocytes> <https://w3id.org/SKGO/phm#obtainedfromPatient> <https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia> .
<https://w3id.org/SKGO/phm#Peripheral_blood_lymphocytes> <http://www.w3.org/2000/01/rdf-schema#label> "Peripheral_blood_lymphocytes"@en .
# 
# https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors
<https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Patient> .
<https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#AML> .
<https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Lung_cancer> .
<https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> <https://w3id.org/SKGO/phm#has_Treatment> <https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> .
<https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> <http://www.w3.org/2000/01/rdf-schema#label> "Phase_III_clinical_trials_with_ABC_transporter_inhibitors"@en .
# 
# https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Patient> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Colerectal_cancer> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Lung_cancer> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Myeloma> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Ovarian_cancer> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Renal_cell_cancer> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <https://w3id.org/SKGO/phm#has_Treatment> <https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> .
<https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients> <http://www.w3.org/2000/01/rdf-schema#label> "Phase_II_clinical_trials_in_patients"@en .
# 
# https://w3id.org/SKGO/phm#Pheochromocytoma
<https://w3id.org/SKGO/phm#Pheochromocytoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Pheochromocytoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Pheochromocytoma> <http://www.w3.org/2000/01/rdf-schema#label> "Pheochromocytoma"@en .
# 
# https://w3id.org/SKGO/phm#Podophyllotoxin
<https://w3id.org/SKGO/phm#Podophyllotoxin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Podophyllotoxin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Podophyllotoxin> <http://www.w3.org/2000/01/rdf-schema#label> "Podophyllotoxin"@en .
# 
# https://w3id.org/SKGO/phm#Podophyllotoxin-etoposide_teniposide
<https://w3id.org/SKGO/phm#Podophyllotoxin-etoposide_teniposide> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Podophyllotoxin-etoposide_teniposide> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Podophyllotoxin-etoposide_teniposide> <http://www.w3.org/2000/01/rdf-schema#label> "Podophyllotoxin-etoposide_teniposide"@en .
# 
# https://w3id.org/SKGO/phm#Poor-risk_acute_leukaemia_samples
<https://w3id.org/SKGO/phm#Poor-risk_acute_leukaemia_samples> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Poor-risk_acute_leukaemia_samples> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#Poor-risk_acute_leukaemia_samples> <https://w3id.org/SKGO/phm#obtainedfromPatient> <https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> .
<https://w3id.org/SKGO/phm#Poor-risk_acute_leukaemia_samples> <http://www.w3.org/2000/01/rdf-schema#label> "Poor-risk_acute_leukaemia_samples"@en .
# 
# https://w3id.org/SKGO/phm#Prazocin
<https://w3id.org/SKGO/phm#Prazocin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Prazocin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Prazocin> <http://www.w3.org/2000/01/rdf-schema#label> "Prazocin"@en .
# 
# https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA
<https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publisher> .
<https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Agent> .
<https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA> <http://ns.nature.com/terms/name> "Proc. Nati. Acad. Sci. USA"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#Promega_Biotec
<https://w3id.org/SKGO/phm#Promega_Biotec> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Promega_Biotec> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
# 
# https://w3id.org/SKGO/phm#RNA_Fingerprinting
<https://w3id.org/SKGO/phm#RNA_Fingerprinting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#RNA_Fingerprinting> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> .
<https://w3id.org/SKGO/phm#RNA_Fingerprinting> <https://w3id.org/SKGO/phm#hasBlotAnalysis> <https://w3id.org/SKGO/phm#Northern_analysis_of_the_expression_of_BCRP_mRNA> .
<https://w3id.org/SKGO/phm#RNA_Fingerprinting> <https://w3id.org/SKGO/phm#useAssay> <https://w3id.org/SKGO/phm#RT-PCR_assay> .
<https://w3id.org/SKGO/phm#RNA_Fingerprinting> <https://w3id.org/SKGO/phm#useAssay> <https://w3id.org/SKGO/phm#Sulforhodamine-B_cytotoxicity_assay> .
<https://w3id.org/SKGO/phm#RNA_Fingerprinting> <http://www.w3.org/2000/01/rdf-schema#label> "RNA_Fingerprinting"@en .
# 
# https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition
<https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> .
<https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition> <https://w3id.org/SKGO/phm#hasTreatment> <https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy> .
<https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition> <https://w3id.org/SKGO/phm#useAssay> <https://w3id.org/SKGO/phm#Surrogate_Assay> .
<https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition> <http://www.w3.org/2000/01/rdf-schema#label> "ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"@en .
# 
# https://w3id.org/SKGO/phm#RT-PCR_assay
<https://w3id.org/SKGO/phm#RT-PCR_assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#RT-PCR_assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#RT-PCR_assay> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#Drosophila_white_gene> .
<https://w3id.org/SKGO/phm#RT-PCR_assay> <http://www.w3.org/2000/01/rdf-schema#label> "RT-PCR_assay"@en .
# 
# https://w3id.org/SKGO/phm#Rajesh_Krishna
<https://w3id.org/SKGO/phm#Rajesh_Krishna> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Rajesh_Krishna> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Refractory_AML_high-risk_MDS_sample
<https://w3id.org/SKGO/phm#Refractory_AML_high-risk_MDS_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Refractory_AML_high-risk_MDS_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#Refractory_AML_high-risk_MDS_sample> <https://w3id.org/SKGO/phm#obtainedfromPatient> <https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> .
<https://w3id.org/SKGO/phm#Refractory_AML_high-risk_MDS_sample> <http://www.w3.org/2000/01/rdf-schema#label> "Refractory_AML_high-risk_MDS_sample"@en .
# 
# https://w3id.org/SKGO/phm#Relapsed_and_refractory_AML_sample
<https://w3id.org/SKGO/phm#Relapsed_and_refractory_AML_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Relapsed_and_refractory_AML_sample> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Specimen> .
<https://w3id.org/SKGO/phm#Relapsed_and_refractory_AML_sample> <https://w3id.org/SKGO/phm#obtainedfromPatient> <https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors> .
<https://w3id.org/SKGO/phm#Relapsed_and_refractory_AML_sample> <http://www.w3.org/2000/01/rdf-schema#label> "Relapsed_and_refractory_AML_sample"@en .
# 
# https://w3id.org/SKGO/phm#Renal_cell_cancer
<https://w3id.org/SKGO/phm#Renal_cell_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Renal_cell_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Renal_cell_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Renal_cell_cancer"@en .
# 
# https://w3id.org/SKGO/phm#Review_Study
<https://w3id.org/SKGO/phm#Review_Study> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Review_Study> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ReviewStudy> .
<https://w3id.org/SKGO/phm#Review_Study> <http://www.w3.org/2000/01/rdf-schema#label> "Review Study"@en .
# 
# https://w3id.org/SKGO/phm#Rhabdomyosarcoma
<https://w3id.org/SKGO/phm#Rhabdomyosarcoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Rhabdomyosarcoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Rhabdomyosarcoma> <http://www.w3.org/2000/01/rdf-schema#label> "Rhabdomyosarcoma"@en .
# 
# https://w3id.org/SKGO/phm#Role_of_P-GP_in_MDR
<https://w3id.org/SKGO/phm#Role_of_P-GP_in_MDR> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Role_of_P-GP_in_MDR> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalProblem> .
<https://w3id.org/SKGO/phm#Role_of_P-GP_in_MDR> <http://www.w3.org/2000/01/rdf-schema#label> "Role_of_P-GP_in_MDR"@en .
# 
# https://w3id.org/SKGO/phm#Ryuichi_Nishii
<https://w3id.org/SKGO/phm#Ryuichi_Nishii> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Ryuichi_Nishii> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Sandra_Van_Schaeybroeck
<https://w3id.org/SKGO/phm#Sandra_Van_Schaeybroeck> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Sandra_Van_Schaeybroeck> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Sarcoma
<https://w3id.org/SKGO/phm#Sarcoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Sarcoma> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Sarcoma> <http://www.w3.org/2000/01/rdf-schema#label> "Sarcoma"@en .
# 
# https://w3id.org/SKGO/phm#Slot_Blot_Analysis
<https://w3id.org/SKGO/phm#Slot_Blot_Analysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Slot_Blot_Analysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#BlotAnalysis> .
# 
# https://w3id.org/SKGO/phm#Small_Cell_Lung_Cancer
<https://w3id.org/SKGO/phm#Small_Cell_Lung_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Small_Cell_Lung_Cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Small_Cell_Lung_Cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Small_Cell_Lung_Cancer"@en .
# 
# https://w3id.org/SKGO/phm#Southern_Blot_Analysis
<https://w3id.org/SKGO/phm#Southern_Blot_Analysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Southern_Blot_Analysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#SouthernBlotting> .
<https://w3id.org/SKGO/phm#Southern_Blot_Analysis> <http://www.w3.org/2000/01/rdf-schema#label> "Southern_Blot_Analysis"@en .
# 
# https://w3id.org/SKGO/phm#StatisticalAnalysis
<https://w3id.org/SKGO/phm#StatisticalAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#StatisticalAnalysis> <http://xmlns.com/foaf/0.1/name> "StatisticalAnalysis"@en .
# 
# https://w3id.org/SKGO/phm#Study
<https://w3id.org/SKGO/phm#Study> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Study> <http://xmlns.com/foaf/0.1/name> "Study"@en .
# 
# https://w3id.org/SKGO/phm#Sulforhodamine-B_cytotoxicity_assay
<https://w3id.org/SKGO/phm#Sulforhodamine-B_cytotoxicity_assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Sulforhodamine-B_cytotoxicity_assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#Sulforhodamine-B_cytotoxicity_assay> <http://www.w3.org/2000/01/rdf-schema#label> "Sulforhodamine-B_cytotoxicity_assay"@en .
# 
# https://w3id.org/SKGO/phm#Surrogate_Assay
<https://w3id.org/SKGO/phm#Surrogate_Assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Surrogate_Assay> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Assay> .
<https://w3id.org/SKGO/phm#Surrogate_Assay> <https://w3id.org/SKGO/phm#hasAssayMethod> "This assay uses flow cytometry to test the ability of human CD56+ cells —\nwhich express high levels of the efflux pump P-glycoprotein (PGP) — to retain the PGP substrate rhodamine after exposure to the efflux pump inhibitor PSC-833."@en .
<https://w3id.org/SKGO/phm#Surrogate_Assay> <http://www.w3.org/2000/01/rdf-schema#label> "Surrogate_Assay"@en .
# 
# https://w3id.org/SKGO/phm#Susan_E._Bates
<https://w3id.org/SKGO/phm#Susan_E._Bates> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Susan_E._Bates> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#TAMMY_KROGMANN
<https://w3id.org/SKGO/phm#TAMMY_KROGMANN> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#TAMMY_KROGMANN> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Takafumi_Tsujiuchi
<https://w3id.org/SKGO/phm#Takafumi_Tsujiuchi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Takafumi_Tsujiuchi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Takeo_Nakanishi
<https://w3id.org/SKGO/phm#Takeo_Nakanishi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Takeo_Nakanishi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod1
<https://w3id.org/SKGO/phm#TargetingMethod1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod10
<https://w3id.org/SKGO/phm#TargetingMethod10> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod11
<https://w3id.org/SKGO/phm#TargetingMethod11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod12
<https://w3id.org/SKGO/phm#TargetingMethod12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod13
<https://w3id.org/SKGO/phm#TargetingMethod13> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod14
<https://w3id.org/SKGO/phm#TargetingMethod14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod15
<https://w3id.org/SKGO/phm#TargetingMethod15> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod16
<https://w3id.org/SKGO/phm#TargetingMethod16> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod17
<https://w3id.org/SKGO/phm#TargetingMethod17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod18
<https://w3id.org/SKGO/phm#TargetingMethod18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod19
<https://w3id.org/SKGO/phm#TargetingMethod19> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod2
<https://w3id.org/SKGO/phm#TargetingMethod2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod20
<https://w3id.org/SKGO/phm#TargetingMethod20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod3
<https://w3id.org/SKGO/phm#TargetingMethod3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod4
<https://w3id.org/SKGO/phm#TargetingMethod4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod5
<https://w3id.org/SKGO/phm#TargetingMethod5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod6
<https://w3id.org/SKGO/phm#TargetingMethod6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod7
<https://w3id.org/SKGO/phm#TargetingMethod7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod8
<https://w3id.org/SKGO/phm#TargetingMethod8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TargetingMethod9
<https://w3id.org/SKGO/phm#TargetingMethod9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://ns.nature.com/terms/publicationYear> "2006"^^<http://www.w3.org/2001/XMLSchema#gYear> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/ontology/bibo/abstract> "Effective treatment of metastatic cancers usually requires the use of toxic\nchemotherapy. In most cases, multiple drugs are used, as resistance to single agents occurs almost universally. For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chemical structures — multidrug resistance — has been a major goal of cancer biologists during the past 35 years. Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters. We describe various approaches\nto combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters."@en .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Catherine_Booth-Genthe> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Gergely_Szak\u00E1cs> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Jill_K._Paterson> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Joseph_A._Ludwig> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Michael_M._Gottesman> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#Nature_Publishing_Group> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/dc/terms/publisher> <https://w3id.org/ScienceOnto/phm#Publisher3> .
<https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer> <http://purl.org/dc/terms/title> "Targeting multidrug resistance in cancer"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#Taurocholate
<https://w3id.org/SKGO/phm#Taurocholate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Taurocholate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Taurocholate> <http://www.w3.org/2000/01/rdf-schema#label> "Taurocholate"@en .
# 
# https://w3id.org/SKGO/phm#Taxenes-paclitaxel_docetaxel
<https://w3id.org/SKGO/phm#Taxenes-paclitaxel_docetaxel> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Taxenes-paclitaxel_docetaxel> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Taxenes-paclitaxel_docetaxel> <http://www.w3.org/2000/01/rdf-schema#label> "Taxenes-paclitaxel_docetaxel"@en .
# 
# https://w3id.org/SKGO/phm#Teniopside
<https://w3id.org/SKGO/phm#Teniopside> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Teniopside> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Teniopside> <http://www.w3.org/2000/01/rdf-schema#label> "Teniopside"@en .
# 
# https://w3id.org/SKGO/phm#Testicular_cancer
<https://w3id.org/SKGO/phm#Testicular_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Testicular_cancer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Disease> .
<https://w3id.org/SKGO/phm#Testicular_cancer> <http://www.w3.org/2000/01/rdf-schema#label> "Testicular_cancer"@en .
# 
# https://w3id.org/SKGO/phm#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP
<https://w3id.org/SKGO/phm#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP> <http://www.w3.org/2000/01/rdf-schema#label> "The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP"@en .
<https://w3id.org/SKGO/phm#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP> <http://www.w3.org/2004/02/skos/core#definition> "The new transporter was\ntermed the breast cancer resistance protein (BCRP),\nbecause of its identification in MCF-7 human breast\ncarcinoma cells."@en .
# 
# https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters> <https://w3id.org/SKGO/phm#hasStudyDesign> <https://w3id.org/SKGO/phm#Review_Study> .
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters> .
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters> <http://www.w3.org/2000/01/rdf-schema#label> "The_physiological_functions_and_structures_of_ABC_transporters"@en .
# 
# https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers> <http://www.w3.org/2000/01/rdf-schema#label> "The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers"@en .
<https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers> <http://www.w3.org/2004/02/skos/core#definition> "The physiological functions and structures of ABC transporters, and\ndevelopment of chemosensitizers are described focusing\non well-known proteins including Pgp, MRP, and BCRP."@en .
# 
# https://w3id.org/SKGO/phm#TissueLocalization1
<https://w3id.org/SKGO/phm#TissueLocalization1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization10
<https://w3id.org/SKGO/phm#TissueLocalization10> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization11
<https://w3id.org/SKGO/phm#TissueLocalization11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization12
<https://w3id.org/SKGO/phm#TissueLocalization12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization13
<https://w3id.org/SKGO/phm#TissueLocalization13> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization14
<https://w3id.org/SKGO/phm#TissueLocalization14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization15
<https://w3id.org/SKGO/phm#TissueLocalization15> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization16
<https://w3id.org/SKGO/phm#TissueLocalization16> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization17
<https://w3id.org/SKGO/phm#TissueLocalization17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization18
<https://w3id.org/SKGO/phm#TissueLocalization18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization19
<https://w3id.org/SKGO/phm#TissueLocalization19> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization2
<https://w3id.org/SKGO/phm#TissueLocalization2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization20
<https://w3id.org/SKGO/phm#TissueLocalization20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization3
<https://w3id.org/SKGO/phm#TissueLocalization3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization4
<https://w3id.org/SKGO/phm#TissueLocalization4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization5
<https://w3id.org/SKGO/phm#TissueLocalization5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization6
<https://w3id.org/SKGO/phm#TissueLocalization6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization7
<https://w3id.org/SKGO/phm#TissueLocalization7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization8
<https://w3id.org/SKGO/phm#TissueLocalization8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TissueLocalization9
<https://w3id.org/SKGO/phm#TissueLocalization9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#Tito_Fojo
<https://w3id.org/SKGO/phm#Tito_Fojo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Tito_Fojo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Topotecan
<https://w3id.org/SKGO/phm#Topotecan> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Topotecan> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Topotecan> <http://www.w3.org/2000/01/rdf-schema#label> "Topotecan"@en .
# 
# https://w3id.org/SKGO/phm#Trastuzumab
<https://w3id.org/SKGO/phm#Trastuzumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Trastuzumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Trastuzumab> <http://www.w3.org/2000/01/rdf-schema#label> "Trastuzumab"@en .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome1
<https://w3id.org/SKGO/phm#TreatmentOutcome1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome10
<https://w3id.org/SKGO/phm#TreatmentOutcome10> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome11
<https://w3id.org/SKGO/phm#TreatmentOutcome11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome12
<https://w3id.org/SKGO/phm#TreatmentOutcome12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome13
<https://w3id.org/SKGO/phm#TreatmentOutcome13> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome14
<https://w3id.org/SKGO/phm#TreatmentOutcome14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome15
<https://w3id.org/SKGO/phm#TreatmentOutcome15> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome16
<https://w3id.org/SKGO/phm#TreatmentOutcome16> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome17
<https://w3id.org/SKGO/phm#TreatmentOutcome17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome18
<https://w3id.org/SKGO/phm#TreatmentOutcome18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome19
<https://w3id.org/SKGO/phm#TreatmentOutcome19> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome2
<https://w3id.org/SKGO/phm#TreatmentOutcome2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome20
<https://w3id.org/SKGO/phm#TreatmentOutcome20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome3
<https://w3id.org/SKGO/phm#TreatmentOutcome3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome4
<https://w3id.org/SKGO/phm#TreatmentOutcome4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome5
<https://w3id.org/SKGO/phm#TreatmentOutcome5> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome6
<https://w3id.org/SKGO/phm#TreatmentOutcome6> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome7
<https://w3id.org/SKGO/phm#TreatmentOutcome7> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome8
<https://w3id.org/SKGO/phm#TreatmentOutcome8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#TreatmentOutcome9
<https://w3id.org/SKGO/phm#TreatmentOutcome9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
# 
# https://w3id.org/SKGO/phm#VAD
<https://w3id.org/SKGO/phm#VAD> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#VAD> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#VAD> <http://www.w3.org/2000/01/rdf-schema#label> "VAD"@en .
# 
# https://w3id.org/SKGO/phm#Vemurafenib
<https://w3id.org/SKGO/phm#Vemurafenib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Vemurafenib> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Vemurafenib> <http://www.w3.org/2000/01/rdf-schema#label> "Vemurafenib"@en .
# 
# https://w3id.org/SKGO/phm#Verapamil
<https://w3id.org/SKGO/phm#Verapamil> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Verapamil> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Verapamil> <http://www.w3.org/2000/01/rdf-schema#label> "Verapamil"@en .
# 
# https://w3id.org/SKGO/phm#Vesicle_transport_experiments
<https://w3id.org/SKGO/phm#Vesicle_transport_experiments> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Vesicle_transport_experiments> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#Vesicle_transport_experiments> <https://w3id.org/SKGO/phm#hasTreatment> <https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators> .
<https://w3id.org/SKGO/phm#Vesicle_transport_experiments> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Daunomycin> .
<https://w3id.org/SKGO/phm#Vesicle_transport_experiments> <https://w3id.org/SKGO/phm#useProbe> <https://w3id.org/SKGO/phm#cDNA> .
<https://w3id.org/SKGO/phm#Vesicle_transport_experiments> <http://www.w3.org/2000/01/rdf-schema#label> "Vesicle_transport_experiments"@en .
# 
# https://w3id.org/SKGO/phm#Vincristine
<https://w3id.org/SKGO/phm#Vincristine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Vincristine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Vincristine> <http://www.w3.org/2000/01/rdf-schema#label> "Vincristine"@en .
# 
# https://w3id.org/SKGO/phm#Vindesine
<https://w3id.org/SKGO/phm#Vindesine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Vindesine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Vindesine> <http://www.w3.org/2000/01/rdf-schema#label> "Vindesine"@en .
# 
# https://w3id.org/SKGO/phm#WEIDONG_YANG
<https://w3id.org/SKGO/phm#WEIDONG_YANG> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#WEIDONG_YANG> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Western_Blot_Analysis
<https://w3id.org/SKGO/phm#Western_Blot_Analysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Western_Blot_Analysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#WesternBlotting> .
<https://w3id.org/SKGO/phm#Western_Blot_Analysis> <http://www.w3.org/2000/01/rdf-schema#label> "Western_Blot_Analysis"@en .
# 
# https://w3id.org/SKGO/phm#YONGMING_GAO
<https://w3id.org/SKGO/phm#YONGMING_GAO> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#YONGMING_GAO> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Yuya_Okui
<https://w3id.org/SKGO/phm#Yuya_Okui> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Yuya_Okui> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
# 
# https://w3id.org/SKGO/phm#Zidovudine
<https://w3id.org/SKGO/phm#Zidovudine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Zidovudine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Zidovudine> <http://www.w3.org/2000/01/rdf-schema#label> "Zidovudine"@en .
# 
# https://w3id.org/SKGO/phm#Zosuquidar
<https://w3id.org/SKGO/phm#Zosuquidar> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Zosuquidar> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#Zosuquidar> <http://www.w3.org/2000/01/rdf-schema#label> "Zosuquidar"@en .
# 
# https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <https://w3id.org/SKGO/phm#hasExperimentMethod> <https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined> .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#CD34+_Leukemic_Blasts> .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Zosuquidar> .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <https://w3id.org/SKGO/phm#useReagent> <https://w3id.org/SKGO/phm#DiOC2> .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <https://w3id.org/SKGO/phm#useReagent> <https://w3id.org/SKGO/phm#Fluorochrome-labeled_anti-CD_antibodies> .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <https://w3id.org/SKGO/phm#useSpecimen> <https://w3id.org/SKGO/phm#Bone_marrow_aspirates> .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <https://w3id.org/SKGO/phm#hasExperimentalResult> "50 AML specimens for MDR function\nusing zosuquidar, a P-gp-selective modulator, and two\nex vivo leukemic blast bioassays confirms the heterogeneous\nnature of MDR efflux pump function by AML\nblasts. Moreover, it supports the supposition that function\nof multiple transporters could have circumvented\nor obscured efficacy of P-gp modulators in AML clinical\ntrials like E3999 with zosuquidar."@en .
<https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments> <http://www.w3.org/2000/01/rdf-schema#label> "Zosuquidar_AML_experiments"@en .
# 
# https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment
<https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> .
<https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment> <https://w3id.org/SKGO/phm#hasTreatment> <https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport> .
<https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment> <https://w3id.org/SKGO/phm#useAssay> <https://w3id.org/SKGO/phm#Functional_Assay> .
<https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment> <http://www.w3.org/2000/01/rdf-schema#label> "antibody-mediated_cytolysis_experiment"@en .
# 
# https://w3id.org/SKGO/phm#cDNA
<https://w3id.org/SKGO/phm#cDNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#cDNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Probe> .
<https://w3id.org/SKGO/phm#cDNA> <http://www.w3.org/2000/01/rdf-schema#label> "cDNA"@en .
# 
# https://w3id.org/SKGO/phm#ex_vivo
<https://w3id.org/SKGO/phm#ex_vivo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ex_vivo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ex_vivo> .
# 
# https://w3id.org/SKGO/phm#hasAssayMethod
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://xmlns.com/foaf/0.1/name> "hasAssayMethod"@en .
# 
# https://w3id.org/SKGO/phm#hasDrugEffects
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://xmlns.com/foaf/0.1/name> "hasDrugEffects"@en .
# 
# https://w3id.org/SKGO/phm#hasEligibilityCriteria
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://xmlns.com/foaf/0.1/name> "hasEligibilityCriteria"@en .
# 
# https://w3id.org/SKGO/phm#hasExperimentalResult
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://xmlns.com/foaf/0.1/name> "hasExperimentalResult"@en .
# 
# https://w3id.org/SKGO/phm#hasFindings
<https://w3id.org/SKGO/phm#hasFindings> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#hasFindings> <http://xmlns.com/foaf/0.1/name> "hasFindings"@en .
# 
# https://w3id.org/SKGO/phm#hasMutationResult
<https://w3id.org/SKGO/phm#hasMutationResult> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#hasMutationResult> <http://xmlns.com/foaf/0.1/name> "hasMutationResult"@en .
# 
# https://w3id.org/SKGO/phm#hasSuggestion
<https://w3id.org/SKGO/phm#hasSuggestion> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#hasSuggestion> <http://xmlns.com/foaf/0.1/name> "hasSuggestion"@en .
# 
# https://w3id.org/SKGO/phm#hasTissueLocalization
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://xmlns.com/foaf/0.1/name> "hasTissueLocalization"@en .
# 
# https://w3id.org/SKGO/phm#identify_and_overcome_underlying_mechanisms_of_resistance
<https://w3id.org/SKGO/phm#identify_and_overcome_underlying_mechanisms_of_resistance> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#identify_and_overcome_underlying_mechanisms_of_resistance> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#identify_and_overcome_underlying_mechanisms_of_resistance> <http://www.w3.org/2000/01/rdf-schema#label> "identify_and_overcome_underlying_mechanisms_of_resistance"@en .
<https://w3id.org/SKGO/phm#identify_and_overcome_underlying_mechanisms_of_resistance> <http://www.w3.org/2004/02/skos/core#definition> "this Review focuses on the mechanisms that enable the survival of cancer\ncells during drug treatment and on current research\nefforts to identify and overcome underlying mechanisms\nof resistance to both standard chemotherapeutic agents\nand molecularly targeted therapies."@en .
# 
# https://w3id.org/SKGO/phm#in_silico
<https://w3id.org/SKGO/phm#in_silico> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#in_silico> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#in_silico> .
# 
# https://w3id.org/SKGO/phm#in_vitro
<https://w3id.org/SKGO/phm#in_vitro> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#in_vitro> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#in_vitro> .
# 
# https://w3id.org/SKGO/phm#in_vivo
<https://w3id.org/SKGO/phm#in_vivo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#in_vivo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#in_vivo> .
# 
# https://w3id.org/SKGO/phm#inhibitors_NB-506_J-107088
<https://w3id.org/SKGO/phm#inhibitors_NB-506_J-107088> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#inhibitors_NB-506_J-107088> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#inhibitors_NB-506_J-107088> <http://www.w3.org/2000/01/rdf-schema#label> "inhibitors_NB-506_J-107088"@en .
# 
# https://w3id.org/SKGO/phm#mdr1
<https://w3id.org/SKGO/phm#mdr1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#mdr1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#mdr1> <http://www.w3.org/2000/01/rdf-schema#label> "MDR1"@en .
# 
# https://w3id.org/SKGO/phm#mdr1_gene_expression
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#hasBlotAnalysis> <https://w3id.org/SKGO/phm#Slot_Blot_Analysis> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#hasTreatment> <https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#CCL_127__PC12> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#Colon_carcinoma> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#HTB_10_HTB_11_HTB_38> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#KB-3-1_KB-8-5_KB-V1> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Actinomycin_D> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Doxorubicin> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Mitomycin_C> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Vincristine> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#mdr1> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#useProbe> <https://w3id.org/SKGO/phm#cDNA> .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#hasExperimentalResult> "Expression of mdr1 in Tumors from Untreated and Treated Patients"@en .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <https://w3id.org/SKGO/phm#name> "Mdr1 Hybridization Probes, RNA Extraction, Electrophoresis"@en .
<https://w3id.org/SKGO/phm#mdr1_gene_expression> <http://www.w3.org/2000/01/rdf-schema#label> "mdr1_gene_expression"@en .
# 
# https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#hasExperimentMethod> <https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#CD56+> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Anthranilic-acid-based_drug> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Immunosuppressant_cyclosporin_A> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Mitoxantrone> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Paclitaxel> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Verapamil> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#ABCA2> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MDR2> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP1> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP2> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP3> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP4> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP5> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#useGene> <https://w3id.org/SKGO/phm#MRP6> .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <https://w3id.org/SKGO/phm#name> "Transfection Experiments" .
<https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells> <http://www.w3.org/2000/01/rdf-schema#label> "multidrug_resistance_to_cancer_cells"@en .
# 
# https://w3id.org/SKGO/phm#topoisomerase_I
<https://w3id.org/SKGO/phm#topoisomerase_I> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#topoisomerase_I> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#topoisomerase_I> <http://www.w3.org/2000/01/rdf-schema#label> "topoisomerase_I"@en .
# 
# https://w3id.org/SKGO/phm#useCellLine
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#useCellLine> <http://xmlns.com/foaf/0.1/name> "useCellLine"@en .
# 
# https://w3id.org/SKGO/phm#useDrug
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#useDrug> <http://xmlns.com/foaf/0.1/name> "useDrug"@en .
# 
# https://w3id.org/SKGO/phm#useGene
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#useGene> <http://xmlns.com/foaf/0.1/name> "useGene"@en .
# 
# https://w3id.org/SKGO/phm#useProbe
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#useProbe> <http://xmlns.com/foaf/0.1/name> "useProbe"@en .
# 
# https://w3id.org/SKGO/phm#useReagent
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#useReagent> <http://xmlns.com/foaf/0.1/name> "useReagent"@en .
# 
# https://w3id.org/SKGO/phm#useSpecimen
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#useSpecimen> <http://xmlns.com/foaf/0.1/name> "Specimen that are used as material in experimental study."@en .
<https://w3id.org/SKGO/phm#useSpecimen> <http://xmlns.com/foaf/0.1/name> "useSpecimen"@en .
# 
# https://w3id.org/SKGO/phm#useStatisticalAnalysis
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://xmlns.com/foaf/0.1/name> "useStatisticalAnalysis"@en .
# 
# https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia
<https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Patient> .
<https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#Leukaemia> .
<https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia> <https://w3id.org/SKGO/phm#has_Treatment> <https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine> .
<https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia> <http://www.w3.org/2000/01/rdf-schema#label> "10_patients_with_acute_lymphocytic_leukemia"@en .
# 
# https://w3id.org/SKGO/phm#50_patients_with_newly_diagnosed_AML
<https://w3id.org/SKGO/phm#50_patients_with_newly_diagnosed_AML> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#50_patients_with_newly_diagnosed_AML> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Patient> .
<https://w3id.org/SKGO/phm#50_patients_with_newly_diagnosed_AML> <https://w3id.org/SKGO/phm#hasDisease> <https://w3id.org/SKGO/phm#AML> .
<https://w3id.org/SKGO/phm#50_patients_with_newly_diagnosed_AML> <http://www.w3.org/2000/01/rdf-schema#label> "50_patients_with_newly_diagnosed_AML"@en .
# 
# https://w3id.org/SKGO/phm#795-bp_cDNA
<https://w3id.org/SKGO/phm#795-bp_cDNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#795-bp_cDNA> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Probe> .
<https://w3id.org/SKGO/phm#795-bp_cDNA> <http://www.w3.org/2000/01/rdf-schema#label> "795-bp_cDNA"@en .
# 
# https://w3id.org/SKGO/phm#99mTc-labeled_compounds_were_exported_via_MRP2–4_and_BCRP
<https://w3id.org/SKGO/phm#99mTc-labeled_compounds_were_exported_via_MRP2\u20134_and_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#99mTc-labeled_compounds_were_exported_via_MRP2\u20134_and_BCRP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#99mTc-labeled_compounds_were_exported_via_MRP2\u20134_and_BCRP> <http://www.w3.org/2000/01/rdf-schema#label> "99mTc-labeled_compounds_were_exported_via_MRP2–4_and_BCRP"@en .
<https://w3id.org/SKGO/phm#99mTc-labeled_compounds_were_exported_via_MRP2\u20134_and_BCRP> <http://www.w3.org/2004/02/skos/core#definition> "We examinedwhether 99mTc-labeled compounds were\nexported via MRP2–4 and BCRP and whether these compounds\nhad affinity for these transporters including MDR1\nand MRP1 in cancer cells."@en .
# 
# https://w3id.org/SKGO/phm#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells
<https://w3id.org/SKGO/phm#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA> .
<https://w3id.org/SKGO/phm#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells> <http://purl.org/dc/terms/description> "The hypothesis that an ATPdependent xenobiotic transporter may contribute significantly to the multidrug-resistance phenotype of MCF-7yAdrVp cells." .
<https://w3id.org/SKGO/phm#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells> <http://www.w3.org/2000/01/rdf-schema#label> "ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells"@en .
# 
# https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#BBR3390> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#CI1033> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Daunorubicin> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Doxorubicin> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Epirubicin> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Flavopiridol> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Iamivudine> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Idarubicinol> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Indolocarbazole> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Methotrexate> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Mitoxantrone> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Prazocin> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Topotecan> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Zidovudine> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#topoisomerase_I> .
<https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors> <http://www.w3.org/2000/01/rdf-schema#label> "BCRP_substrate/inhibitors"@en .
# 
# https://w3id.org/SKGO/phm#CAV/EP
<https://w3id.org/SKGO/phm#CAV/EP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#CAV/EP> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Drug> .
<https://w3id.org/SKGO/phm#CAV/EP> <http://www.w3.org/2000/01/rdf-schema#label> "CAV/EP"@en .
# 
# https://w3id.org/SKGO/phm#CD34+_Leukemic_Blasts
<https://w3id.org/SKGO/phm#CD34+_Leukemic_Blasts> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#CD34+_Leukemic_Blasts> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#CD34+_Leukemic_Blasts> <http://www.w3.org/2000/01/rdf-schema#label> "CD34+_Leukemic_Blasts"@en .
# 
# https://w3id.org/SKGO/phm#CD56+
<https://w3id.org/SKGO/phm#CD56+> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#CD56+> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#CD56+> <http://www.w3.org/2000/01/rdf-schema#label> "CD56+"@en .
# 
# https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined
<https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment> .
<https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined> <https://w3id.org/SKGO/phm#useAssay> <https://w3id.org/SKGO/phm#Accumulation_Bioassay> .
<https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined> <https://w3id.org/SKGO/phm#useAssay> <https://w3id.org/SKGO/phm#Efflux_Bioassay> .
<https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined> <https://w3id.org/SKGO/phm#useAssay> <https://w3id.org/SKGO/phm#Functional_Bioassay> .
<https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined> <https://w3id.org/SKGO/phm#useStatisticalAnalysis> <https://w3id.org/SKGO/phm#Blast_populations_in_the_two_bioassays> .
<https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined> <http://www.w3.org/2000/01/rdf-schema#label> "Comparative_CD34+_blast_responses_were_examined"@en .
# 
# https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells
<https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#ClinicalStudy> .
<https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> <https://w3id.org/SKGO/phm#investigate> <https://w3id.org/SKGO/phm#Breast_Cancer> .
<https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> <https://w3id.org/SKGO/phm#performsExperiment> <https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> .
<https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> <http://ns.nature.com/terms/name> "A multidrug resistance transporter from human MCF-7 breast cancer cells" .
<https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> <https://w3id.org/SKGO/phm#hasSuggestion> "The presence of the phosphopantetheine attachment site on BCRP suggests\nthat BCRP may be part of a multiprotein complex."@en .
<https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> <http://www.w3.org/2000/01/rdf-schema#label> "Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"@en .
<https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells> <http://www.w3.org/2004/02/skos/core#definition> "MCF-7/AdrVp is a multidrug-resistant human\nbreast cancer subline that displays an ATP-dependent\nreduction in the intracellular accumulation of anthracycline\nanticancer drugs in the absence of overexpression of known\nmultidrug resistance transporters such as P glycoprotein or\nthe multidrug resistance protein."@en .
# 
# https://w3id.org/SKGO/phm#ERBB2‑amplified_breast_cancer_cell_lines
<https://w3id.org/SKGO/phm#ERBB2\u2011amplified_breast_cancer_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#ERBB2\u2011amplified_breast_cancer_cell_lines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#CellLine> .
<https://w3id.org/SKGO/phm#ERBB2\u2011amplified_breast_cancer_cell_lines> <http://www.w3.org/2000/01/rdf-schema#label> "ERBB2_amplified_breast_cancer_cell_lines"@en .
# 
# https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#hasExperimentKit> <https://w3id.org/SKGO/phm#Delta_RNA_Fingerprinting_kit> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#hasExperimentMethod> <https://w3id.org/SKGO/phm#RNA_Fingerprinting> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#useCellLine> <https://w3id.org/SKGO/phm#MCF-7_human_breast_carcinoma_cells> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Daunorubicin> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Doxorubicin> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Mitoxantrone> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Paclitaxel> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#useDrug> <https://w3id.org/SKGO/phm#Vincristine> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#useProbe> <https://w3id.org/SKGO/phm#795-bp_cDNA> .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <https://w3id.org/SKGO/phm#hasExperimentalResult> "Sensitivity of selected MCF-7 sublines to antineoplastic agents determined by sulforhodamine-B cytotoxicity assay (21). Experiments such as those\ndisplayed in Figure 4D were used to obtain the LC50. For each drug and cell type, the table displays the median LC50 and range of LC50 measurements\n(nM), the number of experimental determinations of LC50 that were performed (N), and the resistance factor (RF). The RF was calculated by\ndividing the median LC50 for a given drug against a transfected cell line by the median LC50 of that drug against nontransfected MCF-7yW cells.\nFor each drug tested, the LC50 for the BCRP-transfected cells was examined for statistically significant difference from the LC50 of MCF-7yW or\nMCF-7ypcDNA3 by the Mann–Whitney test, using MINITAB statistical software MINITAB release 8 extended, Minitab, State College, PA) and a 95%\nconfidence interval. The values of P for the statistically significant differences are as follows Mitoxantrone: MCF-7yW vs. MCF-7yBCRPclone6,\nP 5 0.0107, MCF-7yW vs. MCF-7yBCRPclone8, P 5 0.0058, MCF-7ypcDNA3 vs. MCF-71BCRPclone6, P 5 0.0142, MCF-7ypcDNA3 vs.\nMCF-7yBCRPclone8, P 5 0.0081; daunorubicin: MCF-7yW vs. MCF-7yBCRPclone6, P 5 0.0107, MCF-7yW vs. MCF-7yBCRPclone8, P 5\n0.0058, MCF-7ypcDNA3 vs. MCF-7yBCRPclone6, P 5 0.0195, MCF-7ypcDNA3 vs. MCF-7yBCRPclone8, P 5 0.0163; doxorubicin: MCF-7yW\nvs. MCF-7yBCRPclone6, P 5 0.0373, MCF-7yW vs. MCF-7yBCRPclone8, P 5 0.02, MCF-7ypcDNA3 vs. MCF-7yBCRPclone8, P 5 0.0304;\ncis-platin: MCF-7yW vs. MCF-7yBCRPclone19, P 5 0.0497."@en .
<https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison> <http://www.w3.org/2000/01/rdf-schema#label> "MCF-7/AdrVp_comparison"@en .
# 
# https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publication> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <https://w3id.org/SKGO/phm#addressesStudy> <https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://ns.nature.com/terms/publicationYear> "2002"^^<http://www.w3.org/2001/XMLSchema#gYear> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://purl.org/ontology/bibo/abstract> "Chemotherapeutics are the most effective treatment for metastatic tumours. However, the ability of cancer cells to become simultaneously resistant to different drugs — a trait known as multidrug resistance — remains a significant impediment to successful chemotherapy. Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents. Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy." .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <https://w3id.org/SKGO/phm#hasTitle> "MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS"@en .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Michael_M._Gottesman> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Susan_E._Bates> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://purl.org/dc/terms/creator> <https://w3id.org/SKGO/phm#Tito_Fojo> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://purl.org/dc/terms/publisher> <https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd> .
<https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS> <http://purl.org/dc/terms/title> "MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS"^^<http://www.w3.org/2000/01/rdf-schema#Literal> .
# 
# https://w3id.org/SKGO/phm#PGP/MDR1
<https://w3id.org/SKGO/phm#PGP/MDR1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#PGP/MDR1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://w3id.org/SKGO/phm#Gene> .
<https://w3id.org/SKGO/phm#PGP/MDR1> <http://www.w3.org/2000/01/rdf-schema#label> "PGP/MDR1"@en .
# 
# https://w3id.org/SKGO/phm#Springer_Science+Business_Media_LLC
<https://w3id.org/SKGO/phm#Springer_Science+Business_Media_LLC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> .
<https://w3id.org/SKGO/phm#Springer_Science+Business_Media_LLC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ns.nature.com/terms/Publisher> .
# 
# 
# 
# #################################################################
# #
# #    Annotations
# #
# #################################################################
# 
# 
<http://purl.org/dc/terms/AgentClass> <http://purl.org/dc/terms/description> "Examples of Agent Class include groups seen as classes, such as students, women, charities, lecturers."@en .
<http://purl.org/dc/terms/AgentClass> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#AgentClass-003> .
<http://purl.org/dc/terms/AgentClass> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/AgentClass> <http://purl.org/dc/terms/modified> "2012-06-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/AgentClass> <http://www.w3.org/2000/01/rdf-schema#comment> "A group of agents."@en .
<http://purl.org/dc/terms/AgentClass> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/AgentClass> <http://www.w3.org/2000/01/rdf-schema#label> "Agent Class"@en .
# 
<http://purl.org/dc/terms/BibliographicResource> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#BibliographicResource-001> .
<http://purl.org/dc/terms/BibliographicResource> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/BibliographicResource> <http://www.w3.org/2000/01/rdf-schema#comment> "A book, article, or other documentary resource."@en .
<http://purl.org/dc/terms/BibliographicResource> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/BibliographicResource> <http://www.w3.org/2000/01/rdf-schema#label> "Bibliographic Resource"@en .
# 
<http://purl.org/dc/terms/Box> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#Box-003> .
<http://purl.org/dc/terms/Box> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Box> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Box> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of regions in space defined by their geographic coordinates according to the DCMI Box Encoding Scheme."@en .
<http://purl.org/dc/terms/Box> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/Box> <http://www.w3.org/2000/01/rdf-schema#label> "DCMI Box"@en .
<http://purl.org/dc/terms/Box> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://dublincore.org/documents/dcmi-box/> .
# 
<http://purl.org/dc/terms/Frequency> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#Frequency-001> .
<http://purl.org/dc/terms/Frequency> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Frequency> <http://www.w3.org/2000/01/rdf-schema#comment> "A rate at which something recurs."@en .
<http://purl.org/dc/terms/Frequency> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/Frequency> <http://www.w3.org/2000/01/rdf-schema#label> "Frequency"@en .
# 
<http://purl.org/dc/terms/ISO3166> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#ISO3166-004> .
<http://purl.org/dc/terms/ISO3166> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/ISO3166> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/ISO3166> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of codes listed in ISO 3166-1 for the representation of names of countries."@en .
<http://purl.org/dc/terms/ISO3166> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/ISO3166> <http://www.w3.org/2000/01/rdf-schema#label> "ISO 3166"@en .
<http://purl.org/dc/terms/ISO3166> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.iso.org/iso/en/prods-services/iso3166ma/02iso-3166-code-lists/list-en1.html> .
# 
<http://purl.org/dc/terms/ISO639-2> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#ISO639-2-003> .
<http://purl.org/dc/terms/ISO639-2> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/ISO639-2> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/ISO639-2> <http://www.w3.org/2000/01/rdf-schema#comment> "The three-letter alphabetic codes listed in ISO639-2 for the representation of names of languages."@en .
<http://purl.org/dc/terms/ISO639-2> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/ISO639-2> <http://www.w3.org/2000/01/rdf-schema#label> "ISO 639-2"@en .
<http://purl.org/dc/terms/ISO639-2> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://lcweb.loc.gov/standards/iso639-2/langhome.html> .
# 
<http://purl.org/dc/terms/ISO639-3> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#ISO639-3-001> .
<http://purl.org/dc/terms/ISO639-3> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/ISO639-3> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of three-letter codes listed in ISO 639-3 for the representation of names of languages."@en .
<http://purl.org/dc/terms/ISO639-3> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/ISO639-3> <http://www.w3.org/2000/01/rdf-schema#label> "ISO 639-3"@en .
<http://purl.org/dc/terms/ISO639-3> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.sil.org/iso639-3/> .
# 
<http://purl.org/dc/terms/LicenseDocument> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#LicenseDocument-001> .
<http://purl.org/dc/terms/LicenseDocument> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/LicenseDocument> <http://www.w3.org/2000/01/rdf-schema#comment> "A legal document giving official permission to do something with a Resource."@en .
<http://purl.org/dc/terms/LicenseDocument> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/LicenseDocument> <http://www.w3.org/2000/01/rdf-schema#label> "License Document"@en .
# 
<http://purl.org/dc/terms/LinguisticSystem> <http://purl.org/dc/terms/description> "Examples include written, spoken, sign, and computer languages."@en .
<http://purl.org/dc/terms/LinguisticSystem> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#LinguisticSystem-001> .
<http://purl.org/dc/terms/LinguisticSystem> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/LinguisticSystem> <http://www.w3.org/2000/01/rdf-schema#comment> "A system of signs, symbols, sounds, gestures, or rules used in communication."@en .
<http://purl.org/dc/terms/LinguisticSystem> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/LinguisticSystem> <http://www.w3.org/2000/01/rdf-schema#label> "Linguistic System"@en .
# 
<http://purl.org/dc/terms/MethodOfAccrual> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#MethodOfAccrual-001> .
<http://purl.org/dc/terms/MethodOfAccrual> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/MethodOfAccrual> <http://www.w3.org/2000/01/rdf-schema#comment> "A method by which resources are added to a collection."@en .
<http://purl.org/dc/terms/MethodOfAccrual> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/MethodOfAccrual> <http://www.w3.org/2000/01/rdf-schema#label> "Method of Accrual"@en .
# 
<http://purl.org/dc/terms/MethodOfInstruction> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#MethodOfInstruction-001> .
<http://purl.org/dc/terms/MethodOfInstruction> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/MethodOfInstruction> <http://www.w3.org/2000/01/rdf-schema#comment> "A process that is used to engender knowledge, attitudes, and skills."@en .
<http://purl.org/dc/terms/MethodOfInstruction> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/MethodOfInstruction> <http://www.w3.org/2000/01/rdf-schema#label> "Method of Instruction"@en .
# 
<http://purl.org/dc/terms/Period> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#Period-003> .
<http://purl.org/dc/terms/Period> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Period> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Period> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of time intervals defined by their limits according to the DCMI Period Encoding Scheme."@en .
<http://purl.org/dc/terms/Period> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/Period> <http://www.w3.org/2000/01/rdf-schema#label> "DCMI Period"@en .
<http://purl.org/dc/terms/Period> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://dublincore.org/documents/dcmi-period/> .
# 
<http://purl.org/dc/terms/PhysicalResource> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#PhysicalResource-001> .
<http://purl.org/dc/terms/PhysicalResource> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/PhysicalResource> <http://www.w3.org/2000/01/rdf-schema#comment> "A material thing."@en .
<http://purl.org/dc/terms/PhysicalResource> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/PhysicalResource> <http://www.w3.org/2000/01/rdf-schema#label> "Physical Resource"@en .
# 
<http://purl.org/dc/terms/Point> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#Point-003> .
<http://purl.org/dc/terms/Point> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Point> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Point> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of points in space defined by their geographic coordinates according to the DCMI Point Encoding Scheme."@en .
<http://purl.org/dc/terms/Point> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/Point> <http://www.w3.org/2000/01/rdf-schema#label> "DCMI Point"@en .
<http://purl.org/dc/terms/Point> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://dublincore.org/documents/dcmi-point/> .
# 
<http://purl.org/dc/terms/Policy> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#Policy-001> .
<http://purl.org/dc/terms/Policy> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Policy> <http://www.w3.org/2000/01/rdf-schema#comment> "A plan or course of action by an authority, intended to influence and determine decisions, actions, and other matters."@en .
<http://purl.org/dc/terms/Policy> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/Policy> <http://www.w3.org/2000/01/rdf-schema#label> "Policy"@en .
# 
<http://purl.org/dc/terms/ProvenanceStatement> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#ProvenanceStatement-001> .
<http://purl.org/dc/terms/ProvenanceStatement> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/ProvenanceStatement> <http://www.w3.org/2000/01/rdf-schema#comment> "A statement of any changes in ownership and custody of a resource since its creation that are significant for its authenticity, integrity, and interpretation."@en .
<http://purl.org/dc/terms/ProvenanceStatement> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/ProvenanceStatement> <http://www.w3.org/2000/01/rdf-schema#label> "Provenance Statement"@en .
# 
<http://purl.org/dc/terms/RFC1766> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#RFC1766-003> .
<http://purl.org/dc/terms/RFC1766> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/RFC1766> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/RFC1766> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of tags, constructed according to RFC 1766, for the identification of languages."@en .
<http://purl.org/dc/terms/RFC1766> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/RFC1766> <http://www.w3.org/2000/01/rdf-schema#label> "RFC 1766"@en .
<http://purl.org/dc/terms/RFC1766> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.ietf.org/rfc/rfc1766.txt> .
# 
<http://purl.org/dc/terms/RFC3066> <http://purl.org/dc/terms/description> "RFC 3066 has been obsoleted by RFC 4646."@en .
<http://purl.org/dc/terms/RFC3066> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#RFC3066-002> .
<http://purl.org/dc/terms/RFC3066> <http://purl.org/dc/terms/issued> "2002-07-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/RFC3066> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/RFC3066> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of tags constructed according to RFC 3066 for the identification of languages."@en .
<http://purl.org/dc/terms/RFC3066> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/RFC3066> <http://www.w3.org/2000/01/rdf-schema#label> "RFC 3066"@en .
<http://purl.org/dc/terms/RFC3066> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.ietf.org/rfc/rfc3066.txt> .
# 
<http://purl.org/dc/terms/RFC4646> <http://purl.org/dc/terms/description> "RFC 4646 obsoletes RFC 3066."@en .
<http://purl.org/dc/terms/RFC4646> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#RFC4646-001> .
<http://purl.org/dc/terms/RFC4646> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/RFC4646> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of tags constructed according to RFC 4646 for the identification of languages."@en .
<http://purl.org/dc/terms/RFC4646> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/RFC4646> <http://www.w3.org/2000/01/rdf-schema#label> "RFC 4646"@en .
<http://purl.org/dc/terms/RFC4646> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.ietf.org/rfc/rfc4646.txt> .
# 
<http://purl.org/dc/terms/RFC5646> <http://purl.org/dc/terms/description> "RFC 5646 obsoletes RFC 4646."@en .
<http://purl.org/dc/terms/RFC5646> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#RFC5646-001> .
<http://purl.org/dc/terms/RFC5646> <http://purl.org/dc/terms/issued> "2010-10-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/RFC5646> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of tags constructed according to RFC 5646 for the identification of languages."@en .
<http://purl.org/dc/terms/RFC5646> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/RFC5646> <http://www.w3.org/2000/01/rdf-schema#label> "RFC 5646"@en .
<http://purl.org/dc/terms/RFC5646> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.ietf.org/rfc/rfc5646.txt> .
# 
<http://purl.org/dc/terms/RightsStatement> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#RightsStatement-001> .
<http://purl.org/dc/terms/RightsStatement> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/RightsStatement> <http://www.w3.org/2000/01/rdf-schema#comment> "A statement about the intellectual property rights (IPR) held in or over a Resource, a legal document giving official permission to do something with a resource, or a statement about access rights."@en .
<http://purl.org/dc/terms/RightsStatement> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/RightsStatement> <http://www.w3.org/2000/01/rdf-schema#label> "Rights Statement"@en .
# 
<http://purl.org/dc/terms/Standard> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#Standard-001> .
<http://purl.org/dc/terms/Standard> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/Standard> <http://www.w3.org/2000/01/rdf-schema#comment> "A basis for comparison; a reference point against which other things can be evaluated."@en .
<http://purl.org/dc/terms/Standard> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/Standard> <http://www.w3.org/2000/01/rdf-schema#label> "Standard"@en .
# 
<http://purl.org/dc/terms/URI> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#URI-003> .
<http://purl.org/dc/terms/URI> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/URI> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/URI> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of identifiers constructed according to the generic syntax for Uniform Resource Identifiers as specified by the Internet Engineering Task Force."@en .
<http://purl.org/dc/terms/URI> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/URI> <http://www.w3.org/2000/01/rdf-schema#label> "URI"@en .
<http://purl.org/dc/terms/URI> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.ietf.org/rfc/rfc3986.txt> .
# 
<http://purl.org/dc/terms/W3CDTF> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#W3CDTF-003> .
<http://purl.org/dc/terms/W3CDTF> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/W3CDTF> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/W3CDTF> <http://www.w3.org/2000/01/rdf-schema#comment> "The set of dates and times constructed according to the W3C Date and Time Formats Specification."@en .
<http://purl.org/dc/terms/W3CDTF> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/W3CDTF> <http://www.w3.org/2000/01/rdf-schema#label> "W3C-DTF"@en .
<http://purl.org/dc/terms/W3CDTF> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.w3.org/TR/NOTE-datetime> .
# 
<http://purl.org/dc/terms/abstract> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#abstract-003> .
<http://purl.org/dc/terms/abstract> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/abstract> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/abstract> <http://www.w3.org/2000/01/rdf-schema#comment> "A summary of the resource."@en .
<http://purl.org/dc/terms/abstract> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/abstract> <http://www.w3.org/2000/01/rdf-schema#label> "Abstract"@en .
# 
<http://purl.org/dc/terms/alternative> <http://purl.org/dc/elements/1.1/description> "An alternative name for the resource."@en .
<http://purl.org/dc/terms/alternative> <http://purl.org/dc/terms/description> "The distinction between titles and alternative titles is application-specific."@en .
<http://purl.org/dc/terms/alternative> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#alternative-003> .
<http://purl.org/dc/terms/alternative> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/alternative> <http://purl.org/dc/terms/modified> "2010-10-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/alternative> <http://www.w3.org/2000/01/rdf-schema#comment> "An alternative name for the resource."@en .
<http://purl.org/dc/terms/alternative> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/alternative> <http://www.w3.org/2000/01/rdf-schema#label> "Alternative Title"@en .
# 
<http://purl.org/dc/terms/bibliographicCitation> <http://purl.org/dc/terms/description> "Recommended practice is to include sufficient bibliographic detail to identify the resource as unambiguously as possible."@en .
<http://purl.org/dc/terms/bibliographicCitation> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#bibliographicCitation-002> .
<http://purl.org/dc/terms/bibliographicCitation> <http://purl.org/dc/terms/issued> "2003-02-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/bibliographicCitation> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/2000/01/rdf-schema#comment> "A bibliographic reference for the resource."@en .
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/bibliographicCitation> <http://www.w3.org/2000/01/rdf-schema#label> "Bibliographic Citation"@en .
# 
<http://purl.org/dc/terms/contributor> <http://purl.org/dc/terms/description> "Examples of a Contributor include a person, an organization, or a service."@en .
<http://purl.org/dc/terms/contributor> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#contributorT-001> .
<http://purl.org/dc/terms/contributor> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/contributor> <http://purl.org/dc/terms/modified> "2010-10-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/contributor> <http://www.w3.org/2000/01/rdf-schema#comment> "An entity responsible for making contributions to the resource."@en .
<http://purl.org/dc/terms/contributor> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/contributor> <http://www.w3.org/2000/01/rdf-schema#label> "Contributor"@en .
# 
<http://purl.org/dc/terms/coverage> <http://purl.org/dc/terms/description> "Spatial topic and spatial applicability may be a named place or a location specified by its geographic coordinates. Temporal topic may be a named period, date, or date range. A jurisdiction may be a named administrative entity or a geographic place to which the resource applies. Recommended best practice is to use a controlled vocabulary such as the Thesaurus of Geographic Names [TGN]. Where appropriate, named places or time periods can be used in preference to numeric identifiers such as sets of coordinates or date ranges."@en .
<http://purl.org/dc/terms/coverage> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#coverageT-001> .
<http://purl.org/dc/terms/coverage> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/coverage> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/coverage> <http://www.w3.org/2000/01/rdf-schema#comment> "The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant."@en .
<http://purl.org/dc/terms/coverage> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/coverage> <http://www.w3.org/2000/01/rdf-schema#label> "Coverage"@en .
# 
<http://purl.org/dc/terms/creator> <http://purl.org/dc/terms/description> "Examples of a Creator include a person, an organization, or a service."@en .
<http://purl.org/dc/terms/creator> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#creatorT-002> .
<http://purl.org/dc/terms/creator> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/creator> <http://purl.org/dc/terms/modified> "2010-10-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/creator> <http://www.w3.org/2000/01/rdf-schema#comment> "An entity primarily responsible for making the resource."@en .
<http://purl.org/dc/terms/creator> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/creator> <http://www.w3.org/2000/01/rdf-schema#label> "Creator"@en .
# 
<http://purl.org/dc/terms/description> <http://purl.org/dc/terms/description> "Description may include but is not limited to: an abstract, a table of contents, a graphical representation, or a free-text account of the resource."@en .
<http://purl.org/dc/terms/description> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#descriptionT-001> .
<http://purl.org/dc/terms/description> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/description> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/description> <http://www.w3.org/2000/01/rdf-schema#comment> "An account of the resource."@en .
<http://purl.org/dc/terms/description> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/description> <http://www.w3.org/2000/01/rdf-schema#label> "Description"@en .
# 
<http://purl.org/dc/terms/hasPart> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#hasPart-003> .
<http://purl.org/dc/terms/hasPart> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/hasPart> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/hasPart> <http://www.w3.org/2000/01/rdf-schema#comment> "A related resource that is included either physically or logically in the described resource."@en .
<http://purl.org/dc/terms/hasPart> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/hasPart> <http://www.w3.org/2000/01/rdf-schema#label> "Has Part"@en .
<http://purl.org/dc/terms/hasPart> <http://www.w3.org/2004/02/skos/core#note> "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."@en .
# 
<http://purl.org/dc/terms/identifier> <http://purl.org/dc/terms/description> "Recommended best practice is to identify the resource by means of a string conforming to a formal identification system."@en .
<http://purl.org/dc/terms/identifier> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#identifierT-001> .
<http://purl.org/dc/terms/identifier> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/identifier> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/identifier> <http://www.w3.org/2000/01/rdf-schema#comment> "An unambiguous reference to the resource within a given context."@en .
<http://purl.org/dc/terms/identifier> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/identifier> <http://www.w3.org/2000/01/rdf-schema#label> "Identifier"@en .
# 
<http://purl.org/dc/terms/isPartOf> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#isPartOf-003> .
<http://purl.org/dc/terms/isPartOf> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/isPartOf> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/isPartOf> <http://www.w3.org/2000/01/rdf-schema#comment> "A related resource in which the described resource is physically or logically included."@en .
<http://purl.org/dc/terms/isPartOf> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/isPartOf> <http://www.w3.org/2000/01/rdf-schema#label> "Is Part Of"@en .
<http://purl.org/dc/terms/isPartOf> <http://www.w3.org/2004/02/skos/core#note> "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."@en .
# 
<http://purl.org/dc/terms/isReferencedBy> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#isReferencedBy-003> .
<http://purl.org/dc/terms/isReferencedBy> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/isReferencedBy> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/isReferencedBy> <http://www.w3.org/2000/01/rdf-schema#comment> "A related resource that references, cites, or otherwise points to the described resource."@en .
<http://purl.org/dc/terms/isReferencedBy> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/isReferencedBy> <http://www.w3.org/2000/01/rdf-schema#label> "Is Referenced By"@en .
<http://purl.org/dc/terms/isReferencedBy> <http://www.w3.org/2004/02/skos/core#note> "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."@en .
# 
<http://purl.org/dc/terms/isVersionOf> <http://purl.org/dc/terms/description> "Changes in version imply substantive changes in content rather than differences in format."@en .
<http://purl.org/dc/terms/isVersionOf> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#isVersionOf-003> .
<http://purl.org/dc/terms/isVersionOf> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/isVersionOf> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/isVersionOf> <http://www.w3.org/2000/01/rdf-schema#comment> "A related resource of which the described resource is a version, edition, or adaptation."@en .
<http://purl.org/dc/terms/isVersionOf> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/isVersionOf> <http://www.w3.org/2000/01/rdf-schema#label> "Is Version Of"@en .
<http://purl.org/dc/terms/isVersionOf> <http://www.w3.org/2004/02/skos/core#note> "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."@en .
# 
<http://purl.org/dc/terms/language> <http://purl.org/dc/terms/description> "Recommended best practice is to use a controlled vocabulary such as RFC 4646 [RFC4646]."@en .
<http://purl.org/dc/terms/language> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#languageT-001> .
<http://purl.org/dc/terms/language> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/language> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/language> <http://www.w3.org/2000/01/rdf-schema#comment> "A language of the resource."@en .
<http://purl.org/dc/terms/language> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/language> <http://www.w3.org/2000/01/rdf-schema#label> "Language"@en .
# 
<http://purl.org/dc/terms/publisher> <http://purl.org/dc/elements/1.1/description> "An entity responsible for making the resource available."@en .
<http://purl.org/dc/terms/publisher> <http://purl.org/dc/terms/description> "Examples of a Publisher include a person, an organization, or a service."@en .
<http://purl.org/dc/terms/publisher> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#publisherT-001> .
<http://purl.org/dc/terms/publisher> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/publisher> <http://purl.org/dc/terms/modified> "2010-10-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/publisher> <http://www.w3.org/2000/01/rdf-schema#comment> "An entity responsible for making the resource available."@en .
<http://purl.org/dc/terms/publisher> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/publisher> <http://www.w3.org/2000/01/rdf-schema#label> "Publisher"@en .
# 
<http://purl.org/dc/terms/references> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#references-003> .
<http://purl.org/dc/terms/references> <http://purl.org/dc/terms/issued> "2000-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/references> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/references> <http://www.w3.org/2000/01/rdf-schema#comment> "A related resource that is referenced, cited, or otherwise pointed to by the described resource."@en .
<http://purl.org/dc/terms/references> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/references> <http://www.w3.org/2000/01/rdf-schema#label> "References"@en .
<http://purl.org/dc/terms/references> <http://www.w3.org/2004/02/skos/core#note> "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."@en .
# 
<http://purl.org/dc/terms/relation> <http://purl.org/dc/terms/description> "Recommended best practice is to identify the related resource by means of a string conforming to a formal identification system."@en .
<http://purl.org/dc/terms/relation> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#relationT-001> .
<http://purl.org/dc/terms/relation> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/relation> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/relation> <http://www.w3.org/2000/01/rdf-schema#comment> "A related resource."@en .
<http://purl.org/dc/terms/relation> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/relation> <http://www.w3.org/2000/01/rdf-schema#label> "Relation"@en .
<http://purl.org/dc/terms/relation> <http://www.w3.org/2004/02/skos/core#note> "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."@en .
# 
<http://purl.org/dc/terms/subject> <http://purl.org/dc/terms/description> "Typically, the subject will be represented using keywords, key phrases, or classification codes. Recommended best practice is to use a controlled vocabulary."@en .
<http://purl.org/dc/terms/subject> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#subjectT-002> .
<http://purl.org/dc/terms/subject> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/subject> <http://purl.org/dc/terms/modified> "2012-06-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/subject> <http://www.w3.org/2000/01/rdf-schema#comment> "The topic of the resource."@en .
<http://purl.org/dc/terms/subject> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/subject> <http://www.w3.org/2000/01/rdf-schema#label> "Subject"@en .
<http://purl.org/dc/terms/subject> <http://www.w3.org/2004/02/skos/core#note> "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."@en .
# 
<http://purl.org/dc/terms/title> <http://purl.org/dc/elements/1.1/description> "A name given to the resource."@en .
<http://purl.org/dc/terms/title> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#titleT-002> .
<http://purl.org/dc/terms/title> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/title> <http://purl.org/dc/terms/modified> "2010-10-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/title> <http://www.w3.org/2000/01/rdf-schema#comment> "A name given to the resource."@en .
<http://purl.org/dc/terms/title> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/title> <http://www.w3.org/2000/01/rdf-schema#label> "Title"@en .
# 
<http://purl.org/dc/terms/type> <http://purl.org/dc/terms/description> "Recommended best practice is to use a controlled vocabulary such as the DCMI Type Vocabulary [DCMITYPE]. To describe the file format, physical medium, or dimensions of the resource, use the Format element."@en .
<http://purl.org/dc/terms/type> <http://purl.org/dc/terms/hasVersion> <http://dublincore.org/usage/terms/history/#typeT-001> .
<http://purl.org/dc/terms/type> <http://purl.org/dc/terms/issued> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/type> <http://purl.org/dc/terms/modified> "2008-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.org/dc/terms/type> <http://www.w3.org/2000/01/rdf-schema#comment> "The nature or genre of the resource."@en .
<http://purl.org/dc/terms/type> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/dc/terms/> .
<http://purl.org/dc/terms/type> <http://www.w3.org/2000/01/rdf-schema#label> "Type"@en .
# 
<https://w3id.org/SKGO/phm#AssayKit> <http://purl.org/dc/elements/1.1/description> "The title of the kit/biologicals used in the assay."@en .
<https://w3id.org/SKGO/phm#AssayKit> <http://www.w3.org/2000/01/rdf-schema#label> "AssayKit"@en .
<https://w3id.org/SKGO/phm#AssayKit> <http://www.w3.org/2004/02/skos/core#definition> "The title of the kit/biologicals used in the assay."@en .
# 
<https://w3id.org/SKGO/phm#AssayMethod> <http://purl.org/dc/elements/1.1/description> "The methods required to perform typical screening assay. Assay methods include laboratory methods."@en .
<https://w3id.org/SKGO/phm#AssayMethod> <http://www.w3.org/2000/01/rdf-schema#label> "AssayMethod"@en .
<https://w3id.org/SKGO/phm#AssayMethod> <http://www.w3.org/2004/02/skos/core#definition> "The methods required to perform typical screening assay. Assay methods include laboratory methods."@en .
# 
<https://w3id.org/SKGO/phm#EasternBlotting> <http://purl.org/dc/elements/1.1/description> "The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates."@en .
<https://w3id.org/SKGO/phm#EasternBlotting> <http://www.w3.org/2000/01/rdf-schema#comment> "The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates."@en .
<https://w3id.org/SKGO/phm#EasternBlotting> <http://www.w3.org/2000/01/rdf-schema#label> "EasternBlotting"@en .
<https://w3id.org/SKGO/phm#EasternBlotting> <http://www.w3.org/2004/02/skos/core#definition> "The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates."@en .
# 
<https://w3id.org/SKGO/phm#ExperimentalStudy> <http://purl.org/dc/elements/1.1/description> "Any Study conducted with a scientific approach, where a set of variables are kept constant while the other set of variables are being measured as the subject of experiment"@en .
<https://w3id.org/SKGO/phm#ExperimentalStudy> <http://www.w3.org/2000/01/rdf-schema#label> "ExperimentalStudy"@en .
<https://w3id.org/SKGO/phm#ExperimentalStudy> <http://www.w3.org/2004/02/skos/core#definition> "Any Study conducted with a scientific approach, where a set of variables are kept constant while the other set of variables are being measured as the subject of experiment"@en .
# 
<https://w3id.org/SKGO/phm#ObservationalStudy> <http://purl.org/dc/elements/1.1/description> "Observational studies are ones where researchers observe the effect of a risk factor, diagnostic test, treatment or other intervention without trying to change who is or isn't exposed to it."@en .
<https://w3id.org/SKGO/phm#ObservationalStudy> <http://www.w3.org/2000/01/rdf-schema#comment> "Observational studies are ones where researchers observe the effect of a risk factor, diagnostic test, treatment or other intervention without trying to change who is or isn't exposed to it."@en .
<https://w3id.org/SKGO/phm#ObservationalStudy> <http://www.w3.org/2000/01/rdf-schema#label> "ObservationalStudy"@en .
<https://w3id.org/SKGO/phm#ObservationalStudy> <http://www.w3.org/2004/02/skos/core#definition> "Observational studies are ones where researchers observe the effect of a risk factor, diagnostic test, treatment or other intervention without trying to change who is or isn't exposed to it."@en .
# 
<https://w3id.org/SKGO/phm#StatisticalAnalysis> <http://purl.org/dc/elements/1.1/description> "Statistical methods involved in carrying out a study include planning, designing, collecting data, analysing, drawing meaningful interpretation and reporting of the research findings."@en .
<https://w3id.org/SKGO/phm#StatisticalAnalysis> <http://www.w3.org/2000/01/rdf-schema#comment> "Statistical methods involved in carrying out a study include planning, designing, collecting data, analysing, drawing meaningful interpretation and reporting of the research findings."@en .
<https://w3id.org/SKGO/phm#StatisticalAnalysis> <http://www.w3.org/2000/01/rdf-schema#label> "StatisticalAnalysis"@en .
<https://w3id.org/SKGO/phm#StatisticalAnalysis> <http://www.w3.org/2004/02/skos/core#definition> "Statistical methods involved in carrying out a study include planning, designing, collecting data, analysing, drawing meaningful interpretation and reporting of the research findings."@en .
# 
<https://w3id.org/SKGO/phm#Study> <http://purl.org/dc/elements/1.1/description> "A detailed investigation and analysis of a subject or situation."@en .
<https://w3id.org/SKGO/phm#Study> <http://www.w3.org/2000/01/rdf-schema#label> "Study"@en .
<https://w3id.org/SKGO/phm#Study> <http://www.w3.org/2004/02/skos/core#definition> "A detailed investigation and analysis of a subject or situation."@en .
# 
<https://w3id.org/SKGO/phm#ex_vivo> <http://purl.org/dc/elements/1.1/description> "Outside the living body; denoting removal of an organ (e.g., the kidney) for reparative surgery, after which it is returned to the original site."@en .
<https://w3id.org/SKGO/phm#ex_vivo> <http://www.w3.org/2000/01/rdf-schema#label> "ex_vivo"@en .
<https://w3id.org/SKGO/phm#ex_vivo> <http://www.w3.org/2004/02/skos/core#definition> "Outside the living body; denoting removal of an organ (e.g., the kidney) for reparative surgery, after which it is returned to the original site."@en .
# 
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://purl.org/dc/elements/1.1/description> "Methods used in Assay."@en .
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://www.w3.org/2000/01/rdf-schema#comment> "Methods used in Assay."@en .
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://www.w3.org/2000/01/rdf-schema#label> "hasAssayMethod"@en .
<https://w3id.org/SKGO/phm#hasAssayMethod> <http://www.w3.org/2004/02/skos/core#definition> "Methods used in Assay."@en .
# 
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://purl.org/dc/elements/1.1/description> "The ability of a drug or treatment to produce a specific result."@en .
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://www.w3.org/2000/01/rdf-schema#label> "hasDrugEffects"@en .
<https://w3id.org/SKGO/phm#hasDrugEffects> <http://www.w3.org/2004/02/skos/core#definition> "The ability of a drug or treatment to produce a specific result."@en .
# 
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://purl.org/dc/elements/1.1/description> "Eligibility criteria for treatment studies often require that patients have a particular type and stage of disease."@en .
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://www.w3.org/2000/01/rdf-schema#label> "hasEligibilityCriteria"@en .
<https://w3id.org/SKGO/phm#hasEligibilityCriteria> <http://www.w3.org/2004/02/skos/core#definition> "Eligibility criteria for treatment studies often require that patients have a particular type and stage of disease."@en .
# 
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://purl.org/dc/elements/1.1/description> "Identification of Experimental results that are the set of facts and conclusions."@en .
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://www.w3.org/2000/01/rdf-schema#label> "hasExperimentalResult"@en .
<https://w3id.org/SKGO/phm#hasExperimentalResult> <http://www.w3.org/2004/02/skos/core#definition> "Identification of Experimental results that are the set of facts and conclusions."@en .
# 
<https://w3id.org/SKGO/phm#hasFindings> <http://purl.org/dc/elements/1.1/description> "A conclusion reached after examination or investigation."@en .
<https://w3id.org/SKGO/phm#hasFindings> <http://www.w3.org/2000/01/rdf-schema#label> "hasFindings"@en .
<https://w3id.org/SKGO/phm#hasFindings> <http://www.w3.org/2004/02/skos/core#definition> "A conclusion reached after examination or investigation."@en .
# 
<https://w3id.org/SKGO/phm#hasMutationResult> <http://purl.org/dc/elements/1.1/description> "The result of an alteration or change, as in nature, form, or quality."@en .
<https://w3id.org/SKGO/phm#hasMutationResult> <http://www.w3.org/2000/01/rdf-schema#label> "hasMutationResult"@en .
<https://w3id.org/SKGO/phm#hasMutationResult> <http://www.w3.org/2004/02/skos/core#definition> "The result of an alteration or change, as in nature, form, or quality."@en .
# 
<https://w3id.org/SKGO/phm#hasSuggestion> <http://purl.org/dc/elements/1.1/description> "An idea is induced in or adopted by another without argument, command, or coercion."@en .
<https://w3id.org/SKGO/phm#hasSuggestion> <http://www.w3.org/2000/01/rdf-schema#label> "hasSuggestion"@en .
<https://w3id.org/SKGO/phm#hasSuggestion> <http://www.w3.org/2004/02/skos/core#definition> "An idea is induced in or adopted by another without argument, command, or coercion."@en .
# 
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://purl.org/dc/elements/1.1/description> "A determination of the tissue place of proteins, genes."@en .
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://www.w3.org/2000/01/rdf-schema#label> "hasTissueLocalization"@en .
<https://w3id.org/SKGO/phm#hasTissueLocalization> <http://www.w3.org/2004/02/skos/core#definition> "A determination of the tissue place of proteins, genes."@en .
# 
<https://w3id.org/SKGO/phm#in_silico> <http://purl.org/dc/elements/1.1/description> "The mimicking or modeling of biological processes within computer hardware and software."@en .
<https://w3id.org/SKGO/phm#in_silico> <http://www.w3.org/2000/01/rdf-schema#label> "in_silico"@en .
<https://w3id.org/SKGO/phm#in_silico> <http://www.w3.org/2004/02/skos/core#definition> "The mimicking or modeling of biological processes within computer hardware and software."@en .
# 
<https://w3id.org/SKGO/phm#in_vitro> <http://purl.org/dc/elements/1.1/description> "In an artificial environment, referring to a process or reaction occurring therein, as in a test tube or culture media."@en .
<https://w3id.org/SKGO/phm#in_vitro> <http://www.w3.org/2000/01/rdf-schema#label> "in_vitro"@en .
<https://w3id.org/SKGO/phm#in_vitro> <http://www.w3.org/2004/02/skos/core#definition> "In an artificial environment, referring to a process or reaction occurring therein, as in a test tube or culture media."@en .
# 
<https://w3id.org/SKGO/phm#in_vivo> <http://purl.org/dc/elements/1.1/description> "Biological processes or experiments occurring in the living organism."@en .
<https://w3id.org/SKGO/phm#in_vivo> <http://www.w3.org/2000/01/rdf-schema#label> "in_vivo"@en .
<https://w3id.org/SKGO/phm#in_vivo> <http://www.w3.org/2004/02/skos/core#definition> "Biological processes or experiments occurring in the living organism."@en .
# 
<https://w3id.org/SKGO/phm#useCellLine> <http://purl.org/dc/elements/1.1/description> "Cell Lines  that are used as material in experimental study."@en .
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/2000/01/rdf-schema#label> "useCellLine"@en .
<https://w3id.org/SKGO/phm#useCellLine> <http://www.w3.org/2004/02/skos/core#definition> "Cell Lines  that are used as material in experimental study."@en .
# 
<https://w3id.org/SKGO/phm#useDrug> <http://purl.org/dc/elements/1.1/description> "Drugs that are used as material in experimental study."@en .
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/2000/01/rdf-schema#label> "useDrug"@en .
<https://w3id.org/SKGO/phm#useDrug> <http://www.w3.org/2004/02/skos/core#definition> "Drugs that are used as material in experimental study."@en .
# 
<https://w3id.org/SKGO/phm#useGene> <http://purl.org/dc/elements/1.1/description> "Genes that are used as material in experimental study."@en .
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/2000/01/rdf-schema#label> "useGene"@en .
<https://w3id.org/SKGO/phm#useGene> <http://www.w3.org/2004/02/skos/core#definition> "Genes that are used as material in experimental study."@en .
# 
<https://w3id.org/SKGO/phm#useProbe> <http://purl.org/dc/elements/1.1/description> "Probes that are used as material in experimental study."@en .
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/2000/01/rdf-schema#label> "useProbe"@en .
<https://w3id.org/SKGO/phm#useProbe> <http://www.w3.org/2004/02/skos/core#definition> "Probes that are used as material in experimental study."@en .
# 
<https://w3id.org/SKGO/phm#useReagent> <http://purl.org/dc/elements/1.1/description> "Reagents that are used as material in experimental study."@en .
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/2000/01/rdf-schema#label> "useReagent"@en .
<https://w3id.org/SKGO/phm#useReagent> <http://www.w3.org/2004/02/skos/core#definition> "Reagents that are used as material in experimental study."@en .
# 
<https://w3id.org/SKGO/phm#useSpecimen> <http://purl.org/dc/elements/1.1/description> "Specimen that are used as material in experimental study."@en .
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/2000/01/rdf-schema#label> "useSpecimen"@en .
<https://w3id.org/SKGO/phm#useSpecimen> <http://www.w3.org/2004/02/skos/core#definition> "Specimen that are used as material in experimental study."@en .
# 
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://purl.org/dc/elements/1.1/description> "Study uses statistical analysis involves collecting and scrutinizing every data sample in a set of items from which samples can be drawn."@en .
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/2000/01/rdf-schema#label> "useStatisticalAnalysis"@en .
<https://w3id.org/SKGO/phm#useStatisticalAnalysis> <http://www.w3.org/2004/02/skos/core#definition> "Study uses statistical analysis involves collecting and scrutinizing every data sample in a set of items from which samples can be drawn."@en .
# 
# 
# 
# #################################################################
# #
# #    General axioms
# #
# #################################################################
# 
# 
_:genid47 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#AllDisjointClasses> .
_:genid47 <http://www.w3.org/2002/07/owl#members> _:genid66 .
_:genid66 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid66 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#AssayKit> .
_:genid66 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid65 .
_:genid65 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid65 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#AssayMethod> .
_:genid65 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid64 .
_:genid64 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid64 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#CellLine> .
_:genid64 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid63 .
_:genid63 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid63 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Chemical> .
_:genid63 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid62 .
_:genid62 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid62 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Drug> .
_:genid62 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid61 .
_:genid61 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid61 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#EasternBlotting> .
_:genid61 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid60 .
_:genid60 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid60 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ExperimentalStudy> .
_:genid60 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid59 .
_:genid59 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid59 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Gene> .
_:genid59 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid58 .
_:genid58 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid58 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#NorthernBlotting> .
_:genid58 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid57 .
_:genid57 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid57 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ObservationalStudy> .
_:genid57 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid56 .
_:genid56 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid56 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Probe> .
_:genid56 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid55 .
_:genid55 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid55 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#Reagent> .
_:genid55 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid54 .
_:genid54 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid54 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ReviewStudy> .
_:genid54 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid53 .
_:genid53 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid53 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#SouthernBlotting> .
_:genid53 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid52 .
_:genid52 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid52 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#WesternBlotting> .
_:genid52 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid51 .
_:genid51 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid51 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#ex_vivo> .
_:genid51 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid50 .
_:genid50 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid50 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#in_silico> .
_:genid50 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid49 .
_:genid49 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid49 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#in_vitro> .
_:genid49 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> _:genid48 .
_:genid48 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#List> .
_:genid48 <http://www.w3.org/1999/02/22-rdf-syntax-ns#first> <https://w3id.org/SKGO/phm#in_vivo> .
_:genid48 <http://www.w3.org/1999/02/22-rdf-syntax-ns#rest> <http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
# 
# Generated by the OWL API (version 5.1.9) https://github.com/owlcs/owlapi/
